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ABSTRACT 
Nature has given nucleic acids irreplaceable roles for all living creatures. It plays 
important roles in genetic information storage and transfer, as well as regulating various aspects 
of biology. The discovery of in vitro evolved functional nucleic acids opens a new field for 
nucleic acid chemistry and applications. The first in vitro isolated functional nucleic acid was 
discovered in 1990 through a process known as SELEX, systematic evolution of ligands by 
exponential enrichment.  These isolated nucleic acids molecules are termed aptamer, which from 
the Latin word “aptus” – fit, and they possess ligand binding activity. In 1994, another class of 
functional nucleic acids, catalytic DNA (DNAzyme) has been isolated using a similar in vitro 
technique (in vitro selection) to catalyze the cleavage of a phosphodiester bond.  Similar in 
principle, both SELEX and in vitro selection are combinatorial chemistry technique that enables 
the isolation of nucleic acid sequences with particular functions from an astronomical number of 
random sequences via iterative cycles of selection, separation and amplification.  After the initial 
discovery of aptamers and DNAzymes, many more functional nucleic acids have been isolated 
for binding a wide variety of ligands and catalyzing a number of chemical transformations. The 
unique properties of nucleic acids have made functional nucleic acids suitable for wide range of 
applications, such as biosensing, drug targeting and therapeutics. Functional DNAs, due to their 
high stability compared to RNAs, are favored in many in vitro applications.  
 Aptamers have been used widely in sensing applications. In theory, aptamer can be 
isolated for any ligands. However, in practice, aptamers for small and negatively charged anion 
are rarely isolated. To demonstrate possibility of isolating aptamer for such ligands, the first 
project aims to isolate an aptamer for a perchlorate anion (ClO4
-
).  In addition, perchlorate is also 
a ubiquitous environmental contaminant. Current detection methods for perchlorate are 
cumbersome and not suitable for routine environmental monitoring. Isolating an aptamer for 
perchlorate can facilitate the development of aptamer based biosensor for more convenient 
environmental monitoring of perchlorate.  A SELEX experiment has been carried out for isolating 
aptamers for perchlorate. Although a potential binder for perchlorate has been obtained, its 
affinity appeared to be weak. Future modifications or re-selection will be needed to improve the 
affinity of the aptamer. A SELEX based on the same experiment design has been carried out to 
isolate aptamers for melamine, which has become a threat in food safety in the U.S. and China. 
Two aptamers have been isolated and characterized with high affinity and selectivity. A biosensor 
based on personal glucose is under development using one of the aptamers, R29C33, for 
convenient detection of melamine.  
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Ribozyme has been discovered for decades. However, due to the lack of 2ꞌ-OH group, 
DNA has once considered incapable of catalyzing any chemical reactions. With the isolation of 
DNAzyme, researchers have demonstrated that DNA possesses the same catalytic power that 
ribozyme and protein enzyme have. Although, DNAzymes have been isolated for catalyzing 
various types of reaction, its catalytic mechanism remains a mystery. Currently, one piece of the 
important information to solve the mystery is still missing, which is the three-dimensional 
structure for a DNAzyme in the active conformation. An immense effort has been spent on 
obtaining diffraction quality crystals for DNAzymes. Among all the DNAzymes attempted, 
including the 17E DNAzyme (an 8-17 variant), 39E DNAzyme and the GR-5 DNAzymes, only 
crystals for the 17E DNAzyme have been obtained. The best crystal diffracted to 7 Å but the 
quality of the crystal was not suitable for data collection. Future direction will be focused on 
getting better quality crystals for data collection.  
One of goals for isolating and characterizing functional DNAs is to make them more 
suitable for various applications. The 17E DNAzyme has been demonstrated in numerous 
literatures for the detection of Pb
2+
 due to the higher selectivity for the metal ion. However, in 
real world application, the 17E DNAzyme based sensor still suffers from interference due to its 
cross reactivity with other common metal ions at high concentrations. Interestingly, the first 
DNAzyme selected decades ago was using Pb
2+
 as the metal cofactor (we named the DNAzyme 
GR-5, since it was not named from the original study). Initial biochemical studies have 
demonstrated excellent selectivity when compared to the 17E DNAzyme. In this case, no other 
metal ions tests have comparable activity with Pb
2+
, even at much higher concentration (e.g., 
millimolar concentration). Based on the GR-5 DNAzyme, a much more selective and slightly 
more sensitive sensor for Pb
2+
 has been developed. 
  
  
iv 
 
 
 
 
 
 
 
 
 
To my father, mother and grandmother, my wife and new born Emma 
Without you, I would either not exist or my existence will be greatly 
devalued 
  
v 
 
ACKNOWLEDGEMENTS 
It will not be possible to carry out the research described in the following chapters 
without the continuous support, guidance, and encouragement from my advisor, Professor Yi Lu. 
I would also like to thank my qualification examination committee members, Professor Wilfred 
van der Donk, Professor Susan Martinis and Professor John Gerlt. They have critically questioned 
the projects that I’ve working on and prompted me to revise my research direction. I would like to 
thank my thesis committee, Professor Scott Silverman, Professor Susan Martinis and Professor 
Satish Nair, for their helpful suggestions during my six months meeting. Specially, Professor 
Scott Silverman has provided insightful conversations with regarding to the selection projects.  
All Lu lab members have just made the research even more exciting. First, I would like to 
thank Dr. Juewen Liu and Dr. Debapriya Mazumdar who provided close guidance when I just 
joined the lab. With Dr. Nandini Nagraj and Ms. Hannah Ihms, our little cubical has become the 
most interesting spot in the lab, as we chat about research and non-research related topics. Dr. 
Weichen Xu, Brian Wong and Dr. Geng Lu have been a great source of entertainment and fun 
when time is slow to pass.  I want to thank the whole DNA and Beckman subgroup as they are 
providing enormous assistance in the crystallization, especially Dr. Marjorie Cepeda Plaza who 
later helps me to manage the daily activity of the crystallization project. Mr. Yigui Gao and 
Elizabeth Gao have been providing constant help during the project. The progress we obtained 
will be impossible without them. Last, Kimberly Furuya, she assisted me in collecting the data for 
the development of GR-5 DNAzyme based sensor for Pb
2+
 detection.  
Finally, I would like to thank my parents, who have provided numerous supports during 
and before my Ph.D career. They’ve given me the courage and strength when the challenge seems 
insurmountable. My wife and now my daughter are giving me all the joy and fun.  
  
vi 
 
Table of Contents 
1 Chapter One: From Nucleic Acids to Functional Nucleic Acids................................. 1 
1.1 Nucleic Acids ...................................................................................................... 1 
1.2 Functional Nucleic Acids .................................................................................... 2 
1.3 Isolation of Functional Nucleic Acids ................................................................. 4 
1.3.1 Systematic Evolution of Ligands by EXponential enrichment (SELEX)....... 4 
1.3.2 In vitro Selection of DNAzymes .................................................................... 9 
1.4 Application of Aptamers and DNAzymes ......................................................... 14 
1.4.1 Functional DNA Based Biosensors .............................................................. 14 
1.4.2 Pharmaceutical Applications ........................................................................ 18 
1.5 Focus of the thesis study .................................................................................... 19 
1.6 Reference ........................................................................................................... 21 
2 Chapter Two: in vitro selection of a DNA aptamer for perchlorate .......................... 37 
2.1 Introduction ....................................................................................................... 37 
2.1.1 Source of perchlorate contamination and biological effects ......................... 37 
2.1.2 Current methods for perchlorate detection in water: pros and cons ............. 37 
2.1.3 Using aptamers as targeting agents; SELEX ................................................ 38 
2.1.4 Expanding the range of targets for SELEX .................................................. 38 
2.2 Materials and Methods ...................................................................................... 39 
2.2.1 Materials ....................................................................................................... 39 
2.2.2 Random pool design ..................................................................................... 39 
2.2.3 PCR cycling parameter optimization using RT-PCR ................................... 39 
2.2.4 BDNA optimization by liquid scintillation counting (LSC)......................... 40 
2.2.5 BDNA optimization by fluorophore labeled DNA template ........................ 40 
2.2.6 Column format binding ................................................................................ 41 
2.2.7 In vitro selection of an ATP binding aptamer .............................................. 41 
vii 
 
2.2.8 In vitro selection of a perchlorate aptamer ................................................... 42 
2.2.9 Cloning and sequencing ............................................................................... 42 
2.2.10 Activity assay ............................................................................................. 43 
2.2.11 Design of the degenerate pool for re-selection ........................................... 43 
2.3 Results and Discussion ...................................................................................... 43 
2.3.1 Random pool design ..................................................................................... 43 
2.3.2 PCR cycling parameter optimization ............................................................ 45 
2.3.3 Optimization of BDNA length ..................................................................... 46 
2.3.4 ATP control selection ................................................................................... 50 
2.3.5 Perchlorate selection ..................................................................................... 51 
2.3.6 Cloning and analysis..................................................................................... 52 
2.3.7 Re-selection with a degenerate pool based on duplicate I ............................ 54 
2.4 Conclusions ....................................................................................................... 54 
2.5 Reference ........................................................................................................... 55 
3 Chapter Three: In vitro selection of a DNA aptamer for melamine .......................... 60 
3.1 Introduction ....................................................................................................... 60 
3.1.1 Melamine contamination found in food ....................................................... 60 
3.2 Materials and methods ....................................................................................... 61 
3.2.1 Materials ....................................................................................................... 61 
3.2.2 Methods ........................................................................................................ 61 
3.3 Results and discussion ....................................................................................... 69 
3.3.1 Isolation of a melamine binding aptamer ..................................................... 69 
3.3.2 Isolation of melamine aptamers after re-selection ........................................ 75 
3.3.3 Sensor development...................................................................................... 80 
3.4 Conclusions ....................................................................................................... 82 
3.5 Future directions ................................................................................................ 83 
viii 
 
3.5.1 Confirm the affinity and calculate the (apparent) Kd forR29C33 ................. 83 
3.5.2 Development of a melamine sensor based on the personal glucose meter ... 83 
3.6 Reference ........................................................................................................... 85 
4 Chapter Four: Crystallization attempts for DNAzymes ............................................ 89 
4.1 Introduction ....................................................................................................... 89 
4.1.1 8-17, 39E and GR-5 DNAzymes .................................................................. 89 
4.1.2 3D structure information of DNAzymes ...................................................... 90 
4.1.3 Crystallization of 17E and 39E DNAzymes ................................................. 90 
4.2 Material and Methods ........................................................................................ 91 
4.2.1 Materials ....................................................................................................... 91 
4.2.2 Sequences for crystallization of 17E DNAzyme .......................................... 91 
4.2.3 Sequences for crystallization of 39E DNAzyme .......................................... 92 
4.2.4 Denature and annealing of DNA .................................................................. 92 
4.2.5 The hanging drop method ............................................................................. 92 
4.2.6 Activity assay ............................................................................................... 93 
4.2.7 Buffer conditions .......................................................................................... 93 
4.2.8 Co-crystallization with Hoechst 33258 ........................................................ 96 
4.2.9 Matrix screen ................................................................................................ 96 
4.2.10 Co-crystallization of 17E DNAzyme with avidin and lysozyme ............. 100 
4.2.11 X-ray diffraction ....................................................................................... 103 
4.3 Result and discussion ...................................................................................... 103 
4.3.1 Predicted secondary structures ................................................................... 103 
4.3.2 Activity assays ............................................................................................ 106 
4.3.3 Buffer conditions ........................................................................................ 109 
4.3.4 Crystallization trials with the matrix screen ............................................... 109 
4.4 Conclusion ....................................................................................................... 112 
ix 
 
4.5 Future direction ............................................................................................... 113 
4.5.1 Matrix screen approach for GJ leadzyme and 39E DNAzyme ................... 113 
4.5.2 Crystallization using molecularly imprinted polymer ................................ 114 
4.6 References ....................................................................................................... 115 
5 Chapter Five: Development of a new fluorescence sensor for Pb2+ ........................ 118 
5.1 Introduction ..................................................................................................... 118 
5.1.1 From basic research to application ............................................................. 118 
5.1.2 Pb2+ as an environment contaminant and DNAzyme based biosensor ....... 118 
5.1.3 GR-5 DNAzyme ......................................................................................... 120 
5.2 Materials and methods ..................................................................................... 120 
5.2.1 Materials ..................................................................................................... 120 
5.2.2 Methods ...................................................................................................... 120 
5.3 Result and discussion ...................................................................................... 122 
5.3.1 GR-5 DNAzyme has excellent selectivity for Pb2+ .................................... 122 
5.3.2 GR-5 catalytic beacon is an excellent sensor for Pb2+ detection ................. 123 
5.4 Conclusions ..................................................................................................... 128 
5.5 Acknowledgement ........................................................................................... 129 
5.6 Reference ......................................................................................................... 130 
 
 1 
 
1 Chapter One: From Nucleic Acids to Functional Nucleic Acids 
1.1 Nucleic Acids 
In any organism, nucleic acids are responsible for storage, transmission, and expression 
of genetic information. The storage and transmission of genes are achieved by DNA while gene 
expression is mediated by RNA. Nucleic acids are composed of five basic bases: adenine (A), 
thymine (T), cytosine (C), guanine (G) and uracil (U). Uracil and thymine share very similar 
chemical structure, but U is found in RNA and T in DNA (Figure 1.1). The bases are linked to the 
C1' of a D-ribose to form different nucleosides; nucleosides with a 5'-phosphate are referred to as 
a nucleoside-5'-phosphate, or nucleotides. A sequence of DNA or RNA is made up of long 
polymer of different nucleotides linked with phosphodiester bonds between each nucleotide. In a 
cellular environment, DNA usually adopts a rigid double-stranded helical structure. In 
comparison, RNA is often in single-stranded form and it is able to form more complex 
structures.11  
 
 
Figure 1.1 Chemical structures of nucleotides 
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1.2 Functional Nucleic Acids 
As part of the central dogma of biology, genetic information is stored in DNA. The stored 
genetic information is transcribed to messenger RNA, which is translated into protein for specific 
biological function.15 Discovery of retroviruses indicate information stored in RNA can be 
integrated back into the genomic DNA, amending the central dogma.11 Later, discovery of 
various ribozymes added another exception to the central dogma that RNA is not merely a 
messenger between DNA and protein, itself can also have catalytic functions.40 Further studies on 
various RNAs and proteins revealed that some of the most important biological processes are 
catalyzed by RNA, such as formation of peptide bond in the ribosome43 and splicing of 
messenger RNA.40,46 The story becomes even more complicated with the discovery of 
riboswitches in bacteria and plant; where RNA sequences were shown to be capable of 
controlling gene expression in response to the presence of metabolites.49-52 Observation of 
ribozymes and riboswitches in the natural system shows RNA, and nucleic acids in general, are 
can have functions in addition to genetic material storage and transfer. 
Such novel functions of nucleic acids were first demonstrated by a series of studies that 
led to the discovery of non-natural functional nucleic acids. In 1990, RNA aptamers (molecules 
capable of selective binding to a ligand) were isolated in vitro by a combinatorial process called 
Systematic Evolution of Ligand by EXponential enrichment (SELEX). Two groups 
independently isolated RNA aptamers binding to T4 polymerase and organic dyes.62,63 Shortly 
after, in 1992, Beaudry and Joyce applied the in vitro evolution procedure to a Tetrahymena 
ribozyme and isolated a DNA cleaving ribozyme.64 In the same year, DNA aptamers binding to 
organic dyes were isolated by Ellington and Szostak.66 These were the same organic dyes which 
the first aptamers had been isolated for in 1990.62 Also in 1992, DNA aptamers for thrombin have 
been isolated and shown to inhibit its enzymatic activity.67 The isolation of both DNA and RNA 
aptamers for the same molecules indicated that they are equally capable to perform the function. 
In 1994, DNA that is capable of catalyzing phosphodiester bond was isolated by Breaker and 
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Joyce, and they are termed deoxyribozymes, or DNAzymes.3 At this stage, both DNA and RNA 
have been demonstrated to perform catalysis and ligand binding activities. Hence, the term 
functional nucleic acids refer to the collective whole of DNA/RNA aptamer, ribozyme, and 
deoxyribozyme. 
After the initial discovery, functional nucleic acids have been isolated to bind to many 
targets and catalyze various types of reactions (Table 1.1). Catalytic RNAs and DNAs have been 
isolated to carry various transformations on nucleic acid substrates, as well as other reactions with 
non-nucleic-acid substrates, such as alcohol reduction and C-C bond formation. Aptamers to a 
wide range of ligands have also been isolated, ranging from metal ions to small organic molecules, 
to enzyme cofactors and proteins. Compared to protein enzymes and antibodies, nucleic acids are 
cheaper and easier to chemically synthesize and modified, more stable in aqueous solution, hence 
functional nucleic acids become to have very versatile applications in the field of sensing,74 
therapeutic,38,75-82 logic gate construction83-86 and nanomachines.88  
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1.3 Isolation of Functional Nucleic Acids 
1.3.1 Systematic Evolution of Ligands by EXponential enrichment (SELEX) 
Although possessing a similar function as antibodies, aptamers can be isolated in a test 
tube from a library of random sequences using a combinatorial technique called Systematic 
Evolution of Ligands by EXponential enrichment, or SELEX. The method was first demonstrated 
in 1990 by two different groups for isolating RNA aptamers binding to T4 DNA polymerase and 
organic dyes.62,63 A SELEX experiment consists of iterative cycles of in vitro selection and 
amplification that mimics a Darwinian process. The outcome of a SELEX experiment is a few 
DNA or RNA motifs that are optimized for solving a particular problem, such as selective 
Catalytic DNA or RNA Metal cofactor Aptamer-Ligands Affinity  
RNA cleavage 3-10                                   
 
Pb2+, Mg2+, Zn2+, 
Ca2+, Mn2+, Mg2+, 
UO22+ 
Zn2+12 
Ethanolamine16 
1.2 mM 
6-19 nM 
DNA cleavage 17-22 Cu2+, Zn2+, Mn2+ Theophylline42 100 nM 
Phosphoramidate bond cleavage 44 Mg2+ Malachite green45 1 µM 
DNA ligation 47,48 Cu2+, Zn2+, Mn2+ Ricin toxin53 58-105 nM 
RNA ligation 54-61 Zn2+, Mg2+, Mn2+ Dopamine65 2.8 µM 
Nucleopeptide linkage formation 68 Mn2+ or Mg2+ L-Arginine69 330 nM 
DNA phosphorylation 70 Mn2+ Adenosine/ATP71,72 0.7-11 µM 
DNA capping 73 Mg2+, Cu2+ Cyanocobalamin87 88 nM 
DNA depurination 89,90 
Redox reaction91,92 
Ca2+ 
Zn2+/NADH 
S-adenosyl 
homocysteine93 
100 nM 
Diels-Alder reaction 94,95 Ca2+ Tobramycin96 2-3 nM 
Porphyrin metallation 98,99 Cu2+ or Zn2+ VEGF100,101 0.05-2 nM 
Table 1.1 A survey of representative functional nucleic acids isolated to date.  
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binding to a ligand of choice.97 The starting point of a SELEX experiment is a random pool of 
oligonucleotides that composed of 1013 - 1015 individual sequences (Figure 1.2). Generally, the 
random pool contains a stretch of randomized sequence with a length from several to more than 
100 nucleotides. The random region is flanked by primer binding sites used for polymerase chain 
reaction. The starting pool can be either a DNA or RNA library. In a RNA aptamer selection, 
initial pool is generated by transcription from the DNA template. The large pool of random 
sequences is directly incubated with the target of interest. The tightly bound sequences are 
separated from the weakly bound ones. These tightly bound sequences are eluted and amplified 
by PCR (for DNA) or RT-PCR (for RNA). The double-stranded PCR products are treated to 
generate the relevant single-stranded DNA or in vitro transcribed into ssRNA. These sequences 
are again exposed to the target of interest commencing the next round of selection. After 
subsequent rounds of selection, separation and amplification, the initial enormous amount of 
sequences is reduced to a much smaller pool of active ones that possess high affinity and 
selectivity for the target. This active pool is cloned and sequenced to identify the aptamers. The 
aptamer identified through SELEX is able to fold into stable three-dimensional structure and 
create a high affinity ligand binding site selectively for the target of interest.  
 
 
Figure 1.2 General schemes for DNA aptamer SELEX 
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Since SELEX is an in vitro method, the outcome of an experiment can be influenced by a 
wide range of parameters.102 For example, selectivity can be enhanced by negative selection, 
which introduces possible interfering molecules and removes sequences that interact with 
them.69,103-105 Binding affinity can be increased by applying more stringent conditions in later 
rounds of selection, such as reducing target concentration or changing the binding and washing 
conditions.106 In addition, the target ligand itself can affect the success of a SELEX experiment. 
In theory, aptamer can be isolated for virtually any target, but practically, it is difficult to isolate 
aptamers to bind to targets that are negatively charged, highly hydrophobic, and small.102,107-111 A 
large number of aptamers have been reported to bind to various targets, from complex structures, 
proteins, small molecules and metal ions.102 
1.3.1.1 Traditional and variations of SELEX methods 
The most critical step in SELEX is the separation of target binding sequences from the 
non-binders. The first and many following SELEX experiments were carried out with affinity 
chromatography using a target-derivatized column (agarose and sepharose column are commonly 
used).62,63,102 However, the target immobilization posts an important requirement for the choice of 
target molecule, which should contain functional groups for immobilization, such as amine, 
hydroxyl or thiol groups. A later experiment has demonstrated an alternative method (Figure 1.3), 
which is capable of selecting aptamer without target molecule immobilization via a structure-
switching approach. In this method, the DNA library is bridged to a column via a biotinylated 
bridging DNA while the incubating target is free in solution.112 Sequences that are capable of 
binding the target will be released from the column, collected and amplified. Although these 
SELEX approaches are versatile, the traditional column based separation methods are low 
throughput and requires large quantity of target.  
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Many variations of SELEX methods have been developed over the years to reduce the 
amount of material needed, increase throughput and speed.113 Using magnetic beads allows a 
relative small amount of target to be efficiently immobilized. Operation with magnetic beads is 
more convenient comparing to use traditional columns.114 Other methods have also been 
developed for easier and better separation of binding and non-binding sequences, such as 
capillary electrophoresis,53,115-118 flow cytometry,119,120 electrophoretic mobility shift assay 
(EMSA),121,122 surface plasmon resonance,122 atomic force microscopy and centrifugation.123 
Although these approaches provide easier and better separation of the potential aptamers, one of 
the most desired attributes for SELEX development is parallel and high speed experiment carried 
out with minimal human intervention. 
To achieve high throughput and high speed isolation, the SELEX procedure will need to 
be automated. A station based on a modified pipetting robot has been developed in 1998 and 
 
Figure 1.3 Illustration of a structure-switching selection 
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demonstrated to carry out SELEX with improved throughput and speed.124 Later, in-line aptamer 
characterization was incorporated into the robotic station to enhance the functionality. Using this 
robotic station, aptamers against lysozyme, CYT-18, Rho and MEK 1 have been isolated with 
affinities comparable to aptamers isolated manually.124-127 Twelve rounds of eight parallel SELEX 
experiments can be completed in two days.124 Although this performance is 10-100 times better 
than using manual procedures, the automated SELEX can resulte in higher rate of failure or other 
artifacts due to the lack of manual quality controls.125 In a subsequently automated SELEX station 
constructed by Eulbert et al., procedures were introduced to control the quality of certain aspect 
of the SELEX cycle, such as the PCR amplification.128  Further advance has been made in 
automated SELEX by miniaturizing the station on a microfluidic assembly and controlled by 
Labview.129  
1.3.1.2 Scope of target molecules 
The complete list of aptamers isolated by in laboratories to date is hard to generate but 
the current list has already included a wide range of molecules, from metal ions to small 
molecules, to proteins and eventually to complex multicomponent systems, such as cell and 
bacterial spore.102  
Other than isolated in laboratory, aptamers are also found in living orgainsms for 
regulating gene expression.49,51,52,55,130,131 Riboswitches, usually found in the untranslated regions 
of messenger RNA, contains an aptamer domain and an expression platform.  They are found to 
be a rather common regulatory mechanism in bacteria and plants.49 The aptamer domain can bind 
to various small molecule metabolites, metal ions and induce a conformational change in the 
expression platform. Such conformational change can regulate the expression level of the 
downstream gene. RNA has also proven its versatile roles in biology through natural evolution.  
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1.3.2 In vitro Selection of DNAzymes 
Naturally existing RNA catalysts or ribozymes have evolved to play very important roles 
in biology.40,46 The existence of ribozyme hints that the structural similar DNA can serve as a 
catalyst. While a naturally occurring DNA catalyst is yet to be found, they have been isolated via 
in vitro selection, a similar process to SELEX. To date, a wide variety of DNAzymes have been 
isolated to carry out a range of chemical transformations with catalytic enhancement sometimes 
rivaling their protein partners.4,5 
In an in vitro selection, the random pool is usually designed to include the substrate 
(which is commonly oligonucleotide) and this random pool is subjected to iterative cycles of 
catalysis, separation and amplification, which can lead to a smaller pool of enzymes that possess 
enhanced catalytic activity. Separation criterion of the active sequences is based on the catalytic 
activity versus binding in SELEX. For example, in the in vitro selection of RNA-cleaving 
DNAzymes, active DNAzyme is capable of cleaving its substrate and generating a fragment with 
a shorter length. The cleaved product can be separated from the uncleaved ones using 
polyacrylamide gel electrophoresis (PAGE). In other case, affinity chromatography can be used 
by utilizing biotinylated DNA and streptavidin column.5 Similar to SELEX, the active sequences 
are collected and amplified by PCR. The purified PCR product will be used for the next round of 
selection (Figure 1.4).3  
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In 1994, the first DNAzyme was isolated by Gerald Joyce and Ronald Breaker to catalyze 
the cleavage of a phosphodiester bond at a specific location on a RNA substrate. The DNAzyme 
utilized a Pb2+ ion as the cofactor and it is highly selective for Pb2+.3,132 The DNAzyme had a 105 
rate enhancement over the uncatalyzed reaction.3 After the initial isolation, various RNA-cleaving 
DNAzymes have been isolated with different conditions. Among all RNA-cleaving DNAzymes, 
the 8-174,5,7,9,133-135 and the 10-234 DNAzymes have been the best characterized DNAzymes and 
have demonstrated for a wide variety of in vitro and in vivo applications.74,136-148 
1.3.2.1 Types of reactions catalyzed by DNAzymes 
Various types of reactions have been shown to be catalyzed by DNAzymes, including 
phosphodiester bond cleavage and formation,3-10,17-22,47,48,54-61 phosphoramidate bond cleavage,44 
nucleopeptide bond formation,68 DNA phosphorylation70 and adenylation,70 Diels-Alder 
reaction,94,95 redox reaction91,92 and porphyrin metallation (Table 1.2).98,99  It is worthy to note that 
recently, large number of isolated DNAzymes (and in vitro selected ribozymes) can carry out 
catalysis with non-oligonucleotide substrates.  
 
Figure 1.4 Illustration of an in vitro selection of DNAzyme 
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Catalytic DNA or RNA REF 
RNA cleavage  3-10                               
DNA cleavage  17-22 
Phosphoramidate bond cleavage  44 
DNA ligation  47,48 
RNA ligation  54-61 
Nucleopeptide linkage formation  68 
DNA phosphorylation  70 
DNA capping  73 
DNA depurination  
Redox reaction 
89,90 
91,92 
Diels-Alder reaction  94,95 
Porphyrin metallation  98,99 
Table 1.2 Reactions have shown to be catalyzed by in vitro selected DNAzymes and 
ribozymes 
1.3.2.2 Metal selectivity of DNAzymes 
Unlike the natural existing ribozymes, which often have looser requirement on divalent 
metal ions, many DNAzymes are isolated with divalent metal ion cofactors and dependent on 
these cofactors for the optimal activity. For example, different RNA-cleaving 8-17 DNAzymes 
have been isolated in the presence of a range of divalent metal ions and its activity is highly 
depending on these cofactors. Although initial selected in the presence of Mg2+,4 a relative broad 
range of divalent metal ions are capable of supporting the 8-17 DNAzyme catalysis, including but 
not limited to Pb2+, Zn2+, and Mn2+.133,149,150 Some DNAzymes have a very strict requirement for 
the metal cofactor, such as the GR-5 and the 39E DNAzyme.132,151,152 The GR-5 DNAzyme has a 
very high preference for Pb2+ and the 39E DNAzyme only show catalytic activity with UO22+. 
Due to such a high metal selectivity, DNAzyme has been widely used for metal ions sensing. 
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1.3.2.3 The 8-17 DNAzyme: biochemical and biophysical studies 
Among all the DNAzymes, the 8-17 DNAzyme is the best characterized DNAzyme. 
Since initial isolation in 1997 by Santoro and Breaker,4 many biochemical and biophysical studies 
have been carried with the 8-17 DNAzyme.36,112,113,128,129,132-145 First biochemical studies focused 
on extracting the reaction parameters, optimal reaction conditions and metal dependence of the 
DNAzyme. Later studies were more focused on the sequence requirements (including functional 
group requirements), local organization and global folding of the DNAzyme. The thorough 
investigation of on the 8-17 DNAzyme can shine some light on the catalytic mechanism of other 
RNA-cleaving DNAzymes in general.  
These early studies have provided insights into the catalytic mechanism of the 8-17 
DNAzyme.133,149,150 With a kobs ~ 1 min-1 at pH 6 using Pb2+ as the metal cofactor, the rate of the 
reaction has a linear relationship with increasing pH on a log scale. This observation suggested 
that a single deprotonation step during the catalysis is the rate limiting step. Metal dependence 
studies correlated the pKa’s of each metal cofactor to the kobs of the DNAzyme. The linear 
relation indicated a metal-assisted catalysis. The cleavage product was analyzed with mass-
spectrometry and the presence of 2′,3′-cyclic phosphate is consistent with a nucleophilic attack 
following a catalytic deprotonation of the 2′-hydroxyl at the cleavage site. Snapshots of the 
catalytic pathway can be deduced from the above observations. With the help from metal 
cofactors, the deprotonation of the 2′-hydroxyl of the RNA base at the cleavage site is followed 
by the nucleophilic attack on the scissile phosphate. The nucleophilic attack results in a penta-
coordinated intermediate. Collapse of the intermediate results in the formation of 2′,3′-cyclic 
phosphate and 5′-hydroxyl in the cleavage products. In the presence of Pb2+, the 2′,3′-cyclic 
phosphate is further hydrolyzed to form 2′ or 3′-phosphate as indicated by mass-spectrometry 
(Figure 1.5).  
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Later studies on the 8-17 DNAzyme involved many types of structural probing, including 
FRET,153-158 UV-crosslinking159-161 and circular dichroism (CD)156. All of the studies surprisingly 
arrive at one common conclusion: presence of Zn2+ or Mg2+ induced global structural 
rearrangement of the DNAzyme and the rearrangement can be correlated with activity; presence 
of Pb2+ has a minimal effect of the global rearrangement of the DNAzyme, yet Pb2+ can support 
the highest level of enzyme activity. These structural probing experiments have suggested that the 
DNAzyme uses two binding modes for different metal ion cofactors, “induced-fit model” for Zn2+ 
and Mg2+, and “lock-and-key” model for Pb2+.155,156,162  
Although much has been learnt from these studies, the high resolution 3D structure of 
any active DNAzyme remains unknown. The only reported crystal structure of DNAzymes is that 
of the 10-23 DNAzyme solved in 1999. Unfortunately, the conformation adopted by the 10-23 
DNAzyme in the crystal structure resembled a four-way junction, which does not agree with 
other biochemical studies.163,164 Obtaining a 3D structure of a DNAzyme in the active 
conformation remains a high priority in the field and will provide meaningful insight into the 
catalytic mechanism and the active site organization employed by these DNA catalysts.  
 
Figure 1.5 Proposed cleavage mechanisms for DNAzyme  
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1.4 Application of Aptamers and DNAzymes 
Having the advantages of chemical stability, easy synthesis, environmental benign and 
highly selective, aptamers and DNAzymes have been used in applications such as in vitro and in 
vivo diagnostic and environmental sensing, drug targeting, and therapeutics. Because functional 
DNAs can be isolated in vitro, and their properties can also be tailored in the selection process, 
they can be used in places when other affinity agents are not available. For example, antibodies 
cannot be raised due to the target is not immunogenic or highly toxic; or the rationally designed 
small molecules are unsatisfying.  
1.4.1 Functional DNA Based Biosensors 
1.4.1.1 Aptamer based sensors 
Isolated as affinity agents, aptamers possess high selectivity, which enables them to be 
excellent sensing molecules. The in vitro selected aptamers have high selectivity, which is often 
comparable to that of antibodies. They have also demonstrated high affinities for their target. 
Normally, aptamers have a micromolar Kd for small molecules and nano- or picomolar Kd for 
protein. Since aptamer can be isolated in vitro, it provides an alternative way of detecting 
molecules that is unable to detect by immunoassays or rational-designed small molecule sensors.  
To construct a sensor, the binding event of the aptamer must be coupled with a 
mechanism to produce a corresponding signal. The signal transduction can be achieved by simply 
employing a fluorophore and quencher pair in the design of a molecular beacon sensor. In this 
aptamer beacon design (Figure 1.6), the stem of an aptamer (or hairpin is engineered into the 
aptamer by extension) is utilized. Fluorophore and quencher pairs are covalently attached to the 
two ends of the aptamer. In the absence of the target, the stem labeled with fluorophore and 
quencher cannot hybridize efficiently, resulting in a high fluorescence. In the presence of the 
target and binding, the hairpin structure is formed and the distance between the fluorophore and 
quencher is decreased, resulting in a low fluorescence state. The classical molecular beacon 
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approach has been demonstrated by Stojanovic et al. for the detection of cocaine.165 This 
molecular beacon design has been employed in a number of aptamer beacon sensors for thrombin,  
166, K+, and PDGF.167,168  
 
To achieve a more general design for aptamer sensors, Li and co-workers have employed 
a structure-switching method which utilizes the conformational change of aptamers from target-
free to target-bound state (Figure 1.7).112,169-171 In the design, a fluorophore labeled aptamer is 
hybridized to a short quencher labeled DNA strand in the absence of target. Binding of the 
aptamer to target triggers a conformational switch from the target-free state to a target-bound 
state, releases the short quencher labeled strand, result in higher fluorescence. The release of the 
complementary DNA is dependent on it length, hence the length is optimized for highest 
fluorescence enhancement. The structure-switching method has become a popular way of 
designing aptamer sensors due to its simplicity and broad applicability.172-174 
 
Figure 1.6. Aptamer beacon design for the 
detection of cocaine. F = fluorophore, Q = 
quencher, yellow oval = cocaine. 
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Other than using fluorophores to generate a signal, other molecules and particles have 
been also used, such as intercalating dyes,175-181 gold nanoparticle,179,182-199 quantum dots,200,201 
SERS reporter groups,202-204 and MRI contrast agent.205-209 The use of these alternative signal 
generation mechanism is aimed to increase the sensitivity of the sensor or to decrease the 
operation complexity.74,210 
1.4.1.2 DNAzyme based sensors 
Due to the metal ion selectivity present in many DNAzymes, metal ion sensors can be 
designed based on DNAzymes.83,132,143,211-224 Currently, toxic metal ions are commonly analyzed 
by instrumental techniques, such as inductively coupled plasma mass spectroscopy (ICP-MS), 
atomic absorption spectrometry, anodic stripping voltammetry, and X-ray fluorescence 
spectrometry. Although these techniques allow highly sensitive detection of metal ions down to 
ppb level,225 on-site and real-time detection by these techniques is limited by the requirement of 
advanced instrument and trained operators.226-228 DNAzyme based sensors have been 
demonstrated to be an alternative method for convenient detection of toxic metal ions with high 
selectivity and sensitivity. For example, the best DNAzyme sensor is capable of detecting 45 pM 
 
Figure 1.7 Structure-switching 
design for aptamer sensor. F = 
fluorophore, Q = quencher, 
yellow oval = target. 
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of UO22+ with million fold selectivity against other metal ions, which rivals the analytical 
instrumental detection methods.151,218  
Designs for DNAzyme sensors are relatively simple and straight forward (Figure 1.8). 
Fluorescent sensor can be easily developed by attaching fluorophore and quencher on the arms of 
a DNAzyme, as demonstrated by the first DNAzyme based sensor for detecting Pb2+.229 Later, a 
dual quencher design was employed to obtain a higher fluorescence enhancement.217 In these 
designs, if the metal cofactor, in this case Pb2+, is present, the DNAzyme becomes active and 
catalyzes the phosphodiester bond cleavage at the cleavage site. After the substrate strand is being 
cleaved, the hybridization of the substrate to the enzyme strand is weakened, and it dissociates 
from the enzyme strand. As a result, the intermolecular quencher can no longer efficiently quench 
the fluorophore, increasing the fluorescence signal. The intramolecular quencher is also included 
to reduce the overall background. The same cleave-and-release approach has been used for 
development of various DNAzyme metal ion sensors with different signal output mechanism, 
very similar to the approaches taken by the structure-switching aptamer sensors (catalysis 
triggered release vs. binding trigger release).74 
 
 
Figure 1.8 Design of DNAzyme based sensor (catalytic beacon) 
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Mentioned above are examples of DNAzymes serving as the recognition module, 
DNAzyme has also been isolated and used as the signal amplification and transduction module. 
The PS2.M DNAzyme was first isolated to bind to the cofactor N-methylmesoporphyrin (NMM), 
but later found out that it possesses HRP-like peroxidase activity in the presence of hemin.98,230,231 
As a result, it can be used to generate a color change by converting ABTS to ABTS- in the 
presence of hemin.231-233 The Willner group has applied the hemin DNAzyme in a wide range of 
biosensing application using its HRP-like activity.222,234-239 
1.4.2 Pharmaceutical Applications 
Due to their selectively binding capabilities, in vitro isolated aptamers are perceived as 
potential therapeutic agents even at the early stage of their discovery. The first aptamer based 
drug, Mucagen®, was approved by the Federal Drug Administration (FDA) in 2004. Mucagen® 
is a 2ꞌ-F modified RNA aptamer, targeting the vascular endothelial growth factor (VEGF) for the 
treatment of wet age-related macular degeneration (AMD).100,101 With the successful 
demonstration of therapeutic application of aptamer, a number of aptamer drugs are currently 
being evaluated at different clinical trials for treating a variety of conditions, including coronary 
artery bypass graft (CABG), percutaneous intervention (PCI), acute coronary syndrome (ACS), 
AMD, obesity, inflammatory diseases, and acute myeloid leukemia (AML). Table 4.2.1 shows 
the list of aptamer drugs currently in clinical studies.240 In depth review on aptamer therapeutic 
agents are covered by Ellington et al.241 and Toulme el al.240 
 19 
 
 
1.5 Focus of the thesis study 
Development of functional nucleic acid biosensors is a main focus of the Lu lab. The 
entire process for developing a new sensor involves the isolation of the functional nucleic acid, 
the characterization, and the actual sensor development. In this thesis, Chapter 2 and Chapter 3 
describe two aptamer SELEX attepmts (against perchlorate and melamine) and the biochemical 
studies associated with aptamers isolated from each SELEX. Keeping sensor development in 
mind for both selections, the perchlorate has one more extra purpose: trying to expand the list of 
aptamer ligands to small anions. The perchlorate selection has completed with the identification 
of a potential aptamer, but further characterization or re-selection will be necessary. The 
melamine selection has completed and isolated two aptamers for melamine, mV-P2 and R29C33. 
A melamine aptamer based sensor in under development using a personal glucose meter as signal 
readout device. Chapter 4 details an immense effort towards determining the structure of RNA-
cleaving DNAzymes. Currently, there is no crystal structure available for any DNAzyme in its 
active conformation. Obtaining the crystal structure of a DNAzyme can be a significant step in 
understanding their mechanism, interaction with (metal) cofactors, and active site organization. 
Several crystals have been obtained and diffracted to 7 Å resolution, however, this resolution is 
Aptamer Target DNA/RNA Conditions Clinical trial Ref. 
NOX-B11 Ghrelin L-RNA Obesity Preclinical 1,2 
NOX-E36 MCP-1 L-RNA Inflammatory 
diseases 
Phase 1 13 
ARC127 PDGF-B DNA AMD Phase 1 14 
ARC1905 complement C5 2'F-RNA AMD Phase 1 23 
RB006 Factor IXa 2'F-RNA CABG Phase 2a 24-28 
ARC1779 von Willebrand 
Factor 
RNA ACS/PCI Phase 2b 29-38 
NU172 Thrombin DNA CABG/PCI Phase 2 39 
AS1411 Nucleolin DNA AML Phase 2 41 
Table 1.3 Aptamer drugs currently under clinical evaluation.  
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still insufficient for solving the structure. Chapter 5 describes the development of a “new” 
catalytic beacon for Pb2+ based on a Pb2+ selective DNAzyme isolated in 1994. The newly 
developed sensor has a much higher selectivity comparing to the older generation 8-17 
DNAzyme based sensor and a slightly better sensitivity.   
  
 21 
 
1.6 Reference 
1 Becskei, C. et al. The anti-ghrelin Spiegelmer NOX-B11-3 blocks ghrelin- but not 
fasting-induced neuronal activation in the hypothalamic arcuate nucleus. J Neuroendocrinol 20, 
85-92, doi:JNE1619 [pii] 
10.1111/j.1365-2826.2007.01619.x (2008). 
2 Kobelt, P. et al. Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and 
orexigenic effects of peripheral ghrelin in rats. Gut 55, 788-792, doi:gut.2004.061010 [pii] 
10.1136/gut.2004.061010 (2006). 
3 Breaker, R. R. & Joyce, G. F. A DNA enzyme that cleaves RNA. Chemistry and Biology 
1, 223-229 (1994). 
4 Santoro, S. W. & Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. 
Proceedings of the National Academy of Sciences of the United States of America 94, 4262-4266 
(1997). 
5 Li, J., Zheng, W., Kwon, A. H. & Lu, Y. In vitro selection and characterization of a 
highly efficient Zn(II)-dependent RNA-cleaving deoxyribozyme. Nucleic Acids Research 28, 
481-488 (2000). 
6 Geyer, C. R. & Sen, D. Evidence for the metal-cofactor independence of an RNA 
phosphodiester-cleaving DNA enzyme. Chemistry and Biology 4, 579-593 (1997). 
7 Faulhammer, D. & Famulok, M. The Ca2+ ion as a cofactor for a novel RNA-cleaving 
deoxyribozyme. Angewandte Chemie, International Edition 35, 2837-2841 (1996). 
8 Feldman, A. R. & Sen, D. A New and Efficient DNA Enzyme for the Sequence-specific 
Cleavage of RNA. Journal of Molecular Biology 313, 283-294 (2001). 
9 Cruz, R. P. G., Withers, J. B. & Li, Y. Dinucleotide Junction Cleavage Versatility of 8-17 
Deoxyribozyme. Chemistry and Biology 11, 57-67 (2004). 
10 Liu, J. et al. A catalytic beacon sensor for uranium with parts-per-trillion sensitivity and 
millionfold selectivity. Proc. Natl. Acad. Sci. U. S. A. 104, 2056-2061 (2007). 
11 Donald Voet, J. G. V.     (Wiley, 2004). 
12 Ciesiolka, J., Gorski, J. & Yarus, M. Selection of an RNA domain that binds Zn2+. RNA 
1, 538-550 (1995). 
13 Maasch, C., Buchner, K., Eulberg, D., Vonhoff, S. & Klussmann, S. Physicochemical 
stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for therapeutic applications. Nucleic Acids 
Symp Ser (Oxf), 61-62, doi:nrn031 [pii] 
10.1093/nass/nrn031 (2008). 
14 Akiyama, H. et al. Intraocular injection of an aptamer that binds PDGF-B: a potential 
treatment for proliferative retinopathies. J Cell Physiol 207, 407-412, doi:10.1002/jcp.20583 
(2006). 
15 Crick, F. Central dogma of molecular biology. Nature 227, 561-563 (1970). 
16 Mann, D., Reinemann, C., Stoltenburg, R. & Strehlitz, B. In vitro selection of DNA 
aptamers binding ethanolamine. Biochem Biophys Res Commun 338, 1928-1934, doi:S0006-
291X(05)02471-X [pii] 
10.1016/j.bbrc.2005.10.172 (2005). 
 22 
 
17 Carmi, N., Shultz, L. A. & Breaker, R. R. In vitro selection of self-cleaving DNAs. 
Chemistry and Biology 3, 1039-1046 (1996). 
18 Carmi, N., Balkhi, H. R. & Breaker, R. R. Cleaving DNA with DNA. Proceedings of the 
National Academy of Sciences of the United States of America 95, 2233-2237 (1998). 
19 Carmi, N. & Breaker, R. R. Characterization of a DNA-Cleaving deoxyribozyme. 
Bioorganic and Medicinal Chemistry 9, 2589-2600 (2001). 
20 Chandra, M., Sachdeva, A. & Silverman, S. K. DNA-catalyzed sequence-specific 
hydrolysis of DNA. Nature Chemical Biology 5, 718-720 (2009). 
21 Xiao, Y., Chandra, M. & Silverman, S. K. Functional Compromises among pH Tolerance, 
Site Specificity, and Sequence Tolerance for a DNA-Hydrolyzing Deoxyribozyme. Biochemistry 
(2010). 
22 Xiao, Y., Allen, E. C. & Silverman, S. K. Merely two mutations switch a DNA-
hydrolyzing deoxyribozyme from heterobimetallic (Zn2+/Mn2+) to monometallic (Zn2+-only) 
behavior. Chemical communications (Cambridge, England) 47, 1749-1751 (2011). 
23 Biesecker, G., Dihel, L., Enney, K. & Bendele, R. A. Derivation of RNA aptamer 
inhibitors of human complement C5. Immunopharmacology 42, 219-230 (1999). 
24 Chan, M. Y. et al. Phase 1b randomized study of antidote-controlled modulation of factor 
IXa activity in patients with stable coronary artery disease. Circulation 117, 2865-2874, 
doi:CIRCULATIONAHA.107.745687 [pii] 
10.1161/CIRCULATIONAHA.107.745687 (2008). 
25 Sullenger, B., Woodruff, R. & Monroe, D. M. Potent anticoagulant aptamer directed 
against factor IXa blocks macromolecular substrate interaction. J Biol Chem 287, 12779-12786, 
doi:M111.300772 [pii] 
10.1074/jbc.M111.300772 (2012). 
26 Szlam, F. et al. Anti-factor IXa Aptamer reduces propagation of thrombin generation in 
plasma anticoagulated with warfarin. Thromb Res 125, 432-437, doi:S0049-3848(09)00525-8 [pii] 
10.1016/j.thromres.2009.11.018 (2010). 
27 Tanaka, K. A., Szlam, F., Rusconi, C. P. & Levy, J. H. In-vitro evaluation of anti-factor 
IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Thromb Haemost 101, 
827-833, doi:09050827 [pii] (2009). 
28 Dyke, C. K. et al. First-in-human experience of an antidote-controlled anticoagulant 
using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair 
for the controlled regulation of factor IXa activity. Circulation 114, 2490-2497, 
doi:CIRCULATIONAHA.106.668434 [pii] 
10.1161/CIRCULATIONAHA.106.668434 (2006). 
29 Cataland, S. R. et al. Initial experience from a double-blind, placebo-controlled, clinical 
outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura. Am J 
Hematol 87, 430-432, doi:10.1002/ajh.23106 (2012). 
30 Jilma-Stohlawetz, P., Gilbert, J. C., Gorczyca, M. E., Knobl, P. & Jilma, B. A dose 
ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with 
congenital thrombotic thrombocytopenic purpura. Thromb Haemost 106, 539-547, doi:11-02-
0069 [pii] 
 23 
 
10.1160/TH11-02-0069 (2011). 
31 Markus, H. S. et al. The von Willebrand inhibitor ARC1779 reduces cerebral 
embolization after carotid endarterectomy: a randomized trial. Stroke 42, 2149-2153, 
doi:STROKEAHA.111.616649 [pii] 
10.1161/STROKEAHA.111.616649 (2011). 
32 Jilma-Stohlawetz, P. et al. Inhibition of von Willebrand factor by ARC1779 in patients 
with acute thrombotic thrombocytopenic purpura. Thromb Haemost 105, 545-552, doi:10-08-
0520 [pii] 
10.1160/TH10-08-0520 (2011). 
33 Jilma, B. et al. A randomised pilot trial of the anti-von Willebrand factor aptamer 
ARC1779 in patients with type 2b von Willebrand disease. Thromb Haemost 104, 563-570, 
doi:10-01-0027 [pii] 
10.1160/TH10-01-0027 (2010). 
34 Mayr, F. B. et al. The aptamer ARC1779 blocks von Willebrand factor-dependent 
platelet function in patients with thrombotic thrombocytopenic purpura ex vivo. Transfusion 50, 
1079-1087, doi:TRF2554 [pii] 
10.1111/j.1537-2995.2009.02554.x (2010). 
35 Spiel, A. O. et al. The aptamer ARC1779 is a potent and specific inhibitor of von 
Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction. Platelets 20, 
334-340, doi:913458773 [pii] 
10.1080/09537100903085927 (2009). 
36 Knobl, P. et al. Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic 
thrombocytopenic purpura. Transfusion 49, 2181-2185, doi:TRF02232 [pii] 
10.1111/j.1537-2995.2009.02232.x (2009). 
37 Diener, J. L. et al. Inhibition of von Willebrand factor-mediated platelet activation and 
thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J Thromb Haemost 
7, 1155-1162, doi:JTH3459 [pii] 
10.1111/j.1538-7836.2009.03459.x (2009). 
38 Gilbert, J. C. et al. First-in-human evaluation of anti von Willebrand factor therapeutic 
aptamer ARC1779 in healthy volunteers. Circulation 116, 2678-2686, 
doi:CIRCULATIONAHA.107.724864 [pii] 
10.1161/CIRCULATIONAHA.107.724864 (2007). 
39 Wagner-Whyte J, K. S., Preiss JR, Kurz JC, Olson K, Hatala P, Boomer RM, Fraone JM, 
Brosnan N, Makim A, Lewis SD, Cai L, McCauley T, Hutabarat R, Horvath C, Funk WD, 
Deitcher SR, Thatte H, Hussaini B, Treanor P, Rottman JB, Diener JL. DISCOVERY OF A 
POTENT, DIRECT THROMBIN INHIBITING APTAMER. J Thromb Haemost 5 Supplement 
2: P-S-067 (2007). 
40 Kruger, K. et al. Self-splicing RNA: autoexcision and autocyclization of the ribosomal 
RNA intervening sequence of Tetrahymena. Cell 31, 147-157 (1982). 
41 Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D. & Trent, J. O. Discovery and 
development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol 
Pathol 86, 151-164, doi:S0014-4800(09)00006-9 [pii] 
 24 
 
10.1016/j.yexmp.2009.01.004 (2009). 
42 Jenison, R. D., Gill, S. C., Pardi, A. & Polisky, B. High-resolution molecular 
discrimination by RNA. Science 263, 1425-1429 (1994). 
43 Ban, N., Nissen, P., Hansen, J., Moore, P. B. & Steitz, T. A. The complete atomic 
structure of the large ribosomal subunit at 2.4 A resolution. Science 289, 902-921 (2000). 
44 Burmeister, J., von Kiedrowski, G. & Ellington, A. D. Cofactor-assisted self-cleavage in 
DNA libraries with a 3'-'5'-phosphoramidate bond. Angew.Chem., Int.Ed.Engl. 36, 1321-1324 
(1997). 
45 Grate, D. & Wilson, C. Inducible regulation of the S. cerevisiae cell cycle mediated by an 
RNA aptamer-ligand complex. Bioorg Med Chem 9, 2565-2570, doi:S0968089601000311 [pii] 
(2001). 
46 Zaug, A. J. & Cech, T. R. In vitro splicing of the ribosomal RNA precursor in nuclei of 
Tetrahymena. Cell (Cambridge, Massachusetts) 19, 331-338 (1980). 
47 Cuenoud, B. & Szostak, J. W. A DNA metalloenzyme with DNA ligase activity. Nature 
375, 611-614 (1995). 
48 Sreedhara, A., Li, Y. & Breaker, R. R. Ligating DNA with DNA. Journal of the 
American Chemical Society 126, 3454-3460 (2004). 
49 Nudler, E. & Mironov, A. S. The riboswitch control of bacterial metabolism. Trends 
Biochem Sci 29, 11-17, doi:S0968000403002822 [pii] (2004). 
50 Mironov, A. S. et al. Sensing small molecules by nascent RNA: a mechanism to control 
transcription in bacteria. Cell 111, 747-756, doi:S0092867402011340 [pii] (2002). 
51 Winkler, W. C., Cohen-Chalamish, S. & Breaker, R. R. An mRNA structure that controls 
gene expression by binding FMN. Proceedings of the National Academy of Sciences of the United 
States of America 99, 15908-15913, doi:DOI 10.1073/pnas.212628899 (2002). 
52 Sudarsan, N., Barrick, J. E. & Breaker, R. R. Metabolite-binding RNA domains are 
present in the genes of eukaryotes. RNA 9, 644-647 (2003). 
53 Tang, J., Xie, J., Shao, N. & Yan, Y. The DNA aptamers that specifically recognize ricin 
toxin are selected by two in vitro selection methods. Electrophoresis 27, 1303-1311, 
doi:10.1002/elps.200500489 (2006). 
54 Coppins, R. L., Purtha, W. E., Wang, Y. & Silverman, S. K. in 229th ACS National 
Meeting    ORGN-653 (San Diego, CA, United States, 2005). 
55 Purtha, W. E., Coppins, R. L., Smalley, M. K. & Silverman, S. K. General 
Deoxyribozyme-Catalyzed Synthesis of Native 3'-5' RNA Linkages. Journal of the American 
Chemical Society 127, 13124-13125 (2005). 
56 Wang, Y. & Silverman, S. K. Characterization of Deoxyribozymes That Synthesize 
Branched RNA. Biochemistry 42, 15252-15263 (2003). 
57 Wang, Y. & Silverman, S. K. Deoxyribozymes That Synthesize Branched and Lariat 
RNA. Journal of the American Chemical Society 125, 6880-6881 (2003). 
58 Coppins, R. L. & Silverman, S. K. A DNA enzyme that mimics the first step of RNA 
splicing. Nature Structural and molecular biology 11, 270-274 (2004). 
 25 
 
59 Coppins, R. L. & Silverman, S. K. A Deoxyribozyme that Forms a Three-Helix-Junction 
Complex with its RNA Substrates and has General RNA Branch-Forming Activity. Journal of the 
American Chemical Society 127, 2900-2907 (2005). 
60 Pratico, E. D., Wang, Y. & Silverman, S. K. A deoxyribozyme that synthesizes 2',5'-
branched RNA with any branch-site nucleotide. Nucleic Acids Research 33, 3503-3512 (2005). 
61 Wang, Y. & Silverman, S. K. Efficient one-step synthesis of biologically related lariat 
RNAs by a deoxyribozyme. Angewandte Chemie (International ed.in English) 44, 5863-5866 
(2005). 
62 Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific 
ligands. Nature 346, 818-822 (1990). 
63 Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA 
ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (1990). 
64 Beaudry, A. A. & Joyce, G. F. Directed evolution of an RNA enzyme. Science 257, 635-
641 (1992). 
65 Mannironi, C., Di Nardo, A., Fruscoloni, P. & Tocchini-Valentini, G. P. In vitro selection 
of dopamine RNA ligands. Biochemistry 36, 9726-9734, doi:10.1021/bi9700633 
bi9700633 [pii] (1997). 
66 Ellington, A. D. & Szostak, J. W. Selection in vitro of single-stranded DNA molecules 
that fold into specific ligand-binding structures. Nature 355, 850-852 (1992). 
67 Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. & Toole, J. J. Selection of 
single-stranded DNA molecules that bind and inhibit human thrombin. Nature (London) 355, 
564-566 (1992). 
68 Pradeepkumar, P. I., Hoebartner, C., Baum, D. A. & Silverman, S. K. DNA-catalyzed 
formation of nucleopeptide linkages. Angewandte Chemie (International ed. in English) 47, 1753-
1757 (2008). 
69 Geiger, A., Burgstaller, P., von der Eltz, H., Roeder, A. & Famulok, M. RNA aptamers 
that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. 
Nucleic Acids Res 24, 1029-1036, doi:5w0225 [pii] (1996). 
70 Wang, W., Billen, L. P. & Li, Y. Sequence diversity, metal specificity, and catalytic 
proficiency of metal-dependent phosphorylating DNA enzymes. Chemistry and Biology 9, 507-
517 (2002). 
71 Huizenga, D. E. & Szostak, J. W. A DNA aptamer that binds adenosine and ATP. 
Biochemistry 34, 656-665 (1995). 
72 Sassanfar, M. & Szostak, J. W. An RNA motif that binds ATP. Nature 364, 550-553, 
doi:10.1038/364550a0 (1993). 
73 Li, Y., Liu, Y. & Breaker, R. R. Capping DNA with DNA. Biochemistry 39, 3106-3114 
(2000). 
74 Liu, J., Cao, Z. & Lu, Y. Functional nucleic acid sensors. Chem Rev 109, 1948-1998, 
doi:10.1021/cr030183i (2009). 
75 Ishiguro, A., Akiyama, T., Adachi, H., Inoue, J. & Nakamura, Y. Therapeutic potential of 
anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of 
autoimmunity in two mouse models. Arthritis Rheum 63, 455-466, doi:10.1002/art.30108 (2011). 
 26 
 
76 Gutsaeva, D. R. et al. Inhibition of cell adhesion by anti-P-selectin aptamer: a new 
potential therapeutic agent for sickle cell disease. Blood 117, 727-735, doi:blood-2010-05-285718 
[pii] 
10.1182/blood-2010-05-285718 (2011). 
77 Reyes-Reyes, E. M., Teng, Y. & Bates, P. J. A new paradigm for aptamer therapeutic 
AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent 
mechanism. Cancer Res 70, 8617-8629, doi:0008-5472.CAN-10-0920 [pii] 
10.1158/0008-5472.CAN-10-0920 (2010). 
78 Trujillo, C. A., Nery, A. A., Alves, J. M., Martins, A. H. & Ulrich, H. Development of 
the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology. Clin Ophthalmol 1, 
393-402 (2007). 
79 Wochner, A. et al. A DNA aptamer with high affinity and specificity for therapeutic 
anthracyclines. Anal Biochem 373, 34-42, doi:S0003-2697(07)00599-4 [pii] 
10.1016/j.ab.2007.09.007 (2008). 
80 Chen, F., Zhou, J., Luo, F., Mohammed, A. B. & Zhang, X. L. Aptamer from whole-
bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. 
Biochem Biophys Res Commun 357, 743-748, doi:S0006-291X(07)00709-7 [pii] 
10.1016/j.bbrc.2007.04.007 (2007). 
81 Lee, J. H. et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the 
heparin binding domain of VEGF165. Proc Natl Acad Sci U S A 102, 18902-18907, 
doi:0509069102 [pii] 
10.1073/pnas.0509069102 (2005). 
82 Nimjee, S. M., Rusconi, C. P. & Sullenger, B. A. Aptamers: an emerging class of 
therapeutics. Annu Rev Med 56, 555-583, doi:10.1146/annurev.med.56.062904.144915 (2005). 
83 Zhou, M., Kuralay, F., Windmiller, J. R. & Wang, J. DNAzyme logic-controlled biofuel 
cells for self-powered biosensors. Chem Commun (Camb) 48, 3815-3817, 
doi:10.1039/c2cc30464c (2012). 
84 Elbaz, J., Wang, F., Remacle, F. & Willner, I. pH-Programmable DNA Logic Arrays 
Powered by Modular DNAzyme Libraries. Nano Lett, doi:10.1021/nl300051g (2012). 
85 Zhu, J., Li, T., Zhang, L., Dong, S. & Wang, E. G-quadruplex DNAzyme based 
molecular catalytic beacon for label-free colorimetric logic gates. Biomaterials 32, 7318-7324, 
doi:S0142-9612(11)00705-8 [pii] 
10.1016/j.biomaterials.2011.06.040 (2011). 
86 Bi, S., Yan, Y., Hao, S. & Zhang, S. Colorimetric logic gates based on supramolecular 
DNAzyme structures. Angew Chem Int Ed Engl 49, 4438-4442, doi:10.1002/anie.201000840 
(2010). 
87 Lorsch, J. R. & Szostak, J. W. In vitro selection of RNA aptamers specific for 
cyanocobalamin. Biochemistry 33, 973-982 (1994). 
88 Teller, C. & Willner, I. Functional nucleic acid nanostructures and DNA machines. Curr 
Opin Biotechnol 21, 376-391, doi:S0958-1669(10)00108-4 [pii] 
10.1016/j.copbio.2010.06.001 (2010). 
 27 
 
89 Claudia Hçbartner, P. I. P. a. S. K. S. Site-selective depurination by a periodate-
dependent deoxyribozyme. Chemical Communications, 2255-2257 (2007). 
90 Sheppard, T. L., Ordoukhanian, P. & Joyce, G. F. A DNA enzyme with N-glycosylase 
activity. Proceedings of the National Academy of Sciences of the United States of America 97, 
7802-7807 (2000). 
91 Tsukiji, S., Pattnaik, S. B. & Suga, H. An alcohol dehydrogenase ribozyme. Nat Struct 
Biol 10, 713-717, doi:10.1038/nsb964 
nsb964 [pii] (2003). 
92 Tsukiji, S., Pattnaik, S. B. & Suga, H. Reduction of an aldehyde by a NADH/Zn2+ -
dependent redox active ribozyme. J Am Chem Soc 126, 5044-5045, doi:10.1021/ja0495213 
(2004). 
93 Gebhardt, K., Shokraei, A., Babaie, E. & Lindqvist, B. H. RNA aptamers to S-
adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-
S-adenosylhomocysteine antibody. Biochemistry 39, 7255-7265, doi:bi000295t [pii] (2000). 
94 Chandra, M. & Silverman, S. K. DNA and RNA can be equally efficient catalysts for 
carbon-carbon bond formation. Journal of the American Chemical Society 130, 2936-2937 (2008). 
95 Seelig, B. & Jaschke, A. A small catalytic RNA motif with Diels-Alderase activity. Chem 
Biol 6, 167-176, doi:S1074-5521(99)89008-5 [pii] 
10.1016/S1074-5521(99)89008-5 (1999). 
96 Wang, Y. & Rando, R. R. Specific binding of aminoglycoside antibiotics to RNA. Chem 
Biol 2, 281-290, doi:1074-5521(95)90047-0 [pii] (1995). 
97 Goringer, H. U., Homann, M. & Lorger, M. In vitro selection of high-affinity nucleic acid 
ligands to parasite target molecules. Int J Parasitol 33, 1309-1317, doi:S0020751903001978 [pii] 
(2003). 
98 Li, Y. & Sen, D. A catalytic DNA for porphyrin metalation. Nature Structural Biology 3, 
743-747 (1996). 
99 Li, Y. & Sen, D. Toward an Efficient DNAzyme. Biochemistry 36, 5589-5599 (1997). 
100 Jellinek, D., Green, L. S., Bell, C. & Janjic, N. Inhibition of receptor binding by high-
affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33, 10450-10456 (1994). 
101 Ruckman, J. et al. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form 
of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-
induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol 
Chem 273, 20556-20567 (1998). 
102 Stoltenburg, R., Reinemann, C. & Strehlitz, B. SELEX--a (r)evolutionary method to 
generate high-affinity nucleic acid ligands. Biomol Eng 24, 381-403, doi:S1389-0344(07)00066-4 
[pii] 
10.1016/j.bioeng.2007.06.001 (2007). 
103 Haller, A. A. & Sarnow, P. In vitro selection of a 7-methyl-guanosine binding RNA that 
inhibits translation of capped mRNA molecules. Proc Natl Acad Sci U S A 94, 8521-8526 (1997). 
104 Blank, M., Weinschenk, T., Priemer, M. & Schluesener, H. Systematic evolution of a 
DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial 
regulatory protein pigpen. J Biol Chem 276, 16464-16468, doi:10.1074/jbc.M100347200 
 28 
 
M100347200 [pii] (2001). 
105 Vater, A., Jarosch, F., Buchner, K. & Klussmann, S. Short bioactive Spiegelmers to 
migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: 
tailored-SELEX. Nucleic Acids Res 31, e130 (2003). 
106 Marshall, K. A. & Ellington, A. D. In vitro selection of RNA aptamers. Methods Enzymol 
318, 193-214 (2000). 
107 Wilson, D. S. & Szostak, J. W. In vitro selection of functional nucleic acids. Annu Rev 
Biochem 68, 611-647, doi:10.1146/annurev.biochem.68.1.611 (1999). 
108 Rimmele, M. Nucleic acid aptamers as tools and drugs: recent developments. 
Chembiochem 4, 963-971, doi:10.1002/cbic.200300648 (2003). 
109 Patel, D. J. et al. Structure, recognition and adaptive binding in RNA aptamer complexes. 
J Mol Biol 272, 645-664, doi:S0022-2836(97)91281-X [pii] 
10.1006/jmbi.1997.1281 (1997). 
110 Patel, D. J. Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1, 32-46, 
doi:S1367-5931(97)80106-8 [pii] (1997). 
111 Hermann, T. & Patel, D. J. Adaptive recognition by nucleic acid aptamers. Science 287, 
820-825, doi:8234 [pii] (2000). 
112 Nutiu, R. & Li, Y. In vitro selection of structure-switching signaling aptamers. Angew 
Chem Int Ed Engl 44, 1061-1065, doi:10.1002/anie.200461848 (2005). 
113 Yang, Y., Yang, D., Schluesener, H. J. & Zhang, Z. Advances in SELEX and application 
of aptamers in the central nervous system. Biomol Eng 24, 583-592, doi:S1389-0344(07)00068-8 
[pii] 
10.1016/j.bioeng.2007.06.003 (2007). 
114 Stoltenburg, R., Reinemann, C. & Strehlitz, B. FluMag-SELEX as an advantageous 
method for DNA aptamer selection. Anal Bioanal Chem 383, 83-91, doi:10.1007/s00216-005-
3388-9 (2005). 
115 Mendonsa, S. D. & Bowser, M. T. In vitro selection of high-affinity DNA ligands for 
human IgE using capillary electrophoresis. Anal Chem 76, 5387-5392, doi:10.1021/ac049857v 
(2004). 
116 Mendonsa, S. D. & Bowser, M. T. In vitro evolution of functional DNA using capillary 
electrophoresis. J Am Chem Soc 126, 20-21, doi:10.1021/ja037832s (2004). 
117 Mosing, R. K., Mendonsa, S. D. & Bowser, M. T. Capillary electrophoresis-SELEX 
selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal Chem 77, 6107-6112, 
doi:10.1021/ac050836q (2005). 
118 Berezovski, M. V., Musheev, M. U., Drabovich, A. P., Jitkova, J. V. & Krylov, S. N. 
Non-SELEX: selection of aptamers without intermediate amplification of candidate 
oligonucleotides. Nat Protoc 1, 1359-1369, doi:nprot.2006.200 [pii] 
10.1038/nprot.2006.200 (2006). 
119 Davis, K. A., Abrams, B., Lin, Y. & Jayasena, S. D. Use of a high affinity DNA ligand in 
flow cytometry. Nucleic Acids Res 24, 702-706, doi:5j0627 [pii] (1996). 
120 Yang, X. et al. Immunofluorescence assay and flow-cytometry selection of bead-bound 
aptamers. Nucleic Acids Res 31, e54 (2003). 
 29 
 
121 Tsai, R. Y. & Reed, R. R. Identification of DNA recognition sequences and protein 
interaction domains of the multiple-Zn-finger protein Roaz. Mol Cell Biol 18, 6447-6456 (1998). 
122 Misono, T. S. & Kumar, P. K. Selection of RNA aptamers against human influenza virus 
hemagglutinin using surface plasmon resonance. Anal Biochem 342, 312-317, doi:S0003-
2697(05)00309-X [pii] 
10.1016/j.ab.2005.04.013 (2005). 
123 Guthold, M., Cubicciotti, R., Superfine, R. & Taylor, R. M. Novel methodology to detect, 
isolate, amplify and characterize single aptamer molecules with desirable target-binding 
properties. Biophysical Journal 82, 163a-163a (2002). 
124 Cox, J. C., Rudolph, P. & Ellington, A. D. Automated RNA selection. Biotechnol Prog 
14, 845-850, doi:10.1021/bp980097h 
bp980097h [pii] (1998). 
125 Cox, J. C. & Ellington, A. D. Automated selection of anti-protein aptamers. Bioorg Med 
Chem 9, 2525-2531, doi:S0968089601000281 [pii] (2001). 
126 Cox, J. C. et al. Automated selection of aptamers against protein targets translated in 
vitro: from gene to aptamer. Nucleic Acids Res 30, e108 (2002). 
127 Sooter, L. J. et al. Toward automated nucleic acid enzyme selection. Biol Chem 382, 
1327-1334, doi:10.1515/BC.2001.165 (2001). 
128 Eulberg, D., Buchner, K., Maasch, C. & Klussmann, S. Development of an automated in 
vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P 
antagonist. Nucleic Acids Res 33, e45, doi:33/4/e45 [pii] 
10.1093/nar/gni044 (2005). 
129 Hybarger, G., Bynum, J., Williams, R. F., Valdes, J. J. & Chambers, J. P. A microfluidic 
SELEX prototype. Anal Bioanal Chem 384, 191-198, doi:10.1007/s00216-005-0089-3 (2006). 
130 Serganov, A. & Patel, D. J. Metabolite recognition principles and molecular mechanisms 
underlying riboswitch function. Annu Rev Biophys 41, 343-370, doi:10.1146/annurev-biophys-
101211-113224 (2012). 
131 Sinha, J., Topp, S. & Gallivan, J. P. From SELEX to cell dual selections for synthetic 
riboswitches. Methods Enzymol 497, 207-220, doi:B978-0-12-385075-1.00009-3 [pii] 
10.1016/B978-0-12-385075-1.00009-3 (2011). 
132 Lan, T., Furuya, K. & Lu, Y. A highly selective lead sensor based on a classic lead 
DNAzyme. Chem Commun (Camb) 46, 3896-3898, doi:10.1039/b926910j (2010). 
133 Peracchi, A. Preferential activation of the 8-17 deoxyribozyme by Ca2+ ions. Evidence 
for the identity of 8-17 with the catalytic domain of the MG5 deoxyribozyme. Journal of 
Biological Chemistry 275, 11693-11697 (2000). 
134 Schlosser, K., Gu, J., Sule, L. & Li, Y. Sequence-function relationships provide new 
insight into the cleavage site selectivity of the 8-17 RNA-cleaving deoxyribozyme. Nucleic Acids 
Research 36, 1472-1481 (2008). 
135 Schlosser, K. & Li, Y. Tracing Sequence Diversity Change of RNA-Cleaving 
Deoxyribozymes under Increasing Selection Pressure during in Vitro Selection. Biochemistry 43, 
9695-9707 (2004). 
 30 
 
136 Baum, D. A. & Silverman, S. K. Deoxyribozymes: useful DNA catalysts in vitro and in 
vivo. Cellular and Molecular Life Sciences 65, 2156-2174 (2008). 
137 Dass, C. R., Choong, P. F. & Khachigian, L. M. DNAzyme technology and cancer 
therapy: cleave and let die. Molecular cancer therapeutics 7, 243-251 (2008). 
138 Santoro, S. W. & Khachigian, L. M. in Synthetic Nucleic Acids as Inhibitors of Gene 
Expression     53-68 (CRC press, 2005). 
139 Chakraborti, S. & Banerjea, A. C. Inhibition of HIV-1 gene expression by novel DNA 
enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates. 
Molecular therapy : the journal of the American Society of Gene Therapy 7, 817-826 (2003). 
140 Goila, R. & Banerjea, A. C. Inhibition of hepatitis B virus X gene expression by novel 
DNA enzymes. Biochemical Journal 353, 701-708 (2001). 
141 Sando, S., Sasaki, T., Kanatani, K. & Aoyama, Y. Amplified Nucleic Acid Sensing Using 
Programmed Self-Cleaving DNAzyme. Journal of the American Chemical Society 125, 15720-
15721 (2003). 
142 Sando, S., Narita, A., Sasaki, T. & Aoyama, Y. Locked TASC probes for homogeneous 
sensing of nucleic acids and imaging of fixed E. coli cells. Organic & Biomolecular Chemistry 3, 
1002-1007 (2005). 
143 Zhang, X.-B., Kong, R.-M. & Lu, Y. Metal Ion Sensors Based on DNAzymes and 
Related DNA Molecules. Annual Review of Analytical Chemistry 4, 
doi:doi:10.1146/annurev.anchem.111808.073617 (2011). 
144 Lu, Y. et al. New highly sensitive and selective catalytic DNA biosensors for metal ions. 
Biosensors & bioelectronics 18, 529-540 (2003). 
145 Stojanovic, M. N., Mitchell, T. E. & Stefanovic, D. Deoxyribozyme-Based Logic Gates. 
Journal of the American Chemical Society 124, 3555-3561 (2002). 
146 Stojanovic, M. N. & Stefanovic, D. Deoxyribozyme-Based Half-Adder. Journal of the 
American Chemical Society 125, 6673-6676 (2003). 
147 Stojanovic, M. N. et al. Deoxyribozyme-Based Ligase Logic Gates and Their Initial 
Circuits. Journal of the American Chemical Society 127, 6914-6915 (2005). 
148 Lederman, H., Macdonald, J., Stefanovic, D. & Stojanovic, M. N. Deoxyribozyme-based 
three-input logic gates and construction of a molecular full adder. Biochemistry 45, 1194-1199 
(2006). 
149 Brown, A. K., Li, J., Pavot, C. M. B. & Lu, Y. A Lead-Dependent DNAzyme with a 
Two-Step Mechanism. Biochemistry 42, 7152-7161 (2003). 
150 Peracchi, A., Bonaccio, M. & Clerici, M. A Mutational Analysis of the 8-17 
Deoxyribozyme Core. Journal of Molecular Biology 352, 783-794 (2005). 
151 Liu, J. et al. A catalytic beacon sensor for uranium with parts-per-trillion sensitivity and 
millionfold selectivity. Proc Natl Acad Sci U S A 104, 2056-2061, doi:0607875104 [pii] 
10.1073/pnas.0607875104 (2007). 
152 Brown, A. K., Liu, J., He, Y. & Lu, Y. Biochemical characterization of a uranyl ion-
specific DNAzyme. ChemBioChem 10, 486-492 (2009). 
153 Liu, J. & Lu, Y. FRET Study of a Trifluorophore-Labeled DNAzyme. Journal of the 
American Chemical Society 124, 15208-15216 (2002). 
 31 
 
154 Kim, H.-K. et al. Metal-Dependent Global Folding and Activity of the 8-17 DNAzyme 
Studied by Fluorescence Resonance Energy Transfer. Journal of the American Chemical Society 
129, 6896-6902 (2007). 
155 Lee, N. K., Koh, H. R., Han, K. Y. & Kim, S. K. Folding of 8-17 deoxyribozyme studied 
by three-color alternating-laser excitation of single molecules. Journal of the American Chemical 
Society 129, 15526-15534 (2007). 
156 Mazumdar, D. et al. Activity, Folding and Z-DNA Formation of the 8-17 DNAzyme in 
the Presence of Monovalent Ions. Journal of the American Chemical Society 131, 5506-5515 
(2009). 
157 Lam, J. C. F. & Li, Y. Influence of Cleavage Site on Global Folding of an RNA-Cleaving 
DNAzyme. ChemBioChem 11, 1710-1719 (2010). 
158 Lee, N. K., Koh, H. R., Han, K. Y., Lee, J. & Kim, S. K. Single-molecule, real-time 
measurement of enzyme kinetics by alternating-laser excitation fluorescence resonance energy 
transfer. Chemical communications (Cambridge, England) 46, 4683-4685 (2010). 
159 Liu, Y. & Sen, D. A contact photo-cross-linking investigation of the active site of the 8-
17 deoxyribozyme. Journal of Molecular Biology 381, 845-859 (2008). 
160 Sekhon, G. S. & Sen, D. A Stereochemical Glimpse of the Active Site of the 8-17 
Deoxyribozyme from Iodine-Mediated Cross-Links Formed with the Substrate's Scissile Site. 
Biochemistry 49, 9072-9077, doi:10.1021/bi1013547; M3: doi: 10.1021/bi1013547 (2010). 
161 Liu, Y. & Sen, D. Local Rather than Global Folding Enables the Lead-dependent Activity 
of the 8-17 Deoxyribozyme: Evidence from Contact Photo-crosslinking. Journal of Molecular 
Biology 395, 234 (2010). 
162 Kim, H.-K., Rasnik, I., Liu, J., Ha, T. & Lu, Y. Dissecting metal ion-dependent folding 
and catalysis of a single DNAzyme. Nature Chemical Biology 3, 763-768 (2007). 
163 Nowakowski, J., Shim, P. J., Joyce, G. F. & Stout, C. D. Crystallization of the 10-23 
DNA enzyme using a combinatorial screen of paired oligonucleotides. Acta Crystallographica. 
Section D: Biological Crystallography D55, 1885-1892 (1999). 
164 Nowakowski, J., Shim, P. J., Prasad, G. S., Stout, C. D. & Joyce, G. F. Crystal structure 
of an 82-nucleotide RNA-DNA complex formed by the 10-23 DNA enzyme. Nature Structural 
Biology 6, 151-156 (1999). 
165 Stojanovic, M. N., de Prada, P. & Landry, D. W. Aptamer-based folding fluorescent 
sensor for cocaine. J Am Chem Soc 123, 4928-4931, doi:ja0038171 [pii] (2001). 
166 Hamaguchi, N., Ellington, A. & Stanton, M. Aptamer beacons for the direct detection of 
proteins. Anal Biochem 294, 126-131, doi:10.1006/abio.2001.5169 
S0003-2697(01)95169-3 [pii] (2001). 
167 Ueyama, H., Takagi, M. & Takenaka, S. A novel potassium sensing in aqueous media 
with a synthetic oligonucleotide derivative. Fluorescence resonance energy transfer associated 
with Guanine quartet-potassium ion complex formation. J Am Chem Soc 124, 14286-14287, 
doi:ja026892f [pii] (2002). 
168 Yang, C. J., Jockusch, S., Vicens, M., Turro, N. J. & Tan, W. Light-switching excimer 
probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A 102, 
17278-17283, doi:0508821102 [pii] 
10.1073/pnas.0508821102 (2005). 
 32 
 
169 Nutiu, R. & Li, Y. Structure-switching signaling aptamers. J Am Chem Soc 125, 4771-
4778, doi:10.1021/ja028962o (2003). 
170 Nutiu, R. & Li, Y. Structure-switching signaling aptamers: transducing molecular 
recognition into fluorescence signaling. Chemistry 10, 1868-1876, doi:10.1002/chem.200305470 
(2004). 
171 Hartig, J. S. et al. Protein-dependent ribozymes report molecular interactions in real time. 
Nat Biotechnol 20, 717-722, doi:10.1038/nbt0702-717 
nbt0702-717 [pii] (2002). 
172 Tang, Z. et al. Aptamer switch probe based on intramolecular displacement. J Am Chem 
Soc 130, 11268-11269, doi:10.1021/ja804119s (2008). 
173 Rankin, C. J., Fuller, E. N., Hamor, K. H., Gabarra, S. A. & Shields, T. P. A simple 
fluorescent biosensor for theophylline based on its RNA aptamer. Nucleosides Nucleotides 
Nucleic Acids 25, 1407-1424, doi:W0235W04PH51W147 [pii] 
10.1080/15257770600919084 (2006). 
174 Li, N. & Ho, C. M. Aptamer-based optical probes with separated molecular recognition 
and signal transduction modules. J Am Chem Soc 130, 2380-2381, doi:10.1021/ja076787b (2008). 
175 Zhou, C. et al. Detection of oncoprotein platelet-derived growth factor using a 
fluorescent signaling complex of an aptamer and TOTO. Anal Bioanal Chem 384, 1175-1180, 
doi:10.1007/s00216-005-0276-2 (2006). 
176 Wood, A. E. & Bishop, G. R. Probing the structure of DNA aptamers with a classic 
heterocycle. Molecules 9, 67-85 (2004). 
177 Huang, C. C. & Chang, H. T. Aptamer-based fluorescence sensor for rapid detection of 
potassium ions in urine. Chem Commun (Camb), 1461-1463, doi:10.1039/b718752a (2008). 
178 Xiang, Y., Tong, A. & Lu, Y. Abasic Site-Containing DNAzyme and Aptamer for Label-
Free Fluorescent Detection of Pb2+ and Adenosine with High Sensitivity, Selectivity, and 
Tunable Dynamic Range. Journal of the American Chemical Society 131, 15352-15357 (2009). 
179 Qi, Y. & Li, B. A sensitive, label-free, aptamer-based biosensor using a gold 
nanoparticle-initiated chemiluminescence system. Chemistry 17, 1642-1648, 
doi:10.1002/chem.201001856 (2011). 
180 Xiang, Y., Wang, Z., Xing, H., Wong, N. Y. & Lu, Y. Label-free fluorescent functional 
DNA sensors using unmodified DNA: a vacant site approach. Analytical Chemistry 82, 4122-
4129 (2010). 
181 Xu, W. & Lu, Y. Label-free fluorescent aptamer sensor based on regulation of malachite 
green fluorescence. Anal Chem 82, 574-578, doi:10.1021/ac9018473 (2010). 
182 Liu, J. & Lu, Y. Preparation of aptamer-linked gold nanoparticle purple aggregates for 
colorimetric sensing of analytes. Nature Protocols 1, 246-252 (2006). 
183 Huang, C. C., Huang, Y. F., Cao, Z., Tan, W. & Chang, H. T. Aptamer-modified gold 
nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. 
Anal Chem 77, 5735-5741, doi:10.1021/ac050957q (2005). 
184 Liu, J. & Lu, Y. Fast colorimetric sensing of adenosine and cocaine based on a general 
sensor design involving aptamers and nanoparticles. Angew Chem Int Ed Engl 45, 90-94, 
doi:10.1002/anie.200502589 (2005). 
 33 
 
185 Chavez, J. L., Lyon, W., Kelley-Loughnane, N. & Stone, M. O. Theophylline detection 
using an aptamer and DNA-gold nanoparticle conjugates. Biosens Bioelectron 26, 23-28, 
doi:S0956-5663(10)00240-X [pii] 
10.1016/j.bios.2010.04.049 (2010). 
186 Du, Y., Guo, S., Qin, H., Dong, S. & Wang, E. Target-induced conjunction of split 
aptamer as new chiral selector for oligopeptide on graphene-mesoporous silica-gold nanoparticle 
hybrids modified sensing platform. Chem Commun (Camb) 48, 799-801, doi:10.1039/c1cc15303j 
(2012). 
187 Wei, H., Li, B., Li, J., Wang, E. & Dong, S. Simple and sensitive aptamer-based 
colorimetric sensing of protein using unmodified gold nanoparticle probes. Chem Commun 
(Camb), 3735-3737, doi:10.1039/b707642h (2007). 
188 Zhao, W., Chiuman, W., Brook, M. A. & Li, Y. Simple and rapid colorimetric biosensors 
based on DNA aptamer and noncrosslinking gold nanoparticle aggregation. Chembiochem 8, 727-
731, doi:10.1002/cbic.200700014 (2007). 
189 Bai, J. et al. [Ru(bpy)2(dcbpy)NHS] labeling/aptamer-based biosensor for the detection 
of lysozyme by increasing sensitivity with gold nanoparticle amplification. Chem Asian J 3, 
1935-1941, doi:10.1002/asia.200800104 (2008). 
190 Liu, Z. F., Ge, J. & Zhao, X. S. Quantitative detection of adenosine in urine using silver 
enhancement of aptamer-gold nanoparticle aggregation and progressive dilution. Chem Commun 
(Camb) 47, 4956-4958, doi:10.1039/c1cc10460h (2011). 
191 Liu, J. & Lu, Y. Preparation of aptamer-linked gold nanoparticle purple aggregates for 
colorimetric sensing of analytes. Nat Protoc 1, 246-252, doi:nprot.2006.38 [pii] 
10.1038/nprot.2006.38 (2006). 
192 Wu, Z. S. et al. Inhibitory effect of target binding on hairpin aptamer sticky-end pairing-
induced gold nanoparticle assembly for light-up colorimetric protein assay. Anal Chem 82, 3890-
3898, doi:10.1021/ac100422h (2010). 
193 Song, K. M. et al. Gold nanoparticle-based colorimetric detection of kanamycin using a 
DNA aptamer. Anal Biochem 415, 175-181, doi:S0003-2697(11)00232-6 [pii] 
10.1016/j.ab.2011.04.007 (2011). 
194 Kim, D., Jeong, Y. Y. & Jon, S. A drug-loaded aptamer-gold nanoparticle bioconjugate 
for combined CT imaging and therapy of prostate cancer. ACS nano 4, 3689-3696, 
doi:10.1021/nn901877h (2010). 
195 Sun, J., Guo, A., Zhang, Z., Guo, L. & Xie, J. A conjugated aptamer-gold nanoparticle 
fluorescent probe for highly sensitive detection of rHuEPO-alpha. Sensors (Basel) 11, 10490-
10501, doi:10.3390/s111110490 
sensors-11-10490 [pii] (2011). 
196 Wang, Y., Yang, F. & Yang, X. Colorimetric biosensing of mercury(II) ion using 
unmodified gold nanoparticle probes and thrombin-binding aptamer. Biosens Bioelectron 25, 
1994-1998, doi:S0956-5663(10)00026-6 [pii] 
10.1016/j.bios.2010.01.014 (2010). 
197 Zhao, Q., Lu, X., Yuan, C. G., Li, X. F. & Le, X. C. Aptamer-linked assay for thrombin 
using gold nanoparticle amplification and inductively coupled plasma-mass spectrometry 
detection. Anal Chem 81, 7484-7489, doi:10.1021/ac900961y (2009). 
 34 
 
198 Wang, W., Wu, W. Y., Zhong, X., Miao, Q. & Zhu, J. J. Aptamer-based PDMS-gold 
nanoparticle composite as a platform for visual detection of biomolecules with silver 
enhancement. Biosens Bioelectron 26, 3110-3114, doi:S0956-5663(10)00719-0 [pii] 
10.1016/j.bios.2010.10.034 (2011). 
199 Guieu, V. et al. Aptamer enzymatic cleavage protection assay for the gold nanoparticle-
based colorimetric sensing of small molecules. Anal Chim Acta 706, 349-353, doi:S0003-
2670(11)01207-4 [pii] 
10.1016/j.aca.2011.08.047 (2011). 
200 Dwarakanath, S. et al. Quantum dot-antibody and aptamer conjugates shift fluorescence 
upon binding bacteria. Biochem Biophys Res Commun 325, 739-743, doi:S0006-291X(04)02394-
0 [pii] 
10.1016/j.bbrc.2004.10.099 (2004). 
201 Choi, J. H., Chen, K. H. & Strano, M. S. Aptamer-capped nanocrystal quantum dots: a 
new method for label-free protein detection. J Am Chem Soc 128, 15584-15585, 
doi:10.1021/ja066506k (2006). 
202 Li, M. et al. Detection of adenosine triphosphate with an aptamer biosensor based on 
surface-enhanced Raman scattering. Anal Chem 84, 2837-2842, doi:10.1021/ac203325z (2012). 
203 Chen, J. W. et al. Detection of adenosine using surface-enhanced Raman scattering based 
on structure-switching signaling aptamer. Biosens Bioelectron 24, 66-71, doi:S0956-
5663(08)00137-1 [pii] 
10.1016/j.bios.2008.03.013 (2008). 
204 Pagba, C. V., Lane, S. M., Cho, H. & Wachsmann-Hogiu, S. Direct detection of aptamer-
thrombin binding via surface-enhanced Raman spectroscopy. J Biomed Opt 15, 047006, 
doi:10.1117/1.3465594 (2010). 
205 Yigit, M. V., Mazumdar, D. & Lu, Y. MRI detection of thrombin with aptamer 
functionalized superparamagnetic iron oxide nanoparticles. Bioconjug Chem 19, 412-417, 
doi:10.1021/bc7003928 (2008). 
206 Zhang, H. Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA 
aptamer-doxorubicin conjugate. doi:NBK23367 [bookaccession] (2004). 
207 Xu, W. & Lu, Y. A smart magnetic resonance imaging contrast agent responsive to 
adenosine based on a DNA aptamer-conjugated gadolinium complex. Chem Commun (Camb) 47, 
4998-5000, doi:10.1039/c1cc10161g (2011). 
208 Zhang, H. Quantum dot-A10 RNA aptamer-doxorubicin conjugate. doi:NBK23117 
[bookaccession] (2004). 
209 Zhang, H. 99mTc-Mercaptoacetyl-Glu-Glu-aptamer specific for tenascin-C. 
doi:NBK24579 [bookaccession] (2004). 
210 Li, Y. & Lu, Y. Functional Nucleic Acids for Sensing and Other Analytical Applications.  
(Springer, 2009). 
211 Wernette, D. P., Mead, C., Bohn, P. W. & Lu, Y. Surface Immobilization of Catalytic 
Beacons Based on Ratiometric Fluorescent DNAzyme Sensors: A Systematic Study. Langmuir 
23, 9513-9521 (2007). 
 35 
 
212 Liu, J. & Lu, Y. Optimization of a Pb2+-Directed Gold Nanoparticle/DNAzyme 
Assembly and Its Application as a Colorimetric Biosensor for Pb2+. Chemistry of Materials 16, 
3231-3238 (2004). 
213 Chang, I.-H. et al. Miniaturized Lead Sensor Based on Lead-Specific DNAzyme in a 
Nanocapillary Interconnected Microfluidic Device. Environmental Science and Technology 39, 
3756-3761 (2005). 
214 Chang, I. H. et al. Miniaturized lead sensor based on lead-specific DNAzyme in a 
nanocapillary interconnected microfluidic device. Environ Sci Technol 39, 3756-3761 (2005). 
215 Wang, F. et al. A label-free DNAzyme sensor for lead(II) detection by quantitative 
polymerase chain reaction. Anal Biochem 405, 168-173, doi:S0003-2697(10)00379-9 [pii] 
10.1016/j.ab.2010.06.026 (2010). 
216 Kim, J. H., Han, S. H. & Chung, B. H. Improving Pb2+ detection using DNAzyme-based 
fluorescence sensors by pairing fluorescence donors with gold nanoparticles. Biosensors and 
Bioelectronics 26, 2125-2129 (2011). 
217 Liu, J. & Lu, Y. Improving Fluorescent DNAzyme Biosensors by Combining Inter- and 
Intramolecular Quenchers. Analytical Chemistry 75, 6666-6672 (2003). 
218 Lee, J. H., Wang, Z., Liu, J. & Lu, Y. Highly Sensitive and Selective Colorimetric 
Sensors for Uranyl (UO22+): Development and Comparison of Labeled and Label-Free 
DNAzyme-Gold Nanoparticle Systems. Journal of the American Chemical Society 130, 14217-
14226 (2008). 
219 Shen, L. et al. Electrochemical DNAzyme Sensor for Lead Based on Amplification of 
DNA-Au Bio-Bar Codes. Analytical Chemistry 80, 6323-6328 (2008). 
220 Nagraj, N., Liu, J., Sterling, S., Wu, J. & Lu, Y. DNAzyme catalytic beacon sensors that 
resist temperature-dependent variations. Chemical Communications (Cambridge, United 
Kingdom), 4103-4105 (2009). 
221 Liu, J. & Lu, Y. A DNAzyme catalytic beacon sensor for paramagnetic Cu2+ ions in 
aqueous solution with high sensitivity and selectivity. J Am Chem Soc 129, 9838-9839, 
doi:10.1021/ja0717358 (2007). 
222 Elbaz, J., Moshe, M., Shlyahovsky, B. & Willner, I. Cooperative multicomponent self-
assembly of nucleic acid structures for the activation of DNAzyme cascades: a paradigm for 
DNA sensors aptasensors. Chemistry A European Journal 15, 3411-3418 (2009). 
223 Liu, J. & Lu, Y. A Colorimetric Lead Biosensor Using DNAzyme-Directed Assembly of 
Gold Nanoparticles. Journal of the American Chemical Society 125, 6642-6643 (2003). 
224 Liu, J. W. & Lu, Y. Colorimetric biosensors based on DNAzyme-assembled gold 
nanoparticles. Journal of Fluorescence 14, 343-354 (2004). 
225 Ewing, G. W. Analytical Instrumentation Handbook.  (M. Dekker, 1997). 
226 Tsien, R. Y. & Czarnik, A. W. in Fluorescenct Chemosensors for Ion and Molecule 
Recognization Vol. 538; 538    130-146 (American Chemical Society, 1993). 
227 Czarnik, A. W. Chemical Communication in Water Using Fluorescent Chemosensors. 
Accounts of Chemical Research 27, 302-308 (1994). 
228 Czarnik, A. W. Desperately seeking sensors. Chemistry and Biology 2, 423-428 (1995). 
 36 
 
229 Li, J. & Lu, Y. A highly sensitive and selective catalytic DNA biosensor for lead ions. 
Journal of the American Chemical Society 122, 10466-10467 (2000). 
230 Li, Y., Geyer, C. R. & Sen, D. High-Specificity Recognition of Anionic Porphyrins by 
DNA Aptamers. Biochemistry 35, 6911-6922 (1996). 
231 Travascio, P., Li, Y. & Sen, D. DNA-enhanced peroxidase activity of a DNA aptamer-
hemin complex. Chemistry and Biology 5, 505-517 (1998). 
232 Travascio, P., Sen, D. & Bennet, A. J. DNA and RNA enzymes with peroxidase activity - 
An investigation into the mechanism of action. Canadian Journal of Chemistry 84, 613-619 
(2006). 
233 Lee, H.-W., Chinnapen, D. J. F. & Sen, D. Structure-function investigation of a 
deoxyribozyme with dual chelatase and peroxidase activities. Pure and Applied Chemistry 76, 
1537-1545 (2004). 
234 Willner, I., Baron, R. & Willner, B. Integrated nanoparticle-biomolecule systems for 
biosensing and bioelectronics. Biosensors and Bioelectronics 22, 1841-1852 (2007). 
235 Willner, I., Willner, B. & Katz, E. Biomolecule-nanoparticle hybrid systems for 
bioelectronic applications. Bioelectrochemistry 70, 2-11 (2007). 
236 Xiao, Y., Pavlov, V., Gill, R., Bourenko, T. & Willner, I. Lighting up 
biochemiluminescence by the surface self-assembly of DNA - hemin complexes. ChemBioChem 
5, 374-379 (2004). 
237 Niazov, T., Pavlov, V., Xiao, Y., Gill, R. & Willner, I. DNAzyme-Functionalized Au 
Nanoparticles for the Amplified Detection of DNA or Telomerase Activity. Nano Letters 4, 1683-
1687 (2004). 
238 Pavlov, V. et al. Amplified Chemiluminescence Surface Detection of DNA and 
Telomerase Activity Using Catalytic Nucleic Acid Labels. Analytical Chemistry 76, 2152-2156 
(2004). 
239 Xiao, Y. et al. Catalytic Beacons for the Detection of DNA and Telomerase Activity. 
Journal of the American Chemical Society 126, 7430-7431 (2004). 
240 Dausse, E., Da Rocha Gomes, S. & Toulme, J. J. Aptamers: a new class of 
oligonucleotides in the drug discovery pipeline? Curr Opin Pharmacol 9, 602-607, doi:S1471-
4892(09)00121-0 [pii] 
10.1016/j.coph.2009.07.006 (2009). 
241 Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat Rev Drug Discov 9, 
537-550, doi:nrd3141 [pii] 10.1038/nrd3141 (2010). 
  
 37 
 
2 Chapter Two: in vitro selection of a DNA aptamer for perchlorate 
2.1 Introduction 
2.1.1 Source of perchlorate contamination and biological effects 
Perchlorate as a strong oxidizing agent is mainly used in solid rocket engines, explosives 
and a wide variety of pyrotechnics. Its industrial scale application and inadequate disposal 
procedures have led to increasing amount of perchlorate being detected in surface and ground 
waters through leaching and infiltration.2 As a result of human or non-human deposition, 
perchlorate now can be found in 36 U.S. states.3,4 For example, perchlorate can be consistently 
detected in the lower Colorado River, which is used for consumption and crop irrigation in 
California and Arizona.5-7 The perchlorate present in the environment can be absorbed and 
concentrated by food crops and move up the food chain.8-12 A recent survey of 2,820 U.S. 
residents found measurable level of perchlorate in all people tested.13 Recent studies shown that at 
higher concentrations, perchlorate can interfere with iodide uptake in thyroid glands and reduce 
hormone production.14,15 Because of its toxicity to living organisms, the United States 
Environmental Protection Agency (EPA) has decided to regulate perchlorate under the Safe 
Drinking Water Act (SDWA) in 2011 and recommended a protective 15 µg/L perchlorate in 
drinking water. National drinking water regulation is currently in development per SDWA 
requirement.16 Some state governments have acted before the federal government. For example, 
California Department of Health Services has established a public health goal of 6 µg/L.2,3 
2.1.2 Current methods for perchlorate detection in water: pros and cons 
Currently, detection of perchlorate ion relies on a wide variety of methods, including 
electrochemistry, capillary electrophoresis (CE), ion chromatography (IC), and mass 
spectroscopy.17-53 First commonly used method is ion chromatography coupled conductivity 
detection. Using this method, perchlorate as low as 3 µg/L can be detected.26,29,32,34 Besides IC, 
CE has recently become another favorable technique for perchlorate detection. Various CE 
methods have reported limits of detection below 15 µg/L.18,54 A third way for perchlorate 
detection is using electrospray mass spectrometry (ESI/MS) and online chromatography is often 
required to remove the interference from other low mass ions in order to observe perchlorate peak 
at m/z 99.10,17,36,37,45 Horlick had recently reported a detection limit of 5 µg/L using ESI/MS.17 Yet, 
at this low concentration, all these methods suffer from trace amount of common ions, such as 
nitrate and sulfate. Also, operations of these instruments required highly trained individuals and 
the cost for acquiring instruments is enormous. The time required to perform individual test 
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ranges from 10 min for a IC/MS/MS28 to 40 min for IC/CD.26 So, it is very beneficial to device a 
method for easy and cost efficient detection of perchlorate in aqueous solution. 
2.1.3 Using aptamers as targeting agents; SELEX 
As an affinity ligand that can be isolated in vitro via SELEX,55,56 aptamer has 
demonstrated a large number of applications in sensing and environmental monitoring.57-59 
Aptamer based sensors can provide an alternative way for detecting perchlorate with lower cost, 
easy operation and on-site monitoring. For example, aptamer based dipstick has been 
demonstrated for qualitative readout60 and personal glucose meter based detection of analytes 
using aptamer has also reported for quantitative measurements.61,62 Although antibody based 
assays can also be developed (if the antibodies are available), generation of aptamer is relatively 
convenient since the isolation of aptamer can be done in vitro versus using animals to raise 
antibodies.63 
The major challenge of using aptamer to construct sensors for detection of perchlorate is 
the isolation of high affinity aptamers. Aptamers bind to small molecules generally can achieve 
micromolar affinity,57 with some exceptional high affinity binding at nanomolar range, such as 
theophylline (~600 nM) and ethanolamine (6 nM).64,65 Detection of perchlorate at 15 µg/L (150 
nM) hence should feasible if an aptamer is isolated with sufficient affinity.  
2.1.4 Expanding the range of targets for SELEX 
Perchlorate is also an interest target given its unique chemical properties. Although 
perchlorate is a very strong oxidizer, due to high activation energy, perchlorate is normally not 
reactive under ambient conditions. Only transition metal perchlorate salts and organic 
perchlorates can decompose violently. As a result, perchlorate (sodium salt) is commonly used in 
electrochemical studies. In additional, perchlorate has a low charge density. As a result, it is also 
an inert anion that rarely forms complexes with other counter ions.2 
Aptamers for targets similar to perchlorate are rarely isolated or even attempted. 
Although aptamers can theoretically be isolated for any ligands, some practical concerns have 
limited the isolation of aptamers for a certain type of targets, such as species which are negatively 
charged, lacking functional groups for hydrogen bonding and very small.57,66-70 Successful 
isolation of an aptamer for binding perchlorate can lead to a break-through in the field by 
expanding the scope of possible targets. 
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Figure 2.1 Schematic of the structure-switching aptamer 
selection.1 
As perchlorate cannot be 
easily attached onto any types of 
solid supports, an alternative 
SELEX procedure will be 
needed to carry out the 
experiment. In 2005, Li et al. has 
demonstrated an altered SELEX 
procedure in which the target is 
not attached on solid support. 
Instead, the random pool is 
indirectly bound to the solid 
support via DNA hybridization. 
Binding of DNA to the target can 
trigger a conformational change and release the target bound DNA (Figure 2.1).1  
2.2 Materials and Methods 
2.2.1 Materials 
All DNA sequences used were order from Integrated DNA Technologies. DyNAmo 
SYBR Green qPCT Kits was purchased from New England Biolabs, Inc. General chemicals used 
in buffers were purchased from Sigma. Avidin resin purchased from PEIRCE. Inc. T4 
polynucleotide kinase, Taq polymerase was purchased from Invitrogen. 
2.2.2 Random pool design 
The random pool was designed based on a structural-switching model reported by Li et 
al.71 The secondary structure of the random pool was checked with mfold72 (at 23°C, 500 mM 
Na+ and 1.5 mM Mg2+) and the template and primers were also checked for self-dimer, hetero-
dimer and hairpin formations using oligo analyzer provided on Integrated DNA Technologies’ 
website using default settings (25 mM salt, 0.25 µM DNA). 
2.2.3 PCR cycling parameter optimization using RT-PCR 
PCR condition optimization was carried out using a MJ Research Opticon continuous 
fluorescence detector. DNA sequences used were shown in Table. 2.1. In a 50 µL PCR reaction, 5 
fmol of DNA template, 10 pmol of P2/P3 and 25 µL SYBR Green enzyme mix were used 
according to manufacturer’s protocol. The annealing temperature was set to vary from 50°C to 
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70°C and the cycle number was set to 40. Melting curve was generated after each run from 50°C 
to 90°C. The PCR product was also run on a 2% agarose gel. 
Random pool  5’- CCTGC ACCTC GTCCA GCATG C N20 CTACG GTAGC TCATA TGC 
N30 TAGTC TACGC GTTCG CACAG C-3’ 
Random pool 
template 
5’-CCTGC ACCTC GTCCA GCATG CCAAG GCGAT TAAGT TGGGT 
ACTAC GGTAG CTCAT ATGCA CATTC TTGCC CGCCT GATGA ATGCT 
CATCT AGTCT ACGCG TTCGC ACAGC -3’ 
BDNA 13 5’-Biotin-TACCGCAAAAAAAAA-TGA GCTAC CGTAG-3’ 
BDNA 14 5’-Biotin-TACCGCAAAAAAAAA-ATGA GCTAC CGTAG-3’ 
BDNA 15 5’-Biotin-TACCGCAAAAAAAAA-TATGA GCTAC CGTAG-3’ 
BDNA 16 5’-Biotin-TACCGCAAAAAAAAA-A TATGA GCTAC CGTAG-3’ 
BDNA 18 5’-Biotin-TACCGCAAAAAAAAA-GCA TATGA GCTAC CGTAG-3’ 
P1 5’- ATG CTG GAC GAG GTG CAG G -3’ 
P2 5’- GCT GTG CGA ACG CGT AGA CTA-3’ 
P2rA 5’- GCT GTG CGA ACG CGT AGA CTrA-3’ 
P3 5’- CCT GCA CCT CGT CCA GCA T–3’ 
Table. 2.1 Oligos used in this study.  
2.2.4 BDNA optimization by liquid scintillation counting (LSC) 
120 pmol of random pool template was labeled with [γ32P]-ATP with T4 polynucleotide 
kinase in a 20 µL reaction. After labeling, the template was purified on a 10% 8 M urea PAGE. 
For each binding assay, 30 pmol radiolabeled template was mixed with 100 pmol of BDNA (13, 
14, 15 and 16 mer) in a PCR tube, then heated at 94°C for 30s and cooled to room temperature in 
2 hours. After annealing, volume was brought up to 500 µL with selection buffer (50 mM HEPES, 
300 mM NaCl, 50 mM KCl, pH 7) and added into 200 µL avidin resin resin (pre-washed with 3 x 
1 mL PBS and 3 x 1 mL selection buffer) in a 1.5mL microcentrifuge tube. After mixing with 
avidin resin for a set period of time, the resin was spun down with a tabletop centrifuge and the 
supernatant was removed. The resin was washed with denaturing buffer (7 M urea, 0.1 M sodium 
citrate, 3 mM EDTA, pH 5) and this urea fraction was collected. 300 µL from each wash fraction 
was mixed with 6 mL scintillation fluent (Fisher) and counted in a liquid scintillation counter. 
Also, 40 µL from each fraction was ran on a 20% 8 M urea PAGE and exposed to phosphoimager 
cassette. Bands were quantified using ImageQuant.  
2.2.5 BDNA optimization by fluorophore labeled DNA template 
In each binding assay, 30 pmol 5′-FAM labeled random pool template was mixed with 
150 pmol of BDNAs (14, 16 and 18mer), 50 pmol of P1 and P2 in a PCR tube (two reactions 
were prepared for each length of BDNA). The DNA was denatured at 94°C for 30s, and then 
cooled to room temperature in 2 hours. After annealing, volume was brought up to 500 µL with 
selection buffer and added into pre-washed avidin resin in a 1.5 mL microcentrifuge tube. The 
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reaction was incubated at room temperature for 1 hour and cover with aluminum foil. After 1 
hour incubation, one reaction was washed with 8 x 1 mL of selection buffer and the other was 
eluted with 8 x 1 mL of denaturing buffer. Fluorescence in each fraction was measured in a 
fluorometer (495 nm excitation, 510-560 nm emission scan range). Alternatively, without eluting 
using denaturing buffer, the fluorescence of second reaction was measure directly. For all 
selection buffer washes, 150 µL 0.5 M HEPES was added. Fluorescence was also quantified on a 
PAGE using a fluorescence imager. 
2.2.6 Column format binding 
DNA solution was prepared using the same procedure as in the fluorescence assays. 
Avidin resin was pack into a 1 mL plastic disposable column and washed with 15 mL PBS and 
selection buffer. DNA solution was then loaded onto the column, either with the volume brought 
up to 500 µL or remained at 20 µL. DNA solution was loaded repeatedly for at least 5 times. 
After 1 hour incubation, column was washed with selection buffer and collected 8 x 1 mL 
fractions. Fluorescence measurements were taken using the same procedure as previous 
experiments.   
2.2.7 In vitro selection of an ATP binding aptamer 
One hundred picomol of P3 was labeled with [γ32P]-ATP. The initial pool was generated 
by PCR. Four PCR mastermixes were prepared by mixing 100 µL 10x PCR buffer, 5 µL 5 µM 
random pool DNA, 20 µL P2rA and P3 (50 µM), 10 µL labeled P3 (2.5 µM), 30 µL MgCl2, 100 
µL dNTPs (2 mM) and 705 µL ddH2O. Twenty PCR reactions were prepared by adding 2 µL Taq 
polymerase to 198 µL of the mastermix. Previously optimized PCR condition was used for 
amplification. PCR product was hydrolyzed with 18 µL 3M NaOH by heating at 90 °C for 10 
minutes; reactions were neutralized with 4.5 µL 12 M HCl. The DNA pool was recovered by 
ethanol precipitation and lyophilized overnight. After the DNA pool was dried, it was re-
dissolved in 80 µL of ddH2O and purified on an 8 M urea 10% PAGE.  
The purified DNA pool was dissolved in 30 µL 1x selection buffer (1xSB). The first 
round of selection was started by annealing the pool DNA with 50 µL of 50 µM P1, P2 and 10 µL 
of 500 µM 18mer BDNA at 4 °C overnight. 300 µL avidin resin (bed volume) was washed with 6 
mL PBS and 6 mL 1xSB on a column.  
The pool DNA was loaded onto the pre-washed avidin resin and incubated for 1 hour at 
room temperature. The resin was washed with 6 mL 1xSB and collected 10 x 500 µL fractions. 
Another two 2 x 500 µL fractions were collected 1 hour later, and these two fractions were used 
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to determine the background. After collecting the last two fractions, about 300 µL solution was 
left on top of the resin bed. 4 µL 50 mM ATP solution was added onto the column and incubated 
for 1 hour at room temperature. Elution was carried out with 7 mL of 400 µM ATP in 1xSB; 12 x 
500 µL fractions were collected. Radioactivity of each fraction was determined by liquid 
scintillation counting (100 µL in 5 mL LSC fluid). S/B (switching activity) ratio was determined 
by dividing the radioactivity from each fraction by the average radioactivity from the last two 
wash fractions. 10 µL from the elution with the highest switching activity was amplified by PCR 
(10 µL elution, 2 µL 50 µM P2rA and P3, 10 µL 10x Taq Polymerase Buffer, 3 µL 50 mM 
MgCl2, 10 µL 2mM dNTPs, 62 µL ddH2O, 1 µL [γ32P]-ATP, 1 µL Taq). Amplification product 
was hydrolyzed and purified by 10% denaturing PAGE.  
Product from the initial round was dissolved in 30 µL 1xSB and used for the second 
round of selection. At round 14, incubation time was reduced to 5 min. At round 15, selectivity of 
the pool was tested by first eluting with 40 µM of GTP/UTP/CTP, and then followed by 40 µM 
ATP. The selection was carried to round 20 with 5 min incubation and 40 µM ATP elution. 
2.2.8 In vitro selection of a perchlorate aptamer 
The procedure developed from the ATP selection was used the perchlorate aptamer 
selection. With the exception that 50 µL of 50 µM P1 and P2 were replaced with 5 µL of 500 µM 
P1 and P2; initial incubation time was changed to 5 hrs; elution was carried out by first adding 20 
µL 2 M NaClO4, then eluted with 100 mM NaClO4 in 1xSB. Round 1 to 13 was performed with 5 
hrs incubation. The incubation time was then reduced to 3 hrs from round 14 to 19, and it was 
further reduced to 1 hr from round 20 to 25. For the last two rounds of selection, incubation time 
was shorten to 5 min and 100 mM NaNO3 was introduced as a negative selection target before 
elution with 100 mM NaClO4.   
2.2.9 Cloning and sequencing 
Standard molecular cloning method was used. Ten microliter from the round 27 DNA 
pool was first PCR amplified. PCR product was purified with QIAquick PCR purification kit 
(Qiagen). The purified PCR fragment was cloned into plasmid and then transformed with 
TOPO® TA Cloning Kit (Invitrogen). Ninety-six individual white colonies were inoculated into 
3 mL LB-Amp media. After overnight growth, plasmids from the 96 clones were extracted and 
purified with QIAprep Spin Miniprep Kit (Qiagen). One microliter from each purified plasmid 
was sent for sequencing. Sequence alignment was performed with VectorNTI® (Invitrogen).  
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2.2.10 Activity assay 
One member from each class was tested for activity with 100 mM perchlorate with 5 min 
incubation time. The activity of several clones was also tested against some other anions, such as 
nitrate, thiocyanate. 
2.2.11 Design of the degenerate pool for re-selection 
Based on the clone Duplicate I, 20% degeneracy was introduced at each position of the 
random region; the primer binding region and the BDNA region remained the same as the 
original selection. Resulting DNA library was used for carrying a re-selection. The selection 
based on the degenerate pool was carried out in the same selection buffer, but starting with 
shorter incubation time (1 hr) and lower concentration of eluting perchlorate (1 mM).  
2.3 Results and Discussion 
2.3.1 Random pool design 
Because there is no convenient way to attach perchlorate ion to a resin without 
dramatically affecting the selection process, we chose to use a structure-switch method for the 
selection. In this method (Figure 2.2 shows the schematic 71), targeted small molecule is not 
required to be fixed on the resins. Instead, the pool DNA is bound to resins through a 5′ 
biotinylated BDNA. On the pool DNA templates, the sequence which is complementary to the 
BDNA is flanked by two random regions (in blue). Base on the model, if a particular sequence is 
able to interact with target molecule, the interaction would be able to disrupt the pool/BDNA 
binding and release the pool DNA from the column. The released pool DNA is collected, 
amplified and used for the next round of selection 71,73. The design of this pool was based on the 
original pool, except the primer binding sites, BDNA binding region had been randomized; also, 
the random sequence had been expanded to twenty and thirty nucleotides to provide more 
structural possibilities for binding perchlorate anion. 
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Folding of the template by mfold revealed no major secondary structure.72 The lowest 
energy structure had a ∆G of -2.95 kcal/mol (Figure 2.3). P1, P2 and P3 were checked for 
heterodimer formation and mis-priming on IDT’s website. Neither obvious heterodimer 
formation nor mis-priming was observed. 
 
Figure 2.2 Design of the random pool based on Li el 
al. for the perchlorate selection. 
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2.3.2 PCR cycling parameter optimization 
A typical fluorescence trace and melting curve is shown in Figure 2.4. The results are 
summarized in Table 2.2. 
 
 
Figure 2.3 The most stable secondary structure 
of the random pool DNA predicted by mfold. 
 
 
Figure 2.4 Fluorescence trace (up) and melting curve 
(lower) for a typical RT-PCR experiment 
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Tm (°C) min.  Fluo min.cyc.# max. Fluo max.cyc.# fold increase 
49.5 0.050 1 0.212 19 4.240 
50.8 0.053 1 0.272 20 5.132 
52.7 0.057 1 0.263 19 4.614 
55.2 0.059 1 0.332 19 5.627 
56.5 0.058 1 0.316 21 5.448 
57.8 0.061 1 0.429 23 7.033 
58.1 0.075 1 0.343 19 4.573 
59.8 0.066 1 0.339 21 5.136 
60.5 0.043 1 0.273 19 6.349 
62.2 0.068 1 0.386 22 5.676 
62.4 0.047 1 0.335 16 7.128 
65.1 0.081 1 0.446 22 5.506 
67.5 0.046 1 0.254 21 5.522 
69.4 0.054 1 0.280 22 5.185 
  Table 2.2 Amplification at various annealing temperature and cycles 
From the fluorescence trace, the fold increase was calculated from maximum and 
minimum fluorescence. Calculation in Table 3.1 indicated that annealing temperature at 62.4 °C 
gave best amplification after 16 cycles.  
2.3.3 Optimization of BDNA length 
2.3.3.1 BDNA length by LSC 
Since the pool design has slight deviation from the original and the binding of BDNA 
determined the DNA population remained on the column, it is crucial to optimize the binding 
between BDNA and pool sequence.  
At first, binding experiments were performed with BDNA 13, BDNA 14, BDNA 15 and 
BDNA 16. From the radioactivity in the wash fractions and elution fractions, fraction of DNA 
template bound on the avidin resin can be calculated (Figure 2.5). As shown in the figure, after 
the initial wash, large amount of DNA template released from the resin and it continued to release 
in the 1st and 2nd wash. Thereafter, the fraction of bound DNA reached a stable level. Also, 
indicated from the graph, BDNA 16 and BDNA 15 retained more DNA template than 14 and 13 
BDNA, but there was no big difference in binding efficiency between 16 BDNA and 15 BDNA. 
Here, it is speculated that the incubation time was not long enough for more complete of the DNA 
template, so another set of binding experiments with 30 min, 1 hour, 2 hour and 4 hour incubation 
time. Since BDNA 16 and 15 gave best capturing and the largest release of the template was right 
after the incubation, only BDNA 16 and the initial wash fraction were chosen for analysis. The 
 47 
 
result is shown in Figure 2.6. In this binding assay, except quantifying the radioactivity by LSC, 
radioactivity from the initial fraction was also quantified by phosphoimaging. The results from 
the timed binding experiment indicates there was a time dependent change on the amount of 
DNA template bound to the column, but there was no dramatic improvement even when 
incubation time was increased from 30 min to 4 hours (Figure 2.6). Only less than 20% of DNA 
template could be recovered by increasing incubation time. The amount of avidin resin used had 
also been increased, yet no obvious improvement observed (data not shown). It is suspected that 
residue [γ32P]-ATP from the labeling reaction might have skewed the results in these experiments.  
 
Figure 2.5 Fraction of DNA template bound after washed by selection buffer 
 
 
Figure 2.6: Time dependent binding of template to BDNA 16.  
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2.3.3.2 BDNA optimization using fluorophore labeled DNA template 
Because the speculation that the LSC result were skewed by residue [γ32P]-ATP, 
fluorophore labeled DNA template was used to repeat the binding experiments instead radioactive 
label. Also, for fluorescence based experiments, BDNA 18 was added to test whether a better 
binding can be achieved. The result was shown in Figure 2.7. From the graph, results indicate that 
a large fraction of DNA template was indeed released during the initial wash and the number was 
in good agreement with LSC measurements. Apparently, BDNA 18 had a higher binding affinity 
to the template than BDNA 16, yet the difference between BDNA 16 and 14 became negligible 
here. Fluorescence PAGE visualized on fluorescence imager revealed this similar observation. To 
find a better way to bind more DNA template on the resins, the amount of BDNA and avidin 
resin were varied in the next experiment. A slightly modified procedure was also tested: after 
annealing at room temperature for 2 hours, the DNA solution was added onto the resin directly 
without addition of selection buffer. As shown in Figure 2.8, the slightly modified procedure 
retained 7-8% more template DNA than the increasing BDNA 18 or avidin resin amount. This 
might be explained by higher template concentration when the loading volume was reduced and 
this increase gave higher binding efficiency.  
 
Figure 2.7 Binding experiment using FAM labeled DNA with BDNA 14, 
BDNA 16 and BDNA 18 
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Figure 2.8 Binding experiment with modified procedure (18mer 1), 2X 
BDNA 18 (18mer 2), 2X BDNA 18 and resin (18mer 3). 
2.3.3.3 Column format binding experiment 
Since column binding is generally more efficient than batch binding, BDNA binding 
experiment was carried out with avidin resin packed into a column. Result is shown in Figure 2.9. 
Great improvement on binding efficiency was observed when loading volume decreased from 
500 µL to 20 µL.  
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Figure 2.9 Column format binding experiment 
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2.3.4 ATP control selection 
Based on the modifications and optimized PCR parameters discussed above, a control 
ATP selection was carried out using the same buffer condition as reported. As expected, at round 
11 there was a slight increase in pool activity (Figure 2.10) whereas little increase was seen 
before this point. At round 13, the activity reached a level that was significantly higher than 
background. In round 14, reaction time was shortened to 5 minutes (vs. 1 hour in previous rounds) 
and there was a substantial jump in activity. From round 15 to 19, ATP concentration was 
decreased from 400µM to 40µM. The selectivity was tested in round 15, using 40 µM GTP, CTP, 
TTP and ATP. Although the activity decreased significantly from round 14 to round 15, but there 
was a clear discrimination between ATP and other three nucleotides. In these later rounds, large 
decreases in the activity could be accounted for by the 10-fold lower target concentration. In the 
last round the target concentration was increased to 100 µM giving a better response.  suspected 
that the sudden decrease in both reaction time and target concentration in rounds 14 and 15 
resulted in the loss of some active sequences. By the time the selection reached round 20, there 
were insufficient active sequences to give a large response even though there was a higher ATP 
concentration. Given this result, which is in agreement with the literature reported result, the 
selection for a perchlorate binding aptamer was started.  
 
 
Figure 2.10 Selection progression of the ATP control selection. % DNA eluted is 
depicted by the blue line and the switching activity is shown on the bar graph. 
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2.3.5 Perchlorate selection 
In summary, a total of 27 rounds of selection were carried out for perchlorate. For the 
first 19 rounds of selection, five hour incubation was used to elute the perchlorate binding 
sequence. From round 20 to 25, 3 hours incubation was used and for the last two rounds, 5 min 
incubation was used. The NaClO4 concentration was kept constant throughout the selection. A 
selection progress plot is shown in Figure 2.11. The switching activity was slowly increasing 
during the first twenty rounds, but remained below the background (S.A. = 2)*. At round 20, 
incubation time was reduced to 3 hours and the switching activity was increased to 3.17. The 
activity observed at round 20 disappeared after the vocation. Seven more rounds of selection were 
carried out to recover the activity back to the same level (Rd 26 at 3.03 and Rd 27 at 2.96). 
Negative selections were introduced for Rd 26 and Rd 27 with 100 mM NaNO3. The pool 
responded to 100 mM NaNO3, but at a lower level (Rd 26 at 2.09 and Rd 27 at 2.01).  
(*The choice of using S.A.  = 2 as the cutoff value was somewhat arbitrary. It is largely based on 
experience gained from the selections carried out for ATP and melamine aptamers. In most 
instances when the S.A. has increased beyond 2, the S.A. can keep increase in the later rounds, if 
the selection conditions are unchanged. An S/N = 3 (S.A. = 3) should have been used and it is a 
more common practice. If a higher cutoff value is used, such as S.A. = 4, the signal obtained from 
the selection will be considered background. As a result, caution should be taken when deciding 
the cutoff S.A. values in this type of selections, especially when the signal is weak.) 
 
Figure 2.11 Perchlorate selection profile 
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2.3.6 Cloning and analysis 
Round 26 pool was cloned and sequenced. Five classes of DNA were identified from the 
sequencing result; additionally, seven duplicated and two triplicated sequences were identified. 
From the sequence alignment shown in Figure 2.12, many of the clones have major deletion in 
the region which is hybridizing with the BDNA, which can cause the non-specific release of the 
DNA pool, resulting in higher background. There is no significant sequence similarity between 
the random regions between all classes. 
 
Class I 
 
Class II 
 
Class III 
 
Class IV 
 
Figure 2.12 Sequence alignment of Round 26 pool clones 
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Switching activity for each of the classes was measured, but none of them show 
switching activity matching the pool at round 26. Both the truncated and full length constructs 
have been tested. In the truncated constructs, the primer binding sites (yellow regions) were 
removed. Then the activity for all the duplicate and triplicate sequences was measured (Table 2.3). 
Results showed that duplicate I has an activity matching the pool activity. Additional binding 
assays had been carried and confirmed the activity of duplicate I to be 2.70 ± 0.39. Also, activity 
assay showed duplicate I can also respond to a similar anion, iodide (I-) with similar activity as 
ClO4-.  
 
Figure 2.12 continue 
Class V 
 
Duplicates and triplicates 
 
 
Table 2.3 Switching activity identified clones 
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2.3.7 Re-selection with a degenerate pool based on duplicate I 
Based on duplicate I, 20% degeneracy was introduced into the N20 + N30 region. A new 
selection was carried out with lower concentration of ClO4- (1 mM) and 1 hr incubation time.  
A total of 18 rounds of selection were carried out and the result is shown in Figure 2.13. 
No rise of switching activity was observed for the 18 rounds of selection, while a large increase 
of the W11/W1 ratio was observed towards the end of the selection. Based on previous 
observations, W11/W1 ratio is an indication of “health” of the selection. From the previous ATP 
control selection, first perchlorate selection and the melamine selection, an increasing W11/W1 
ratio was observed as the selection proceed further and the pool showed many deletions, 
insertions and mutations.  
 
Figure 2.13 Profile for the re-selection using the degenerate pool. 
2.4 Conclusions 
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rose to ~3 at round 26 and 27. Several characterizations have been carried out to validate the 
switching activity and the result was as expected: Cl- didn’t raise the signal while NO3- could 
cause a slightly increased switching activity, at ~2.  
The pool at Rd 26 has been cloned and sequenced. Five major classes were identified and 
several duplicated/triplicated sequences. Switching activity for each of them were measured and 
only duplicated I showed a matched activity (2.70 ± 0.39). At the same concentration (100 mM), 
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level to ClO4-. Overall, the first rounds of selection resulted in a potentially active sequence, but 
with low affinity and selectivity.  
Re-selection was carried out with a degenerate pool based on Duplicate I. After 18 
rounds of selection, no increase in the switching activity was observed and an increase in the 
W11/W1 ratio was observed. A large W11/W1 ratio could indicate a deteriorated DNA library 
and the selection was paused at this point. Further analysis of the Duplicate I reveals a high GC 
content (57.9%), which could result in problems during PCR; and this may also contribute to the 
quick deterioration of the DNA pool. PCR protocols tailored for high GC content should be used.  
A recent published report suggested an inverse relationship between concentration of 
Mg2+ used in selection and the affinity of the selected RNA aptamers. High affinity binding 
aptamer normally does not have a requirement for Mg2+. As a result, we should also consider 
reducing the concentration of Mg2+ used in the perchlorate selection.  
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3 Chapter Three: In vitro selection of a DNA aptamer for melamine 
3.1 Introduction 
3.1.1 Melamine contamination found in food  
Melamine is a common and inexpensive industrial chemical for producing melamine 
resin, a heat tolerant polymer. The melamine polymer is widely used in fire-retardant pigments, 
plastics, and fertilizers.1 It has been considered as a non-protein nitrogen supplement for cattle but 
has been stopped due to incomplete hydrolysis.2 Although  used heavily in industry, due to 
melamine’s high nitrogen content (66.7% by mass), it is recently adulterated into foods supplied 
to pets and human.1,3 The protein product, such as pet foods and infant formula, adulterated with 
melamine will have high apparent protein due to the standard protein analysis methods, such as 
Kjeldahl and Dumas, are measuring the nitrogen content.4 High concentration of melamine may 
cause formation of crystals in kidney if cyanuric acid is present. The melamine adulteration in pet 
food and milk have affected thousands of pets in the U.S., caused thousands of renal failure cases 
and several deaths of infants in China.5 Due to these incidences of intended melamine 
contamination, different governments have imposed limits of detectable melamine in food and 
milk products. In the U.S., the Federal Food and Drug Administration (FDA) has established a 
2.5 ppm threshold for non-infant-formula products and a 1 ppm threshold for melamine in infant 
milk products.5   
Currently, detection of melamine in various food sources involved using analytical 
instruments,5-29 such as various types of mass spectroscopy,7,9,10,15,16,28,30 high performance liquid 
chromatography6,8-10,22,27, and immunoassays.10,31-34 Although these techniques can provide 
detection limits down to ppb level,10,31,32,35-37 they require the use of delicate instrument, careful 
calibration and a long time to obtain result. Field applications with most of these techniques are 
not possible, with the exception of immunoassay, which has the potential to become field 
deployable. There are also some newly developed detection methods based on various 
nanoparticles platforms, which have showed some promise for the convenient detection of 
melamine.23,25,26,29,38-50 The goal of this thesis project is to isolate an aptamer for melamine, which 
can later lead to the development of aptamer based biosensors for convenient, real-time and on-
site melamine detection.  
Selection is carried out with the same design as the perchlorate selection in the previous 
chapter, and a structure-switching aptamer selection was carried out.51 Although melamine can be 
attached on solid support via covalent linkage, this structure-switching design was chosen due to 
 61 
 
potential easier sensor conversion. To construct a structure-switching aptamer fluorescent sensor, 
fluorophore and quencher can be attached on to different strands of DNA. In the absence of 
melamine, the fluorophore is in close proximity of the quencher; therefore, the fluorescence is 
low. Upon binding of melamine, the BDNA labeled with quencher will dehybridize from the 
isolated aptamer, hence, the fluorescence will increase. This direct aptamer-to-sensor conversion 
has been demonstrated by Li et al. upon isolation of structure-switching aptamer.51  
3.2 Materials and methods 
3.2.1 Materials 
All DNA sequences used were ordered from Integrated DNA technologies. DyNamo 
SYBR Green qPCR Kits was purchased from New England Biolabs, Inc. General chemical, 
buffers were purchased from Sigma. Avidin resin was purchased from PIERCE. Inc. T4 
polynucleotide kinase, and Platinum Taq polymerase was purchased from Invitrogen.  
3.2.2 Methods 
3.2.2.1 The structure-switching selection 
The pool design was the same as the pool used for perchlorate selection and it is based on 
a structure-switching model reported by Li et.al.51 The selection was carried out with the identical 
procedure for the perchlorate selection, except: 
Selection buffer was changed to 100 mM NaCl, 5 mM KCl, 5 mM MgCl2, 20 mM 
Ca(NO3)2, 100 mM NaHEPES at pH 7.0. The concentration of melamine used for elution was 
started with 0.5 mM from round 1 to 10, and subsequently decreased to 5 µM at the end of the 
selection. Elution time was held at 1 hr for the whole selection process. From round 14 onwards, 
the activity of the pool in the presence and absence of milk has also been assessed. From round 
14-17 (+/- milk), 1 % commercially purchased milk was present during the selection procedure.  
DNA sequences used for selection were listed in the table below (Table 3.1): 
Melamine 
random pool 
5’CCTGCACCTCGTCCAGCATGC(N20)CTACGGTAGCTCATATGC(N30)T
AGTCTACGCGTTCGCACAGC-3' (N = random sequence) 
BDNA 18 5’-Biotin-TACCGCAAAAAAAAA-GCATATGAGCTACCGTAG-3’ 
P1 5’- ATGCTGGACGAGGTGCAGG -3’ 
P2 5’- GCTGTGCGAACGCGTAGACTA-3’ 
P2rA 5’- GCTGTGCGAACGCGTAGACT(rA)-3’ 
P3 5’- CCTGCACCTCGTCCAGCAT–3’ 
Table 3.1 Sequences for melamine selection. N in the random pool denotes the randomized 
sequences. rA denotes a ribonucleotide.  
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3.2.2.2 Cloning and sequencing 
Ten microliter from the round 13 DNA pool was first PCR amplified. PCR product was 
purified with QIAquick PCR purification kit (Qiagen). The purified PCR fragment was then 
cloned into plasmid and then transformed with TOPO® TA Cloning Kit (Invitrogen). 96 
individual white colonies were inoculated into LB-Amp media. After overnight growth, plasmids 
from the 96 clones were extracted and purified with QIAprep Spin Miniprep Kit (Qiagen). One 
microliter from each purified plasmid was sent for sequencing. Alignment of the sequences 
obtained was performed with VectorNTI (Invitrogen).  
3.2.2.3 Truncations and switching activity of individual clone 
After alignment and identification of different classes of sequences, the primer binding 
sites on the sequences were removed and tested individually for switching activity. Ten minutes 
elution time and 20 µM melamine were used for assessing switching activity. Sequences tested 
were shown in Table 3.2 below. 
Class_I 
 
CCACACCACAAAGTGGGTTCCCTACGGTAGCCATATGCCGTTGGGGT
CTCTAGTGGGTGTGGCTGCAC 
Class_II 
 
ACCGAACAGTGTGTTTTGTTCTACGGCAGCTCATATGCAGTAGTCACA
AGTTGTCGTGAGTGTGCCCA 
Class_III 
 
GGGCTGCGAGAAGCAAACAGACTACGCTCATATGCTTCTTCGCGGAT
GTCGGTTCGTGTGGGAAC 
Class _VI 
 
GCAAGAGAGCACAGAGGTAAACTACGGTAGTATGCGTCCTATGGCTG
CGGTTAGTCGTGTCCTCC 
Class _V 
 
ACCCCGATGGCGGTCCAGTTCTACGGTAAGCTCATATGCCGGACGTA
GAGACTGGGGAGGTGCGGTTGC 
Class _VI 
 
TCGGTGACGGGGGCCGACCGGTCACGGTAGCTCTATGCGGGTTGGAG
GGGTACAGTCACCGATGTGTG 
Class _VII 
 
AACGGTGGGGCTGCGAGGCCCTACGGTAGCTTACATGCTCGAGGGCG
GAGCGCGTGTTGCGCGGTGGG 
QUAD I 
 
 
CCTGCACCTCGTCCAGCATGCACAGGGCCCGCCGCCGTAGGCTACGG
TAGCTCATATGTGGCGTAGTGTCGCGTGGGGGGTGGCGGGTCTAGTC
TACGCGTTCGCACAGC 
QUAD II 
 
 
CCTGCACCTCGTCCAGCATGCGGGTCGCCGGAAGTTTGGAGCTAGCT
CATATGCGGGTGTGGGGACGCAATCCCCTGGGCCTGGTAGTCTACGC
GTTCGCACAGC 
Table 3.2 Truncated versions of different classes of sequences 
More careful truncations of Class V has been carried out. First, the secondary structure of 
Class V was predicted using mfold52 and various truncations, mutations and deletions have been 
made for testing their activity (Table 3.3) 
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mClass V 
 
 
CCTGCACCTCGTCCAGCATGCACCCCGATGGCGGTCCAGTTCTA
CGGTAAGCTCATATGCCGGACGTAGAGACTGGGGAGGTGCGGT
TGCTAGTCTACGCGTTCGCACAGC 
mV –P1 
 
ACCCCGATGGCGGTCCAGTTCTACGGTAAGCTCATATGCCGGA
CGTAGAGACTGGGGAGGTGCGGTTGCTAGTCTACGCGTTCGCA
CAGC 
mV Core 
 
ACCCCGATGGCGGTCCAGTTCTACGGTAAGCTCATATGCCGGA
CGTAGAGACTGGGGAG 
mV –P2 
 
CCTGCACCTCGTCCAGCATGCACCCCGATGGCGGTCCAGTTCTA
CGGTAAGCTCATATGCCGGACGTAGAGACTGGGGAGGTGCGGT
TGC 
mV minimal CCAGTTCTACGGTAAGCTCATATGCCGGACGTAGAGACTGG 
mV minimal C∆∆A CCAGTTCTACGGTAAGCTCATATGCCACGTAGAGACTGG 
mV minimal CccA CCAGTTCTACGGTAAGCTCATATGCCCCACGTAGAGACTGG 
mV minimal ∆GG∆ CCAGTTCTACGGTAAGCTCATATGCGGCGTAGAGACTGG 
Table 3.3 Truncations, mutations and deletions based on Class V aptamer. ∆ denotes a deletion 
and nucleotide in lower case indicates a mutated base. 
3.2.2.4 Assessment of the apparent binding constant for mV-P2 
The switching activities at various concentration of melamine were used to generate a 
binding curve for mV-P2. Generally, mV-P2 was first labeled with [γ32P]-ATP using T4 
polynucleotide kinase. 50 µL of 50 pmol  mV-P2 (with a small amount of radiolabeled mV-P2), 
75 pmol P1 and 100 pmol BDNA 18 in 1x selection buffer (1xSB) were annealed by slowly 
cooling down to room temperature in a hot water bath. After annealing, 48 µL of the DNA 
solution was added to 400 µL avidin resin (washed with 3 mL 1xSB before use) and incubated at 
room temperature for 1 hr. Then, the DNA was washed with 4 mL 1xSB, incubated for 10 min. 
After 10 mins, 2 x 500 µL 1xSB were collected for background measurements. Small volume of 
25 mM melamine (in 1xSB) was added to the column to achieve the desired elution concentration 
and incubated for 10 mins. After 10 mins incubation with melamine, 2 x 500 µL elution fractions 
were collected. 100 µL from the background and elution fractions was added to 5 mL liquid 
scintillation fluid and measured the radioactivity using a Beckman Coulter LS6000 LSC counter. 
The switching activity (S/B) was determined as 𝐸𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 1 𝐿𝑆𝐶 𝑐𝑜𝑢𝑛𝑡𝑠
𝐴𝑣𝑒𝑟𝑎𝑔𝑒(𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐿𝑆𝐶 𝑐𝑜𝑢𝑛𝑡𝑠)  (since elution 
fraction 1 usually has the highest amount of radioactivity).  
The selectivity of mV-P2 has also been assessed by measuring the switching activity in 
the presence of two other melamine analogs: 2,4,6-triaminopyrimidine (pY) and 6-methyl-1,3,5-
triazine-2,4-diamine (Sigma) (1Me).  
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3.2.2.5 Electrophoresis mobility shift assay (EMSA) 
A representative EMSA DNA sample was prepared as 200 nM [γ-32P] labeled aptamer, 
375 nM P1, 375 nM P2 and 1.25 µM BDNA 18 in 1xSB. The DNA was mixed, denatured at 
90 °C for 10 min in a PCR block and annealed to room temperature in 1 hour. After annealing, 60% 
glycerol in 1xSB was added to the sample for loading. 10% (29:1) polyacrylamide gel was 
prepared in 1xSB and polymerized for 4 hrs at room temperature. Samples were run on a native 
gel for 10 hrs at 5W constant power (~140V). The gel was removed from the gel plates and 
exposed to a phosphoimager screen. The PI screen was scanned on STORM and quantified using 
ImageQuant (Molecular Dynamics).  
3.2.2.6 Sensor designed based on clone mV-P2 
First design of the sensor was based on Li et al.’s design, in which, a fluorophore (6-
FAM®) was covalently attached on the 5ꞌ end of P1 and a quencher (BHQ1) was attached on the 
3ꞌ end of BDNAs of different lengths. In the second design, an internal T base on the aptamer was 
modified with a fluorophore (FAM). The same quencher BDNAs were used (Figure 3.1) 
  
The sensing experiment was carried out on a Fluoromax-2 fluorometer (HORIBA Jobin 
Yvon Inc, Edison NJ). Excitation at 495 nm and emission at 520 nm were used for monitoring the 
FAM fluorescence. Briefly, the fluorophore labeled aptamer was mixed with quencher labeled 
BDNAs in different ratios in 1xSB to prepare a 10x sensor stock solution. To carry out the 
sensing experiment, 3 µL of the 10x sensor solution was added to 294 µL 1xSB in a test tube. 
The test tube was inserted into the holder in the fluorometer and started collecting data (15s 
 
Figure 3.1 Sensor designs based 
on mV(-P2). Upper panel, design 1 
and lower panel, design 2. 
 
Chemical structures of melamine analogues, 
2,4,6-triaminopyrimidine (pY) and 6-methyl-
1,3,5-triazine-2,4-diamine (1Me) 
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collection interval for 300s). After the first two data points were collected, 3 µL of melamine was 
added to the test tube and mixed well by vortexing. Before the next data point was collected, the 
test tube was inserted back to the sample holder and data collection was continued for the rest of 
the duration. Melamine, pY and 1Me were tested in the sensing experiment.  
3.2.2.7 Re-selection with a degenerate pool 
Based on the clone mV and truncation mV-P2, a pool for re-selection was designed. 
Twenty percent degeneracy was introduced to the N20 and N30 regions in mV-P2. A new 
selection (1xNSB) was used for the re-selection, which contained 50 mM NaHEPES, 50 mM 
NaCl, 0.5 mM MgCl2 and 0.5 mM Ca(NO3)2 at pH 7.0. The starting incubation condition was 100 
µM melamine for 1 hr, and this condition was gradually decreased to 60 µM and 10 min.  
 The DNA sequences used for the re-selection are listed in Table 3.4. The PCR parameter 
was optimized using radiolabeled assays. Briefly, in a 50 µL PCR reaction, 50 pmol of primers 
(P2 and P3) were used to amplify 1 fmol of the degenerate pool. 20 rounds of amplifications were 
carried out with annealing temperatures ranging from 53.0 °C to 68.0 °C. The PCR products were 
run on a 10% denaturing PAGE and imaged by phosphoimger. After the annealing temperature 
was optimized, the Mg2+ concentration during PCR amplification was also optimized by sampling 
several concentrations.  
P3(mVdeg) CCT GCA CCT CGT CCA GCA T 
P2rC(mVdeg) GCAACCGCACCTCCC/rU/ 
P2(mVdeg) GCAACCGCACCTCCCC 
18BDNA  Biotin  TACCGCAAAAAAAAA GCA TATGA GCTAC CGTAG 
P2 GCTGTGCGAACGCGTAGACTA 
P1 CCTGCACCTCGTCCAGCATGC 
Degenerate 
pool 
CCT GCA CCT CGT CCA GCA TGC ACC CCG ATG GCG GTC CAG 
TTC TAC GGT AAG CTC ATA TGC CGG ACG TAG AGA CTG GGG 
AGG TGC GGT TGC 
Table 3.4 DNA sequences used in the re-selection. rC denotes a U base in the sequence. The 
blue sequences in the degenerate pool denotes the region where 20% degeneracy was 
introduced 
A total of 32 rounds of selection were carried out for the re-selection. The selection 
progress was monitored by calculating the switching activity (S.A.) as well as percentage of DNA 
eluted for each round. Briefly, 1 µL of the starting pool for each round of selection was saved for 
liquid scintillation counting, which was used as an approximate amount of total DNA present 
during the selection. The radiolabeled DNA pool (with BDNA/P1) was added to 300 µL of avidin 
resin which has been washed with 1xNSB. The DNA was allowed to bind to the avidin column 
for 45 to 60 mins. After the incubation with the column, 10 x 500 µL wash fractions were 
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collected and the DNA was incubated with the column for 1hr. After the 1 hr incubation, 2 x 500 
µL fractions were collected and served as the background for calculating the switching activity. 
Three hundred microliter of final volume was left in the column before addition of melamine. 
Small volume of 25 mM melamine was added to the DNA to achieve the desire target 
concentration. DNA library was incubated with melamine for 1 hr and eluted with 1xNSB with 
100 µM melamine. Five elution fractions were collected and the first two fractions were counted 
by liquid scintillation.  
Ten microliter of the first elution fraction was PCR amplified using the optimized 
condition. The PCR product was hydrolyzed with 6 M NaOH and neutralized before separating 
on a 10% denaturing PAGE. The band with the appropriate molecular weight was cut out and the 
DNA was extracted, ethanol precipitated and used for next round of selection.  
 
Rounds 1-20 were carried out with 1 hr incubation with 0.1 mM melamine. At round 21, 
the selection was branched out: one selection was carried out with 1 hr incubation and the other 
with 15 min incubation. The 1 hr incubation selection was carried out to 22nd round and stopped. 
The 15 min incubation was carried out to the 25th round and branched out once more: one was 
carried on with the first elution fraction (E1 lineage) and the other was carried out with the 
second elution fraction (E2 lineage) (of the 25th round). The E1 lineage was stopped at the 26th 
round and the E2 lineage was carried out to the 29th round. For round 28 and 29 of the E2 lineage, 
the melamine concentration during elution was further decreased to 0.06 mM.  
For round 29 (E2 lineage), no incubation was used, melamine was added to the DNA 
library and elution fractions were collected continuously. After binding the DNA library to the 
avidin column, it was washed with 6 x 0.5 mL 1xNSB. Two 500 µL negative wash fractions (1 
 
Figure 3.2 Representative gel images by 
phosphoimaging for a PCR amplification 
and excision of desired product.   
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mM adenosine, pY and 1Me) were collected.  The DNA was washed with 6 x 0.5 mL 1xNSB and 
eluted with 0.1 mM melamine (4x0.5 mL).  Two hundred microliter from each fraction was 
counted using liquid scintillation. The elution fractions were pooled together, ethanol precipitated 
and amplified by PCR. Normal selection procedure was used for 30th, 31st and 32nd round with 10 
min incubation and 0.1 mM melamine.  
Round 29 and round 32 pools were cloned and sequenced as previously described. 
Sequence alignment was carried out with VectorNTI (Invitrogen).  
3.2.2.8 Clone and truncation analysis (re-selection) 
The switching activity of the clones from round 29 and round 32 sequencing was 
assessed via the column assay as previously described. The clones tested were list in Table 3.5 
below. All the oligos were ordered standard desalted and they were gel purified in house, using 
15% denaturing polyacrylamide gel (29:1). 
Rd32 (Deg) 
Clone 48 
CCTGCACCTCGTCCAGCATGCACACCGCGCTGGCGGATCCTGGTTTA
CGGTAGCTTATATGCAGGGGGTGTGCGCTGGGGAGGTGCGGTTGC 
Rd32 (Deg) 
Clone 12 
CCTGCACCTCGTCCAGCATGGGGTCAGATAGTGGTCAGCGCTATGGT
AGGCTATATGTTGTGTTTGCTGTGTGGGGAGGTGCGGTTGC 
Rd32 (Deg) 
Clone 45 
CCTGCACCTCGTCCAGCATGGGGCTCGGTTGCGGTATAGATCTACGG
TAAGCATATGTTGGTCTTGGTGGGTGGGGATGGTGCGGTTGC 
Rd32 (Deg) 
Clone 24 
CCTGCACCTCGTCCAGCATGGGGATCCGATGACGGTAAAGTTCTATG
GTAAGCTCATATGTCTTACGTTGCTGGGTGGGGAGGTGCGGTTTGC 
Rd32 (Deg) 
Clone 24.1 
CCAGCATGGGGATCCGATGACGGTAAAGTTCTATGGTAAGCTCATAT
GTCTTACGTTGCTGGGTG 
Rd32 (Deg) 
Clone 2 
CCTGCACCTCGTCCAGCATGCAGGGTTGCTGGGGGGCCACGTCTACG
GTAAGCTGTATGCTTGATTGCGTGGGTGGGGAGGTGCGGTTGC 
Rd32 (Deg) 
Clone 6 
CCTGCACCTCGTCCAGCATGGACGTAGCAGGGCATTAAATTGCTACG
GTGAGCTTATGCCTGTCATTGTGGGTGGGGAGGTGCGGTTGC 
Rd29 (Deg) 
Clone 33 
CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTTACGG
TAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC 
Rd29 (Deg) 
Clone 45 
CCTGCACCTCGTCCAGCATGCAGTTCGCTTCGTGGACCAGTTTTAGG
TAAGCTCATATGCTGGCCTGGTGTGGGTGGGGAGGTGCGGTTGC 
Rd29 (Deg) 
Clone 6 
CCTGCACCTCGTCCAGCATGGTGTGATGCTCAGATGCAAATTTACGG
TATGTTTATATGTAGCGGGTTGGGTGTGGGGAGGTGCGGTTGC 
Rd29 (Deg) 
Clone 48 
CCTGCACCCTCGTCCAGCATGGGCATAGCAAGGTGGATTTAGGTTTA
CGGTAAGCTATATGTGGTATATCGTGGGTGGGGAGGTGCGGTTGC 
Rd29 (Deg) 
Clone 48.1 
TCCAGCATGGGGATCCGATGACGGTAAAGTTCTATGGTAAGCTCATA
TGTCTTACGTT 
Rd29 (Deg) 
Clone 48.2 
CCAGCATGGGGATCCGATGACGGTAAAGTTCTATGGTAAGCTCATAT
GTCTTACGTTGCTGGGTG 
Table 3.5 Clones for melamine re-selection 
 Truncations for Round 29 Clone 33 (Rd29C33) are shown below in Table 3.6. 
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Rd29_Clone33_Trunc1 CCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCT
TATATGCAGGGGGTGTGCGTG 
Rd29_Clone33_Trunc2 CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGT
TTTACGGTAGCTTATATGCAGGGGGTGTGCGTG 
Rd29_Clone33_Trunc3 CCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCT
TATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC 
Rd29_Clone33_Trunc4 GATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGG 
Rd29_Clone33_Trunc5 CCTCGCCCAGCATGCACACCGATGGCGGTCCTGTTTTACG
GTAGCTTATATGCAGGGGGTGTGCGTGGCGAGGTGCGGT
TGC 
Rd29_Clone33_Trunc6 CCTGCACCTCGTCCAGGCACACGATGGCGGTCCTGTTTTA
CGGTAGCTTATATGCAGGGGTGTGCACGAGGTGCGGTTG
C 
Rd29_Clone33_Trunc7 CCTCGCCCAGGCACACGATGGCGGTCCTGTTTTACGGTAG
CTTATATGCAGGGGTGTGCGCGAGG 
Rd29_Clone33_Mut1 CCTGCACCTCGCGAAACATGCACACCGATGGCGGTCCTG
TTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGCGAG
GTGCGGTTGC 
Rd29_Clone33_Mut2 CCTGCACCTCGCCCAGCATGCACACCGATCACAGTCCTGT
TTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGCGAGG
TGCGGTTGC 
Rd29_Clone33_Del1 CTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTT
TTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGT
GCGG  
18BDNA (R29C33) Biotin TACCGCAAAAAAAAA GCA TATAA GCTAC CGTAA 
P1’’_1 CCTGCACCTCGT 
P1’’_2 GCAACTGCACCTCGT 
Table 3.6 Truncations of Rd29 clone 33 (Rd29C33) 
3.2.2.9 Sensor development based on Rd29C33 
Fluorescent sensor development was designed and tested the same as the second strategy 
mV-P2. Different lengths of BDNAs were tested.  
3.2.2.10 Assessment of the apparent Kd for Rd29C33 
The apparent Kd of R29C33 to melamine was assessed using the same column binding 
method as previously described for mV-P2. 
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3.3 Results and discussion 
3.3.1 Isolation of a melamine binding aptamer 
3.3.1.1 Selection profile, clone analysis 
Twenty-one rounds of selection were carried out and the selection profile is shown in 
Figure 3.3. At round 8, the switching activity (S.A.) was starting to rise and peaked at round 10, 
which S.A. was 5.95. At round 11, stringency was introduced by reducing the eluting melamine 
concentration to 50 µM. The S.A. at round 11 dropped to 3.34 but recovered to 4.9 at round 12. 
During round 13, the eluting melamine concentration was further reduced to 5 µM and the S.A. 
dropped to 2.01. Additional rounds of selection were carried out in attempt to recover the S.A. 
with 5 µM melamine and 1 hr incubation, but the S.A. remained low. In round 21, melamine 
concentration was increased to 10 µM. A second trial was started from the eluted DNA at round 
12, with eluting melamine at 20 µM. Two more rounds were carried out with 20 µM eluting 
melamine and 1 hr incubation. Another set of parallel selections were carried out from round 13 
elution product in the second trial (20 µM). In parallel, 1% milk was added to one of the selection 
and they were carried out to round 17. The eluting concentration of melamine was kept at 20 µM. 
Figure 3.4 shows the progress of the +/- milk parallel selections. The selection with 1% milk 
suffered a drop in activity at round 15, but both selections recovered to a similar activity level at 
round 17 with S.A. approx. 3. 
 
 
Figure 3.3 Selection progress for melamine aptamer 
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The eluted DNA pool after round 13 in the second trial was cloned and sequenced. 
Ninety clones returned valid sequences and they were aligned and grouped together using 
VectorNTI (Invitrogen). After alignment, seven classes of clones plus two quadruplicate, one 
triplicate, six duplicate and five orphan sequences were obtained. They are shown in Figure 3.5. 
Class I 
 
Class II 
 
Figure 3.5 Alignment of sequence obtained from melamine selection 
 
Figure 3.4 Selection profile for the parallel selection with milk 
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Figure 3.5 continue 
Class III 
 
Class IV 
 
Class V 
 
Class VI 
 
Class VII 
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Truncated Full length 
Class I 1.29  
Class II 1.37  
Class III 1.12  
Class IV 1.17  
Class V 2.27 3.43 ± 0.41 
Class VI 0.98  
Class VII 1.51  
Quad I  1.38 
Quad II  3.68 
Table 3.7 switching activities of Class I-
VII (truncated) and Class V, Quad I and II 
(full length). S.A. measured in the presence 
of 20 µM melamine and 10 minute elution 
 
Figure 3.6 Selectivity of Class V and Quad 
II (20 µM target concentration and 10 min 
elution) 
Figure 3.5 continue 
Quad I and Quad II 
 
 The truncated versions of Class I-VII were first tested for their S.A. and the results are 
shown in Table 3.7. Only Class V showed some activity with a S.A. of 2.27 (with 20 µM 
melamine and 10 min elution). The full length Class V, Quad I and II were also tested later for 
activity. Class V and Quad II have shown binding activity towards melamine.  
The binding of Class V, Quad II aptamer to two melamine analogue was also tested. The 
result (Figure 3.6) shows that the Class V aptamer has a better selectivity against the two 
analogues comparing to Quad II.  
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3.3.1.2 Electrophoretic mobility shift assay for melamine aptamer class V (mV)  
Since the binding of the aptamer to melamine can trigger the release of BDNA, which 
should be a major conformational change, the binding in theory can be visualized by EMSA. A 
representative EMSA image is shown in Figure 3.7. Some major band shifts were observed when 
P1, P2 or BDNA were added to the mV aptamer.  Interestingly, even when P1, P2 and BDNA 
were in excess to mV, the major band in the mV/P1/P2/BDNA complex still co-migrated with the 
mV aptamer alone band. In the presence of increasing amount of melamine, there was an 
observable change in intensity of two bands in the EMSA image. As the concentration increase to 
1 mM, the intensity of the lower band increases while the upper band decreases. Many other 
attempts have been performed with EMSA to obtain the binding constant for mV, but the results 
were not satisfactory.  
  
3.3.1.3 Truncation study reveal a smaller aptamer, mV-P2 
Truncations were made to the mV aptamer according to the predicted secondary structure 
(Figure 3.8). The switching activity for all the truncations was measured by using column binding 
assay. Based on these results, only one truncation (mV-P2) maintained the activity of the full 
length mV aptamer (S.A. = 5.35). Most of the truncations or mutations resulted in a significant 
loss of switching activity.  
 
Figure 3.7 Representative EMSA gel image for mV. Buffer 
condition: 50 mM NaCl, 30 mM KCl, 10 mM MgCl2 1xTA, pH 7.4, 
10% Native PAGE in TA buffer, 18 hrs at 5W  
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Some interesting observations have also been made in the truncation study. Although P1 
was used in the selection to mask the primer binding site, so that it will not participate in binding, 
the switching activity of mV-P2 was significantly reduced in the absence of P1. Removal of the 
region formed by P1 and P1 binding site (mV-P1) resulted in an inactive aptamer. P2 was also 
used during the selection to mask the other primer site, but removal of P2 binding site has no 
effect on the activity of the aptamer (mV-P2). Other than the requirement for P1 for proper 
function, mV-P2 also required at least 10 mM MgCl2 for optimal activity, and this can limit the 
application of mV-P2. 
The apparent binding affinity of mV-P2 was assessed using the column method (Figure 
3.9), since the EMSA yield no satisfactory results.  From the column binding assay, mV-P2 has 
an apparent Kd of 68 µM for melamine. The affinity of mV-P2 for 1Me and pY is approximately 
ten times lower. Based on the relative low affinity and high reliance on high concentration of 
Mg2+, a new selection was designed and carried out based on the sequence of mV-P2.  
 
Figure 3.8 Truncation study on mV aptamer; secondary 
structure predicted by mfold 
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3.3.2 Isolation of melamine aptamers after re-selection 
The pool used for the re-selection was based on mV-P2. Twenty percent degeneracy was 
introduced into the N20 and N30 region of mV-P2. Since one of the primer binding sites was 
removed, part of the sequence belongs to the N30 region was used as the new primer binding site 
in the re-selection (Table 3.4). To reduce the reliance on divalent metal ions, the Mg2+ and Ca2+ 
concentrations were reduced to 0.5 mM each; to improve the affinity, the re-selection was started 
with 0.1 mM melamine during elution.  Detail procedure was described in the materials and 
methods section.  
3.3.2.1 PCR optimization 
The optimization results indicate an optimal Tm  = 62.5 °C and 1.5 mM MgCl2 for PCR 
amplification. Twenty cycles of amplification was used.   
3.3.2.2 Selection profile, clone analysis 
The selection profile is shown in Figure 3.10 – 3.12. Figure 3.10 shows the selection 
progression before it was branched out. Figure 3.11 shows the progress for the E1 lineage and 
Figure 3.12 shows the progress of the E2 lineage. From these results, the activity for the E1 
lineage remained very low.  However, high switching activity can be observed in the E2 lineage, 
and the activity was changing as the stringency was changing.  
 
Figure 3.9 Affinity of mV-P2 to melamine, 1Me and pY.  
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Figure 3.10 Re-selection profile, round 1-22 (0.1 mM melamine elution 
and 1 hr incubation) 
 
Figure 3.11 Re-selection profile, E1 lineage (15 min incubation) 
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Figure 3.12 Re-selection profile, E2 lineage (1 hr incubation) 
After 32 rounds of selection, activity was observed in the pool in the E2 lineage. Two 
DNA pools from round 29 and 32 were cloned and sequenced.  The alignment result is shown in 
Figure 3.13 below. 
Round 29 alignment 
 
Round 32 alignment 
 
Figure 3.13 Alignment result for melamine re-selection 
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3.3.2.3 Clone analysis and truncation studies 
Several clones were chosen for further analysis based on their predicted secondary 
structures. Clones chosen includes: Rd33 Clone 2, 6, 12, 24, 24.1, 45 and 48; Rd 29 Clone 3, 24, 
33, 48, 48.1, and 48.2. The sequences for these clones are listed in Table 3.5.  Among all the 
clones tested, only Rd29 Clone 33 showed an observable switching activity, which was 42.1 ± 0.5.  
 
The activity of R29C33 was initially assessed at several melamine concentrations and 
with pY and 1Me. The result was shown in Figure 3.14. The activity with melamine was much 
higher than mV-P2. Even at 10 µM melamine, the switching activity was still at around 8. The 
cross reactivity with pY and 1Me appears to be lower. The requirement P1 in mV-P2 was also 
removed, since R29C33 maintained the same switching activity in the presence and absence of P1.  
Based on the predicted secondary structure of R29C33, a number of truncations, 
mutations, and deletions were designed and tested (Figure 3.15).  From these results, several 
constructs also possess substantial activity, such as truncation 6, mutation 1 and 2, although the 
original R29C33still has the highest activity.  
 
Figure 3.14 Initial assessment of R29C33. 
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The apparent affinity of R29C33 to melamine was assessed using column binding method 
as previously described for mV-P2. The result is shown in Figure 3.16 below. R29C33 was 
demonstrated to have a much high affinity for melamine comparing to mV-P2.  
 
Figure 3.15 Truncation, mutation and deletion studies on R2933  
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3.3.3 Sensor development 
Fluorescent sensor was designed based on the original literature reported by Li et al. 
Fluorophore (FAM) and quencher (BHQ-1) were added to different strands of the DNA to 
assemble the sensing complex as depicted in Figure 3.17.  
 
Before testing the aptamer for sensing application using the designs in Figure 3.17, the 
ability of the fluorophore and quencher DNA to correctly hybridize with the R29C33 was tested 
using EMSA. The results indicated that P1ꞌꞌ was not capable of binding to the aptamer, but P1 can 
hybridize with R29C33 relatively effectively. Even at 1:1 (P1:R29C33), majority of FAM labeled 
P1 was associated with the R29C33, as indicated by the shift toward a higher molecular weight 
product (Figure 3.18 top left). Later, the binding of BDNAs (16-21 bp) with different lengths to 
 
Figure 3.16 Binding of R29C33 to melamine, comparing to mV-P2. 
 
Figure 3.17 Fluorescent sensor designs for R29C33 
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the aptamer was also tested with EMSA (top right). The results indicated BDNAs with all lengths 
tested were capable of efficiently hybridized with R29C33 (ratio of R29C33: BDNA increased 
from 1 to 4) and no free BDNA can be observed. The mobility of the complex formed by 
P1/BDNA/R29C33 was also analyzed by EMSA. In the presence of 4:1:1 
R29C33:P1FAM:FCAP, the major band observed indicates the formation of the complex. With 
increasing amount of P1FAM and FCAP (4:1:2 and 4:1:4) (lane 2 and 3), free P1FAM and FCAP 
increase and the complex band remain similar in intensity. Addition of melamine does not show a 
significant change in the pattern of bands (lane 6).  
 
Sensing melamine using R29C33 was first tested with different QDNA18 (BDNAs 
labeled with quenchers) and P1FAM, with a ratio of 4:1:1. The results in Figure 3.19 indicate the 
sensor did not perform as expected. Only the sensor constructed with BDNA18s4 shows a small 
increase in the fluorescence output after addition of melamine. More optimizations will be needed 
to complete the fluorescence sensor using the R29C33.  
 
 
Figure 3.18 Binding of fluorescent DNAs to 
R29C33 by EMSA. Top left, EMSA of truncation 6 
(lane 1-3) and R29C33 (lane 4-6) with  P1’’FAM and P1FAM 
(lane 7). Top right, different lengths of BDNA binding to 
R29C33. Bottom left, binding of P1 (lane 4) and 18BDNA 
(FCAP) and QDNA18 (lane 5) to R29C33. Lane 1-3, increasing 
amount of18 BDNA and QDNA18. Lane 6, + melamine 
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3.4 Conclusions 
In conclusion, two selections have been carried out to isolate melamine binding aptamers. 
The first selection yields an aptamer, mV-P2, which binds to melamine with a Kd of ~ 68 µM and 
has a 10 fold selectivity against two structurally similar analogues. However, mV-P2 has a large 
M2+ dependence and a relative low affinity for melamine. A second selection was designed based 
on mV-P2 to obtain a higher affinity aptamer with lower M2+ dependence. The aptamer R29C33 
was identified from the re-selection. The initial characterization shows that the aptamer has a 
significant higher affinity for melamine and improve selectivity against the two analogues. Due to 
the M2+ concentration was reduced in the re-selection, the reliance on high concentration of M2+ 
was reduced. Truncation, mutation and deletion were carried out for R29C33. These studies yield 
several active R29C33 constructs, including truncation 6, mut 1 and mut 2.The truncation 6 can 
be useful for future sensor development, due to its shorter length. The modifications performed 
 
Figure 3.19 Performance of the R29C33 based fluorescent sensor. 
 83 
 
aid in defining the potential ligand binding region. Based on the aptamer R29C33, a fluorescent 
sensor has been constructed and tested. However, at this point, more optimization and re-design 
are necessary to produce a functional fluorescent sensor using R29C33.  
3.5 Future directions 
3.5.1 Confirm the affinity and calculate the (apparent) Kd forR29C33 
The affinity of R29C33 needs to be measured. Current, the column binding method does 
not reflect the true Kd of the aptamer, since a releasing step is required to generate a signal. The 
apparent Kd generated from the column binding is useful when constructing a sensor based on the 
release of BDNA.  
Attempts to use EMSA to measure the Kd for mV-P2 was not successful. Hence, future 
direction will focus on the use of other techniques, such isothermal titration calorimetry or 
nuclear magnetic resonance, to determine the Kd of R29C33 for melamine.   
3.5.2 Development of a melamine sensor based on the personal glucose meter 
Recently, the Lu group has reported a new method which allows the use of a personal 
glucose meter for quantification of non-glucose target.53-55 The original design also employs an 
aptamer for the detection of adenosine via a structure switching mechanism. This design can be 
easily translated for the melamine aptamer isolated. The design of the sensing system is depicted 
in the Figure 3.20. Briefly, R29C33 is modified with a biotin on one end. The modified R29C33 
can be immobilized on streptavidin modified magnetic beads via the streptavidin-biotin 
interaction. Instead of using fluorophore and quencher for signal generation, the BDNA is now 
covalently linked with an enzyme, invertase, which is capable of converting sucrose to glucose. 
Upon binding of melamine, the invertase can be released from R29C33, which is immobilized on 
the magnetic beads. Invertase remains hybridized with the aptamer are removed using a magnet, 
or a syringe filter with appropriate pore size (0.22 µM). The released invertase is then use to 
produce glucose from sucrose. Last, the glucose produced is measured by using a personal 
glucose meter. Initial test demonstrated that this method can be used to produce a glucose signal 
which is proportional to melamine present in the solution. More optimization and test are 
necessary to complete the sensor development using this method.   
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Figure 3.20 Design and proof of concept of a glucose meter 
based method for detecting melamine using aptamer R29C33.  
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4 Chapter Four: Crystallization attempts for DNAzymes 
4.1 Introduction 
4.1.1 8-17, 39E and GR-5 DNAzymes 
Unlike naturally occurring ribozymes, all known DNAzymes are isolated using a method 
called in vitro selection, which is pioneered by Gold and Szostak and applied to isolated 
DNAzyme by Gerald Joyce and Ronald Breaker.1,2 In an in vitro selection for DNAzyme, a 
library composed of approximately 1015 different DNA sequences is exposed to a cofactor 
(normally a metal ion). The sequences that are able to catalyze a desired chemical reaction are 
separated and PCR amplified. The enriched pool of DNA enters subsequent round of selection 
until the desired activity is observed. Currently, in vitro selected DNAzymes are capable of 
performing various types of reaction, including mostly cleavage and formation of phosphodiester 
bond. One of the best studied phosphodiester bond cleavage DNAzyme is the 8-17 DNAzyme.  
The 8-17 DNAzyme is first discovered by Santoro and Joyce in 1997, in a selection 
searching for DNAzyme that cleaves RNA substrate in the presence of Mg2+.3 The 8-17 
DNAzyme composed of two substrate binding arms, which recognize the substrate by Watson-
Crick base pairing, and an unpaired hypothetical catalytic domain (Figure 4.1B). In the presence 
of Mg2+, the 8-17 DNAzyme catalyzes a phosphodiester bond cleavage reaction at a specific 
RNA base. Following its discovery, several RNA-cleaving DNAzymes have been selected by 
different laboratories under different conditions, but they all share the similar 8-17 catalytic 
domain (Figure 4.1), which is crucial for activity.3-6 The 17E DNAzyme (a variant of 8-17) is 
selected for Zn2+ dependent cleavage, but later find out to be most active with Pb2+.4,7,8 The Mg5 
DNAzyme, another 8-17 variant, uses histidine and Mg2+ as cofactors.5,6  
Comparing to the 8-17 family DNAzymes, the 39E DNAzyme is a relative new discovery 
(Figure 4.1D).9 It is selected in the presence of UO22+, a naturally occurring radioactive 
compound, and used as a sensor for UO22+ detection. There is no other DNAzyme shares 
sequence similarity with the 39E DNAzyme to date. One striking feature of the 39E DNAzyme is 
that the stem in the catalytic domain can be extended substantially without affecting the activity,10 
while almost any mutation/extension in the catalytic domain of the 8-17 family greatly reduces 
the activity.11 There are numerous biochemical studies for 8-17 DNAzymes11-15 and only a 
handful of them on the 39E,9,10 yet structural information is virtually absent. There are only 
several folding studies based on various types of footing techniques and FRET.13,16  
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Although the first DNAzyme (GR-5) was selected in 1990 by Joyce and Breaker,17 
further biochemical characterization was absent.18 Very recently, this lead dependent DNAzyme 
was developed into a fluorescence sensor for lead detection with very high selectivity for Pb2+.19  
 
      A 
 
      B 
 
      C 
 
      D 
Figure 4.1: Predicted secondary of 8-17 DNAzyme variants (A-C) and 39E DNAzyme 
4.1.2 3D structure information of DNAzymes 
As close relative to ribozymes, which have many available structural studies including 
NMR and X-ray crystallography, DNAzyme structure remains a mystery. The only crystal 
structure of a DNAzyme, 10-23, was obtained in 1999 by Nowakowsky and Joyce. The 
crystallized DNAzyme adopts a four way junction structure formed by a 2:2 enzyme/substrate 
complex. This novel nucleic acid fold does not indicate an active conformation.20 With many 
biochemical studies on these DNAzymes and the implication from these studies, a structural 
model will be very important for confirming these biochemical studies and improve our 
understanding these nucleic acid enzymes.  
4.1.3 Crystallization of 17E and 39E DNAzymes 
Several properties of nucleic acid pose difficulty for obtaining single crystal for structural 
determination. First, the negative charges on the surface of nucleic acids result in non-specific 
contact for crystal packing, which introduce defects into the crystal lattice.21 Second, nucleic 
acids structures are highly heterogeneous in solution, making it even harder to form order 
structure.22 Two methods are currently used for growing diffraction grade nucleic acid crystals: 
one involves “helix-engineering” and the other uses protein to co-crystallize nucleic acids.  
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The “helix-engineering” approach utilizes known sequences that are easily crystallized, 
and engineers these sequences into the helical region of nucleic acids to be crystallized. One of 
these “crystal-driving” sequences is d(GCGCTTAAGCGC) (Drew Dickerson Dodecamer).23-37 
Co-crystals of protein/nucleic acid usually contained an engineering nucleic acids sequence and a 
protein, which would bind to the sequence with high affinity and it is easily crystallized by itself. 
In this project, both routes have been explored in order to obtain the crystal structure for 17E, 39E 
and GR-5 DNAzymes. 
4.2 Material and Methods 
4.2.1 Materials  
All DNA sequences were purchased from IDT. Chemicals used were purchased from 
Sigma-Aldrich except otherwise mentioned. The TEG-biotin labeled DNA was obtained from 
IDT and HPLC purified. Avidin (BioUltra, A9275) and lysozyme were purchased from Sigma-
aldrich. 
4.2.2 Sequences for crystallization of 17E DNAzyme 
Chosen sequences for initial crystallization screen are shown in Table 4.1. 
GCG-dickerson 8-17ES 5’-CGCTCCGAGCCGGTCGAAAGCGCTTAAGCGC-3’   
5’-GCGCTTAAGCGCT r(OMe)A GGCG 
Dickerson-GCG 8-17ES 5’- GCGCTTAAGCGC TCCGAGCCGGTCGAAA CGC 
5’- GCG Tr(OMe)AG GCGCTTAAGCGC-3’ 
Thrombin aptamer 8-17ES 5’-CGCTCCGAGCCGGTCGAAAAGGTTGGTGTGGTTGGT 
Tr(OMe)AG GCG 
Thrombin 
aptamer/Dickerson 8-17ES 
5’-GCGCTTAAGCGCTCCGAGCCGGTCGAAAA 
GGTTGGTGTGGTTGG T Tr(OMe)AG GCGCTTAAGCGC-3’ 
NMR Pb9 5’-CGTACATAGGCGAAGCTCCGAGCCGGTCGAAATGTA 
CG-3’  
8-17E G4CG 5’-GGGGCGGCCCGCGGCGCGCGCGAATTCGCG-3’ 
5’- CGCGAATTCGCG rG GGCCCC-3’ 
8-17E GCG-Dickerson 
overhangs 
5’-CGCTCCGAGCCGGTCGAACGCGAATTCGCG-3’ 
5’-GCGCTCCGAGCCGGTCGAACGCGAATTCGCG-3’ 
5’-CGCTCCGAGCCGGTCGAACGCGAATTCGCGT-3’ 
5’-GCGCTCCGAGCCGGTCGAACGCGAATTCGCGT-3’ 
5’-CGCGAATTCGCGAGGCG-3’ 
5’-ACGCGAATTCGCGAGGCG-3’ 
5’-CGCGAATTCGCGAGGCGC-3’ 
5’-ACGCGAATTCGCGAGGCGC-3’ 
5’-GGTTGGTGTGGTTGG-3’ 
Table 4.1: sequences for 17E crystallization 
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4.2.3  Sequences for crystallization of 39E DNAzyme 
Chosen sequences for 39E crystallization are shown in Table 4.2.  
39E_Dickerson_GCG 5’-GCGCT TAAGC GCAGT TCGGA AACGA ACCTT CAGAC 
GCGLL LLCGC AGGCG CTTAA GCGC-3’  
39E_CGCG_Dickerson 5’-CGCGA GTTCG GAAAC GAACC TTCAG ACGCG CTTAA 
GCGCL LLLGC GCTTA AGCGC AGCGC G-3’  
39E_CGCG_StemDick
erson  
5’-CGCGA GCGCT TAAGC GCGAA AGCGC TTAAG CGCCT 
TCAGA CCCAA GATTG GLLLL CCAAT CTTGG AGCGC G-3’  
39E_GCG_StemDicker
son 
5’ -GCGAG CGCTT AAGCG CGAAA GCGCT TAAGC GCCTT 
CAGAC CCAAG ATTGG LLLLC CAATC TTGGA GCGC-3’ 
39E_Dickerson_StemT
6 
5’-GCGCT ATAGC GCAGT TTTTT TCGGA AACGT TTTTT 
ACCTT CAGAC GCGLL LLCGC AGGCG CTTAA GCGC-3’  
Table 4.2: sequences for 39E crystallization 
4.2.4 Denature and annealing of DNA 
DNA sequences were purified by PAGE. Lyophilized DNA was then dissolved in the 
appropriate buffer and its concentration was determined by UV spectroscopy. DNA was 
denatured by placing it in near boiling water and annealed by slowly cooling the hot water to 
room temperature.   
A more precisely controlled denaturation and annealing was used. Appropriate 
concentration of DNA was prepared in slightly buffered solution (e.g., 5 mM NaCac. pH 6.5 and 
2 mM MgCl2) in a 200 μL PCR tube. The PCR machine was programmed first heat to 85 °C, then 
cool to 25 °C at a rate of 0.1 °C/min. 
4.2.5 The hanging drop method 
This method uses the vapor phase to bring about equilibration and is very well suited to 
screening a large number of conditions when only a small quantity of materials is available. With 
this approach, a microdroplet of mother liquor is suspended from the underside of a microscope 
cover slip, which is then placed over a small well containing 0.4 mL of the precipitating solution. 
An important point is that the cover slips must be thoroughly and carefully coated with non-
wetting silicone to ensure proper drop formation and prevent spreading. The wells are most 
conveniently supplied by disposable plastic tissue culture plates with flat ground rims that permit 
airtight sealing by application of a light coating of silicone grease on the circumference.38 
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4.2.6 Activity assay  
To test the activity of the candidate DNAzyme constructs for crystallization, activity 
assays under single turn over condition was performed. Briefly, the cleavable substrate was 
labeled with [γ-32P]-ATP using T4 kinase. Five hundred fold excess of the enzyme was 
incubated with the substrate to anneal. To initiate the reaction, small volume of high 
concentration metal ion stock solution was added to the reaction mixture. A small aliquot of the 
reaction was withdraw and quenched with 8 M urea at the particular time point. After the activity 
assay, the DNA sample at each time point was run on a denaturing PAGE to separate the cleaved 
and uncleaved substrate. The gel was exposed to a phosphoimager screen and scanned. The 
scanned gel image was quantified using ImageQuant (Molecular Dynamics)  
For activity assays involving proteins, the DNAzyme-substrate was first annealed and 
following by the addition of proteins at different concentrations. The rest of the assay was carried 
out the same as a DNAzyme only activity assay.  
The activity assays for 8-17 DNAzymes were generally carried out in 100 mM NaCl, 50 
mM NaHEPES and pH 7.0. For 39E DNAzyme, the buffer generally contained 100 mM NaMES, 
100 mM NaCl at pH 5.5.  
4.2.7 Buffer conditions 
All buffer conditions used are summarized in Table 4.3-4.6.  
 pH 
12mM 
SpCl4 
40% 
MPD 
50mM 
NaCaco. 
40mM 
LiCl 
40mM 
KCl 
40mM 
RbCl 
20mM 
Ca(NO3)2 
20mM 
BaCl2 
20mM 
SrCl2 
1 6 + + + + - - + - - 
2 6 + + + + - - - + - 
3 6 + + + + - - + + - 
4 6 + + + - + - + - - 
5 6 + + + - + - - + - 
6 6 + + + - + - + + - 
7 6 + + + - - + + - - 
8 6 + + + - - + - + - 
9 6 + + + - - + + + - 
10 6 + + + + + - + - - 
11 6 + + + + + - - + - 
12 6 + + + + + - + + - 
13 6 + + + + - + + - - 
14 6 + + + + - + - + - 
15 6 + + + + - + + + - 
16 6 + + + - + + + - - 
17 6 + + + - + + - + - 
18 6 + + + - + + + + - 
19 6 + + + + + + + - - 
20 6 + + + + + + - + - 
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21 6 + + + + + + + + - 
22 6 + + + + - - - - + 
23 6 + + + - + - - - + 
24 6 + + + - - + - - + 
Table 4.3 
 
pH, 50mM 
NaCac. %MPD Ca(NO3)2 
1 pH 6.5 5% 100mM 
2 pH 6.5 10% 100mM 
3 pH 6.5 15% 100mM 
4 pH 6.5 20% 100mM 
5 pH 6.5 25% 100mM 
6 pH 6.5 30% 100mM 
7 pH 6.5 35% 100mM 
8 pH 6.5 40% 100mM 
9 pH 6.0 5% 100mM 
10 pH 6.0 10% 100mM 
11 pH 6.0 15% 100mM 
12 pH 6.0 20% 100mM 
13 pH 6.0 25% 100mM 
14 pH 6.0 30% 100mM 
15 pH 6.0 35% 100mM 
16 pH 6.0 40% 100mM 
17 pH 6.5 45% 100mM 
18 pH 6.5 50% 100mM 
19 pH 6.5 55% 100mM 
20 pH 6.5 60% 100mM 
21 pH 6 45% 100mM 
22 pH 6 50% 100mM 
23 pH 6 55% 100mM 
24 pH 6 60% 100mM 
Table 4.4 
  50mM 
NaCac, pH 6 
% MPD 50mM 
Li 
50mM K 50mM 
Rb 
20mM 
Ca 
20mM 
Ba 
12mM 
SpCl4 
1 + 20% + - - + - - 
2 + 20% - + - + - - 
3 + 20% - - + + - - 
4 + 20% - - - + + - 
5 + 20% - - - + - + 
6 + 20% + - - + - + 
7 + 20% - + - + - + 
8 + 20% - - + + - + 
9 + 25% + - - + - - 
10 + 25% - + - + - - 
11 + 25% - - + + - - 
12 + 25% - - - + + - 
13 + 25% - - - + - + 
14 + 25% + - - + - + 
15 + 25% - + - + - + 
16 + 25% - - + + - + 
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17 + 30% + - - + - - 
18 + 30% - + - + - - 
19 + 30% - - + + - - 
20 + 30% - - - + + - 
21 + 30% - - - + - + 
22 + 30% + - - + - + 
23 + 30% - + - + - + 
24 + 30% - - + + - + 
Table 4.5 
  
50mM NaCac 
pH 6 
% 
MPD 
Ca(NO3)2 20mM Ba2+ 50mM K+ 
1 + 3 100mM - - 
2 + 4 100mM - - 
3 + 5 100mM - - 
4 + 6 100mM - - 
5 + 7 100mM - - 
6 + 8 100mM - - 
7 + 3 50mM + - 
8 + 4 50mM + - 
9 + 5 50mM + - 
10 + 6 50mM + - 
11 + 7 50mM + - 
12 + 8 50mM + - 
13 + 3 50mM - + 
14 + 4 50mM - + 
15 + 5 50mM - + 
16 + 6 50mM - + 
17 + 7 50mM - + 
18 + 8 50mM - + 
19 + 3 50mM + + 
20 + 4 50mM + + 
21 + 5 50mM + + 
22 + 6 50mM + + 
23 + 7 50mM + + 
24 + 8 50mM + + 
Table 4.6 
Additionally, buffer conditions have been used with addition of various amines. 
Commercially available DNA crystallization kit (HR2-116) had been used.  
  
Figure 4.2 Additional polyamines used for crystallization trials 
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4.2.8 Co-crystallization with Hoechst 33258 
8-17ES(OMe)-Dickerson-GCGC and GCG-Dickerson-8-17ES(OMe) have been set up to 
co-crystallized with a small molecule Hoechst 33258. 1 mM enzyme and substrate was first 
denatured and annealed in the presence of 5 mM NaCac pH 6.5 and 2 mM MgCl2 in a PCR 
machine. After annealing, 2 mM Hoechst 33258 was added to the DNA and incubated for 3~4 hrs 
at room temperature. Hampton Research HR2-116 kit was used for setting up crystallization trials.  
4.2.9 Matrix screen 
A matrix screen has been set up for searching for the more appropriate candidates for 
crystallization.21 The matrix was composed of four enzyme and four substrate strands (GCG-
Dickerson-17ES), each of them has a 5ꞌ or 3ꞌ overhang base. 16 different combinations (Figure 
4.3 upper panel) were possible and crystallization trials were carried out with Modified Jing’s 
condition.  1 mM of each enzyme and substrate was denatured and annealed in the presence of 5 
mM NaCac pH 6.5 and 2 mM MgCl2. Denaturation and annealed was carried out by first heating 
the DNA to 85 °C and then cooled to 25 °C at a rate of 0.1 °C/min. The whole process took about 
10 hrs to complete. After annealing, 1 μL of DNA was mixed 1 μL buffer and spotted on a glass 
slide, equilibrating against 300 μL of reservoir precipitant.  
Sequences showed promising results were subject to a series of conditions modified from 
the original Jing’s condition (100 mM NaCac, 250 mM MgCl2, 15% isopropanol, pH 6.5) (Figure 
4.3) 
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Figure 4.3 Matrix screen for GCG-Dickerson-17ES 
 
Figure 4.4 From top to bottom, Modified Jing’s condition, Seaman conditions, precipitant screen, 
RJ II, RJ II with additives, RJ III, RI IV and RJ V. 
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Figure 4.4 (continue) From top to bottom, Modified Jing’s condition, Seaman conditions, 
precipitant screen, RJ II, RJ II with additives, RJ III, RI IV and RJ V. 
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Figure 4.4 (continue) From top to bottom, Modified Jing’s condition, Seaman conditions, 
precipitant screen, RJ II, RJ II with additives, RJ III, RI IV and RJ V. 
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Figure 4.4 (continue) From top to bottom, Modified Jing’s condition, Seaman conditions, 
precipitant screen, RJ II, RJ II with additives, RJ III, RI IV and RJ V.  
4.2.10 Co-crystallization of 17E DNAzyme with avidin and lysozyme 
All 17E sequences used for avidin and lysozyme crystallization were shown in Figure 4.5. 
For avidin co-crystallization, 0.6 mM respective DNA was annealed in 50 mM KOAc, pH 4.85 
by heating to 85 °C and slowly cooled to 25 °C at a rate of 0.1 °C/min. Avidin was dissolved in 
KOAc pH 4.85. After DNA was annealed, avidin was added to the DNA to achieve a final 
concentration of 20 mg/mL (condition Strepxbiotin) and 16.6 mg/mL. The DNA was allowed to 
interact with the avidin for overnight at 4 °C. Then, crystallization trials were set up according to 
the two conditions by mixing equal volume of buffer with DNA/protein solution. The final DNA 
concentration was 0.3 mM and the final protein concentrations were 10 mg/mL and 8.3 mg/mL.  
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Three different lengths of lysozyme aptamer (Figure 4.5, middle panel) were first used to 
set up crystallization trials with lysozyme. DNA was first annealed in 5 mM NaCac, 1 mM MgCl2 
(pH 6.5) as previously described. After annealing, the DNA was mixed with the lysozyme and 
incubated for about 4 hr at 25 °C. After incubation, equal volume of DNA/protein solution was 
mixed with the crystallization buffer for setting up the trials. Final concentration of DNA and 
protein is indicated in Figure 4.6 (third panel). The DNAzyme/lysozyme trials were set up 
similarly and the conditions were shown in Figure 4.6 fourth panel. Besides using lysozyme 
aptamer, lysozyme has also been directly introduced into the crystallization condition without 
aptamer.  
 
 
 
Figure 4.5 Sequences for avidin/DNAzyme (up), lysozyme aptamers/lysozyme 
(middle) and lysozyme/DNAzyme (bottom) co-crystallization.  
 102 
 
 
 
 
Figure 4.6 Conditions for co-crystallization with avidin (upper two, Strepxbiotin and Strepxbiotin 
2) and lysozyme. 
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Figure 4.6 (continue) Conditions for co-crystallization with avidin (upper two, Strepxbiotin and 
Strepxbiotin 2) and lysozyme.  
4.2.11 X-ray diffraction 
X-ray diffraction data was collected at the Brookhaven National Laboratory and data 
analysis was carried out by Mr. Gao at the macromolecule crystallization facility at UIUC. 
4.3 Result and discussion 
4.3.1 Predicted secondary structures 
4.3.1.1 17E DNAzyme 
Secondary structure of Dickerson_GCG_17ES and GCG_Dickerson_17ES were 
predicted using mfold,39 as shown below in Figure 4.7 (100mM NaCl, 25 °C). From the mfold 
prediction, both sequences maintained the same substructure as the classical 17E.  
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A 
 
B 
 
C 
 
D 
 
Figure 4.7: Secondary structure predictions by mfold: A, GCG_Dickerson_17ES; B, 
Dickerson_GCG_17ES; C, Pb9 and D, classical 17E 
4.3.1.2 39E DNAzyme 
Secondary structures for the 39E DANzyme sequences are shown in Figure 4.9. The 
crystallization sequences share the same predicted structure with the canonical 39E DNAzyme. 
For 39E_Dickerson_StemT6, the actually sequence had a stretch of six T’s in the stem region. 
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The rationale for using a stretch of T’s is that as previous observation shown, Hg2+ can intercalate 
between two T’s and stabilize two strands of polythymidine.40,41 Also, it has been shown that 39E 
with polyT modification at the stem is active in the presence of Hg2+. Therefore, crystallization of 
this particular sequence involved Hg2+. 
A 
 
B 
 
C  
 
D 
 
Figure 4.8: sequences for 39E crystallization: A, 39E_Dickerson_GCG; B, 
39E_CGCG_Dickerson; C, 39E_CGCG_StemDickerson; D, 
39E_GCG_StemDickerson; E, 39E_Dickerson_StemT6 (for prediction purpose, A-T 
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basepairs were used; F, canonical 39E 
E 
 
F 
 
Figure 4.8: sequences for 39E crystallization: A, 39E_Dickerson_GCG; B, 
39E_CGCG_Dickerson; C, 39E_CGCG_StemDickerson; D, 
39E_GCG_StemDickerson; E, 39E_Dickerson_StemT6 (for prediction purpose, A-T 
basepairs were used; F, canonical 39E 
4.3.2 Activity assays 
4.3.2.1 17E 
Activity assay for Pb9 (truncated 17E) has been performed by our collaborator. Activity 
assay results for GCG_Dickerson_17ES are shown in Figure 4.9. As demonstrated, 
GCG_Dickerson_17ES is active and it is used for later crystallization trials.  
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Figure 4.9: Activity assay of GCG_Dickerson_17ES in the presence of 
5mM Zn2+ (pH 7), 20mM Mg2+ (pH 7) and 100uM Pb2+ (pH6).  
Activity assay results for Dickerson_GCG_17ES indicates that they are not active under 
the conditions tested and this may due to a conformational change after the introduction of the 
Dickerson sequence.  
4.3.2.2 Dickerson_CGATCG GR-5 DNAzyme activity assay 
   
 
 
Figure 4.10 Activity of Dickerson_CGATCG GR-5 DNAzyme in the presence of 50 µM lead. 
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Activity for the GR-5 DNAzyme construct showed that it is active in the presence of Pb2+. 
Also, the presence of the small molecule Hoechst 33258 did not have a significant effect on the 
activity of this DNAzyme.  
4.3.2.3 39E DNAzyme activity assays 
 
The results for various 39E DNAzyme constructs are shown in the Figure 4.11. Among 
them only several construct showed activity in the presence of UO22+, including 
Dickerson_GCGC_39ES,  O_O_StemDickerson_39ES, and Ori_Dickerson_39ES.  
 
 
Figure 4.11 Activity assays for 39E constructs 
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4.3.3 Buffer conditions 
Initial screen using Pb9 indicated that presence of 12 mM spermine causes precipitation 
of DNA immediately and MPD higher than 10% causes precipitation within one month even 
without spermine.  
Through further testing, we discovered almost all the amines we tried were not 
compatible for the DNAzyme crystallization. They inevitably caused precipitation. Among all 
conditions tested, none of them seemed to promote the crystal growth. Incorporation of Hoechst 
33258 into Jing’s and the modified Jing’s conditions resulted in more useful information and the 
formation of crystals. A list of crystal forming conditions will be discussed in 4.3.6. 
4.3.4 Crystallization trials with the matrix screen 
From the matrix screen, one combination of enzyme and substrate overhangs resulted in 
crystal formation in one particular buffer condition. After two months of growth, the two crystals 
grew to a size about 200 µm x 100 µm. Diffraction data was collected for this crystal (Figure 
4.12). No diffraction was observed for this crystal.  
 
  NaCac: pH 5.5 100 mM 
  MgCl2:  250 mM 
  (NH4)2SO4: 1 M 
  Iso-pro: 5% (reservoir)  
 
Figure 4.12 5ꞌA CGC-Dickerson 17S and CGC-Dickerson 3ꞌT 17E; formation of 
crystal under the specified buffer conditions 
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Additional crystals were obtained and sent for data collection (Figure 4.13-4.16): 
The crystal in Figure 4.13 was a salt crystal. From the diffraction patterns, it is suggested 
the rest of the crystals were DNA crystals. The diffraction quality for all of them was not good 
enough to solve the structure. The last diffraction pattern had a limit of diffraction of 5 Å. 
  
Figure 4.13 0.5 mM 17E/GCG-Dickerson_17S3′A with 1 mM Hoechst 
33258. Well condition: 100 mM NaCac pH 5.5, 250 mM MgCl2, 20 
mM CdCl2, 0.5 M (NH4)2SO4 and 5% isopropanol.  
 
 
 
Figure 4.14 0.5 mM 17E/GCG-Dickerson_17S3′A with 1 mM 
Hoechst 33258. Well condition: 100 mM NaCac pH 5.5, 250 mM 
MgCl2, 0.8 M (NH4)2SO4 and 5% MPD. 
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Figure 4.15 0.5 mM GCG_Dickerson_17E3′T and 
GCG_Dickerson_17S5′A with 1 mM Hoechst 33258. Well condition: 
100 mM NaCac pH 5.5, 250 mM MgCl2, 1 M (NH4)2SO4, and 3% 
isoproponal. 
  
 
Figure 4.16 
Diffraction pattern obtained from 
0.5 mM GCG-Dickerson 17E 
witth GCG-Dickerson_17S3′A 
with 1 mM Hoechst 33258; well 
condition: 100 mM NaCac pH 
5.5, 250 mM MgCl2, 0.8 M 
(NH4)2SO4 and 5% MPD.  
 
Diffraction pattern obtained from  
0.5 mM GCG Dickerson 17E 
with GCG-Dickerson_17S3′A 
with 1 mM Hoechst 33258; well 
condition: 100 mM NaCac pH 
5.5, 250 mM MgCl2, 100 µM 
Pb(OAc)2,  0.5 M (NH4)2SO4 and 
5% isopropanol. 
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Diffraction pattern obtained from  
0.5 mM GCG-Dickerson 17E 
with GCG-Dickerson_17S3′A 
with 1 mM Hoechst 33258; well 
condition: 100 mM NaCac pH 
5.5, 250 mM MgCl2, 1 M 
(NH4)2SO4 and 5% isopropanol. 
4.4 Conclusion 
The effort towards crystallizing a DNAzyme started with a very broad approach, 
including testing a number of DNAzymes, such as the 8-17 DNAzyme, 39E DNAzyme and the 
GR-5 DNAzyme. The initial DNAzyme alone approach for all of them was not successful and 
later proteins were included to try to facilitate the crystallization. However, protein aid 
crystallization takes a long time to set up and expensive to carry out. Later, the matrix screen 
approach, which was utilized for the 10-23 crystallization, yielded some promising progress and 
several crystals were observed for different constructs. As a result, the matrix screen became the 
most important approach for crystallization of DNAzyme.   
From the matrix screen, a set of conditions which favor the crystallization of DNAzyme 
constructs was identified. The crystallization contains 50 mM NaCac pH 5.5, 250 mM MgCl2, 
0.8-1 M (NH4)2SO4, 3-5% isopropanol or MPD. Two DNA constructs repeatedly yield crystals 
under these conditions (Figure 4.17). All crystals contained 2:1 ration of Hoechst 33258:DNA. 
The Dickerson sequence with Hoechst 33258 is also very important for the crystallization. Future 
DNA crystallization should focus on these two constructs and refining the buffer conditions.  
     
Figure 4.17 Two best DNAzyme candidates for crystal growth 
The matrix screen method is shown to be very fruitful for determining the initial 
conditions for 17E DNAzyme crystallization.  It is adopted to screen candidates and buffer 
conditions for GR-5 and 39E DNAzymes.  
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4.5 Future direction 
4.5.1 Matrix screen approach for GJ leadzyme and 39E DNAzyme 
Based on the initial results obtained from the 8-17 matrix screens, a set of GR-5 
DNAzyme candidates have been designed. Initial screening with this set of GR-5 DNAzyme 
candidates has begun (Figure 4.18).  
 
  
Figure 4.18 Constructs of GR-5 DNAzyme candidates for the matrix 
screen 
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 Similar approach should be taken for screening the 39E DNAzyme. Buffer conditions 
from the 8-17 matrix screens will serve as the starting points for both the GR-5 DNAzyme and 
39E DNAzyme screens.  
4.5.2 Crystallization using molecularly imprinted polymer 
Recently, using molecular imprinted polymer can facilitate the growth of better quality 
crystal has been reported.42 In this instance, polyacrylamide gel will be imprinted with 
DNAzymes, Drew Dickerson Dodecamer, or ribozyme. The imprinted polymer will be added into 
the crystallization buffer and potentially can help the growth of DNAzyme crystals. Initial tests 
have been set up using Drew Dickerson Dodecamer and the classical 8-17 DNAzyme imprints 
using the buffer conditions obtained from the 8-17 screen.  
  
Figure 4.18 continue 
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5 Chapter Five: Development of a new fluorescence sensor for Pb2+ 
5.1 Introduction 
5.1.1 From basic research to application 
In the previous chapters, the isolation of DNA aptamers against two different targets, 
perchlorate and melamine, have been descibed. Chapter four describes the effort towards 
obtaining structural information regarding to DNAzymes using crystallography. In this chapter, 
moving from basic research to application, it describes the development of a highly selective Pb2+ 
sensor using a classical DNAzyme isolated almost two decades ago.  
5.1.2 Pb2+ as an environment contaminant and DNAzyme based biosensor  
Metal ions play important roles in biology as well as in our everyday life. However, some 
metal ions, even when present in trace amount, can have long term toxic effect on human. Many 
of these toxin metal ions are heavy metal ions, including but not limited to lead, mercury, 
cadmium, thallium, and chromium. Many of these metal ions can contaminate the water and soil 
that human lives are depending on, therefore, detection of heavy metal ions in the environment 
are particularly important. It is not only a non-essential metal ion, lead ion is toxic even when it is 
present in a small amount. It is present widely in the environment due to its usage over time, first 
used in vessels, more recently in paint, pipes and additives in gasoline. Chronic ingestion of Pb2+ 
will cause renal malfunction, anemia, gout and nervous system disorder. Particularly, Pb2+ can 
damage the developing brain in children and fetuses. Comparing to adults, they are more 
susceptible very low amount of Pb2+ in chronic exposure (which is non-toxic) and resulting in 
neurodegeneration and learning disabilities.1-5 As a result, the U.S Environmental Protection 
Agency (EPA) has set the maximum contaminant level for Pb2+ at 72 nM (www.epa.gov/lead/).  
In standard laboratories, Pb2+ is detected using inductively coupled plasma-mass 
spectrometry (ICP-MS)6-9 and atomic absorption spectrometry (AAS).10-13 These methods are 
extremely sensitive and selective for Pb2+, as well as other metal ions. They can detect Pb2+ down 
to 0.1 parts-per-trillion range.14 However, being sensitive and accurate, these techniques require 
expensive equipment and highly train personnel for operation and maintenance. As a result, their 
availability is only limited to fixed laboratory locations. For efficient on-site and real-time 
detection of Pb2+, other techniques have to be developed and used.  
Over the years, many other sensors have been developed for monitoring Pb2+ 
concentration in the environment.  Electrochemical and optical sensors have been developed for 
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Pb2+ detection, but they are less selective and more expensive.15-17 Fluorescent sensor has been 
developed based on the Pb2+ chelation by rhodamine B, but the sensor requires operation in 100% 
acetonitrile, which is not compatible with sensing in aqueous solution.18 Monoclonal antibody has 
been raised by Blake et al. and ELISA assay for Pb2+ using this antibody has been developed with 
a reported limit of detection at 56 nM.19-21 Portable detection kits for Pb2+ have also been reported 
based on the color change upon Pb2+ chelation by sodium rhodizonate.22-24  
Among all these sensors, DNAzyme catalytic beacon received much of the attention, 
because it offers high selectivity and sensitivity, stability, and convenience. Currently, most of the 
DNAzyme catalytic beacons are based on the 8-17 DNAzyme, which is capable of catalyzing 
phosphodiester bond cleavage reaction in the presence of Pb2+ (Figure 5.1).25 To construct a 
fluorescent sensor using the 8-17 DNAzyme, a fluorophore (in this case, FAM) is placed on the 5ʹ 
end of the substrate strand (black). Two quenchers are placed on the 3ʹ ends of the substrate and 
enzyme strands. The quencher on the substrate is incorporated to reduce overall background 
during the sensing application.26 When Pb2+ is present, the enzyme becomes active and catalyzes 
the cleavage of the phosphodiester at the RNA cleavage site. The cleaved substrate is insufficient 
to keep hybridized to the enzyme, hence releasing the fluorophore containing fragment and 
generating a fluorescence signal.  After the DNAzyme based catalytic beacon was first developed 
in 2000,27 many other Pb2+ sensor based on the 8-17 DNAzyme has been developed by various 
groups and shown good sensitivity and selectivity.28-38  
 
The 8-17 DNAzyme is discovered by a combinatorial technique called in vitro 
selection.39-41 From its first discovery, multiple variants of the 8-17 DNAzyme have been selected 
 
Figure 5.1 8-17 DNAzyme and the catalytic beacon 
sensor. Black strand is the substrate strand 
containing the rA cleavage site. The green strand is 
the enzyme strand. F = FAM, Q = BHQ1.  
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under different conditions against a number of targets.42-45 A recent comparison between these 8-
17 variants showed substantially higher activity in the presence of Pb2+.46,47 Although being 
highly selective for Pb2+, the 8-17 variants are still active when their original targets are present at 
higher concentrations, such as Zn2+ and Mg2+. Further biochemical studies demonstrated the 
DNAzyme is also active with some other divalent ions, such as Mn2+, Co2+, Ca2+, and etc... At 
millimolar concentration, Zn2+ is shown to as active as Pb2+ and Mn2+ and Co2+ are only an order 
of magnitude slower than Pb2+.48,49 As a result, presence of these metal ions can potentially 
interfere with the sensor function and this interference from other divalent metal ions cannot be 
eliminated unless a different and more selective DNAzyme is found. 
5.1.3 GR-5 DNAzyme 
Surprisingly, the GR-5 DNAzyme (as no name was given to this DNAzyme when it’s 
isolated, we have named it GR-5 DNAzyme for convenience) selected was using Pb2+ as the 
cofactor more than a decade ago by Ronald Breaker and Gerald Joyce.39 The selection was 
carried out with 500 mM NaCl, 500 mM KCl, 50 mM MgCl2, 50 mM HEPES (pH 7.0 at 23 ºC). 
Similar to the 8-17 DNAzyme, the Pb2+ dependent GR-5 DNAzyme can catalyze the cleavage of 
an internal RNA base embedded in the DNA substrate in the presence of Pb2+. There is little 
biochemical studies on this DNAzyme and it holds a potential to be a better DNAzyme than the 
8-17 for Pb2+ sensing.  
5.2 Materials and methods 
5.2.1 Materials 
All DNA was synthesized and HPLC purified by Integrated DNA Technologies, Inc. 
Ultrapure NaHEPES, NaMES and Tris were purchased from Sigma-Aldrich. Ultrapure 
hydrochloric acid and metal salts (puratonic®) were purchased from Alfa Aesar. T4 
polynucleotide kinase was purchased from Invitrogen.  
5.2.2 Methods 
5.2.2.1 Activity assays for GR-5 DNAzyme 
The substrate was labeled with [γ-32P]-ATP on the 5ꞌ termini using T4 polynucleotide 
kinase (Invitrogen). The enzyme and substrate were first heated to 80 °C and slowly cooled to 
room temperature in about 45 mins. Before starting the activity assay, 2.5 μL DNA solution was 
taken out and added to 17.5 μL stop solution (50 mM EDTA, 8 M urea, 90 mM boric acid, 0.05% 
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xylene cyanol, and 0.05% bromophenol blue).To initiate the reaction, equal volume of 2X metal 
solution was mixed with the enzyme-substrate complex. At each time point, 5 μL of DNA was 
taken out and added into the stop solution. The final condition for the activity assay was: 5 μM 
enzyme, 5 nM substrate, 0.5 M NaCl, 0.5 M KCl, 50 mM MgCl2, and 50 mM HEPES at pH 7.0. 
The reaction product was resolved on an 8 M urea 20% polyacrylamide gel and quantified on a 
Molecular Dynamics Storm 430 phosphorimager (Amersham Biocsciences). The percent 
cleavage versus time was fitted to an exponential decay function in Origin to obtain the kobs. 
5.2.2.2 Fluorescence sensor based on the GR-5 DNAzyme 
Fluorescence measurement was carried out on a Fluoromax-2 (HORIBA Jobin Yvon inc., 
Edison, NJ) fluorometer using the constant wavelength analysis mode with excitation at 473 nm 
and emission at 520 nm.  
For observing the Pb2+ dependence, the fluorescence signal at 520 nm was monitored 
when various concentration of Pb2+ was added to 10 nM of the sensor for duration of six minutes. 
The total volume of the sensing solution was 500 μL. Data was collected at ten second intervals. 
A trace of F/F0 vs. time was generated for each concentration of Pb2+. Pb2+ concentration tested 
for the GR-5 DNAzyme based sensor were 0 nM, 10 nM, 25 nM, 50 nM, 75 nM, 100 nM, 200 
nM, 500 nM, 1 μM and 2 μM. For +5_17E sensor, Pb2+ concentrations at 0 nM, 50 nM, 100 nM, 
200 nM, 300 nM, 500 nM, 700 nM, 1 μM and 2 μM were tested.   
For the selectivity, the background fluorescence before addition of metal ions was 
monitored for 10s (2 data acquisition/s), followed by addition of various metal ions (5 μL) at 
different concentrations (total volume 500 μL). After six minutes, the fluorescence was measured 
the same way as the background fluorescence. The final F/F0 was plotted for each metal ion. 
Metal ions tested included Zn2+, Mn2+, Cd2+, Co2+, Ni2+, Ca2+, Ba2+, Cu2+, Sr2+ and Hg2+ with 
concentrations at 4 μM, 40 μM, 400 μM and 1mM. Pb2+ was tested at 25 nM, 50 nM, 1 μM and 2 
μM.  
For the initial rate measurements, the fluorescence was monitored for 30s after addition 
of various concentrations of Pb2+. Data was collected at 2s intervals. The initial rates were 
obtained by linear fitting the data in Excel. 
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5.3 Result and discussion 
5.3.1 GR-5 DNAzyme has excellent selectivity for Pb2+  
Selected more than a decade ago, The selection was carried out with 500 mM NaCl, 500 
mM KCl, 50 mM MgCl2, 50 mM HEPES (pH 7.0 at 23 ºC).14 Similar to the 8-17 DNAzyme, this 
classic DNAzyme can also catalyze the cleavage of an internal RNA base embedded in the DNA 
substrate in the presence of Pb2+. To find out if this DNAzyme has a higher selectivity for Pb2+ 
over other competing metal ions, metal ion-dependent activity assays on this DNAzyme have 
been carried out.  
Under single turnover conditions, the kobs was measured to be 0.6369 min-1 for 100 μM 
Pb2+ in HEPES buffer (500 mM NaCl, 500 mM KCl, 50 mM MgCl2 at pH 7.0). In constrast, 
under the same conditions, the kobs was measued to be 0.0141 min-1 for 20 mM Zn2+, and no other 
metal ions surveyed has a kobs better than 0.0034 min-1 (Table 5.1 and Figure 5.2). Presence of 
different concentrations of Na+ and Mg2+ has not significant effect on the catalytic activity of the 
GR-5 DNAzyme. Based on these results, a catalytic beacon based on the GR-5 DNAzyme was 
developed and tested.  
 
Metal ion kobs (min-1) 
50 M Pb2+ 0.3204±0.0157 
100 M Pb2+ 0.6369±0.0984 
20 mM Zn2+ 0.0141±0.0029 
20 mM Ba2+ 0.0034 
20 mM Ca2+ not detected 
20 mM Sr2+ not detected 
20 mM Cd2+ not detected 
20 mM Mn2+ not detected 
20 mM Co2+ not detected 
20 mM Hg2+ not detected 
Table 5.1 Rate constants of the GR-5 DNAzyme in the 
presence of various metal ions at pH 7.0 
 123 
 
 
 
5.3.2 GR-5 catalytic beacon is an excellent sensor for Pb2+ detection  
5.3.2.1 Design of the GR-5 catalytic beacon 
The design of the GR-5catalytic beacon is very similar to the 8-17 DNAzyme catalytic 
beacons. Two BHQ1 (Q) quenchers are covalently attached to the 3ʹ ends of both the substrate 
and the enzyme; a fluorescent group, FAM, is attached to the 5ʹ end of the substrate. When Pb2+ is 
present, the enzyme catalyzes the cleavage of the embedded RNA phosphodiester bond. After 
cleavage, the basepairing between the enzyme and substrate is weaker; hence, the cleaved 
substrate is dehybridized and released. Once released, the fluorophore is no longer quenched by 
the quencher and can generate a detectable fluorescent signal (Figure 5.3 and 5.1).  
The performance of the new GR-5 catalytic beacon was tested and compared to the 8-17 
DNAzyme based catalytic beacon.  
  
Figure 5.2 Initial selectivity assay on the GR-5 Pb2+ DNAzyme. A DNA substrate containing an internal 
RNA base is 5′ labeled with γ-[32P]-ATP. The enzyme (5 μM) substrate (5 nM) (ES) complex is prepared in 500 mM NaCl, 500 
mM KCl, 50 mM MgCl2, in 50 mM HEPES at pH 7. The complex is heated to 80 ºC and slowly cooled to room temperature over 
an approximately 45 minute time period. To start the reaction, an equal volume of each respective metal ion (2X the target 
concentration) is mixed with the annealed ES complex. At each time point, a 5 μL aliquot is withdrawn and the reaction is 
stopped with 15 μL of stop solution (8M urea, 50 mM EDTA, 90 mM Tris, 90 mM boric acid, 0.05% xylene cyanol, and 0.05% 
bromophenol blue). The cleaved substrate is separated from the uncleaved by 20% PAGE and quantified by a Molecular 
Dynamics Storm 430 phosphorimager (from Amersham Biosciences). The rate of reaction was obtained by fitting the curves to 
an exponential decay function using Origin Pro 8. 
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5.3.2.2 Selectivity of the 8-17 catalytic beacon 
To fairly compare the selectivity of the GR-5 and 8-17 DNAzyme based catalytic 
beacons, the 8-17 DNAzyme sensor was re-assessed, albeit numerous studies have been 
published previously. To test the performance of the s 8-17 sensor, reported optimal condition 
was used: 50 mM NaHEPES, 50 mM NaCl at pH 7.2. A range of metal ions have been tested, 
including Zn2+, Mn2+, Cd2+, Co2+, Ni2+, Ca2+, Ba2+, Sr2+, Cu2+ and Hg2+. Concentrations from 4 
µM to 1 mM of these metal ions have been tested. Pb2+ concentration ranges from 25 nM to 2 µM 
was tested with the 8-17 DNAzyme sensor.  
About eight fold fluorescent enhancement (F/F0) was observed with 2 µM Pb2+ and 25 
nM Pb2+ did not generate an observable fluorescent enhancement. This is consistent with results 
previously reported. However, the results (in Figure 5.4) have shown large interference can be  
observed from a range of metal ions (for example, Zn2+, Mn2+, Cd2+, Co2+) at higher concentration 
(> 40 µM). At > 400 µM Zn2+ and Co2+, the fluorescence enhancement was comparable to that of 
2 µM Pb2+. To a lesser degree, presence of Mn2+ and Cd2+ at concentrations > 40 µM can cause a 
significant interference. Much less activity was observed for Ni2+, Ca2+, Ba2+, Sr2+ and Hg2+, 
which have less than 1 fold enhancement even at 1 mM. In some practical application, where 
many of these interfering metal ions can exist in much high concentration than Pb2+, the 8-17 
DNAzyme catalytic beacon will not be suitable. 
 
Figure 5.3 Design of the GR-5 catalytic beacon 
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5.3.2.3 Optimization of the GR-5 catalytic beacon 
The sensing conditions have been optimized before testing the performance of the GR-5 
catalytic beacon. The salt concentration, pH and Mg2+ have been optimized to ensure the best 
performance of the GR-5 catalytic beacon.  
The salt concentration was first optimized and as shown in Figure 5.5 (left panel). 
Increasing concentrations of Na+ have been tested to obtain optimal performance in the presence 
of 2 µM Pb2+. From the results, 0.1 M Na+ combined with 5 mM Mg2+ gave the highest 
fluorescence enhancement. After finding the optimal salt condition, the pH was optimized by 
testing the GR-5 catalytic beacon at different pHs (right panel). Similar to the 8-17 DNAzyme 
sensor, pH of 7.26 was found to be optimal for the GR-5 sensor with 2 µM of Pb2+. Last, a range 
of Mg2+ concentrations were tested. Higher concentration resulted in slower enhancement of 
fluorescence (lower panel). Based on the above results, the final sensing condition for the GR-5 
catalytic beacon was determined to be 50 mM NaHEPES, 50 mM NaCl, 5 mM MgCl2 at pH 7.26. 
 
Figure 5.4 Selectivity of 8-17 catalytic beacon in the presence of various metal ions. 
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5.3.2.4 Selectivity of the GR-5 catalytic beacon 
Similar to the 8-17 DNAzyme sensor, the GR-5 catalytic beacon was tested for selectivity 
using the same set of metal ions at the same concentrations. As shown in the Figure 5.6, first the 
GR-5 sensor has a higher fluorescence enhancement comparing to the 8-17 DNAzyme sensor 
(~23 versus ~8). The higher signal can be explained by the lower background of the GR-5 sensor, 
due to the presence of Mg2+ in the buffer, as Mg2+ can increase the stability of hybridized DNA. 
Second, and the most important, the GR-5 catalytic beacon has a much higher selectivity than the 
8-17 DNAzyme sensor. As shown in Figure 5.6, the GR-5 catalytic beacon almost did not 
respond to any metal ions tested except for Pb2+. Up to 1 mM, only Zn2+ and Cu2+ can only 
generate an approximate two fold fluorescence enhancement. 
 
 
Figure 5.5 Optimizations for the new lead sensor, in 50 mM NaHEPES. In each 
activity assay, 2 μM Pb2+ was used. (a) Salt dependence, pH 7.0 (b) pH dependence, 
0.1 M Na+, 5 mM Mg2+ (c) Mg2+ dependence, 0.1 M Na+ pH 7.26. 
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To demonstrate the suitability for real world application, where multiple metal ions 
species can be present, the GR-5 catalytic beacon was tested in a metal soup (Figure 5.6 inset), 
which contained a mixture of 100 μM Zn2+, Mn2+, Cd2+, Co2+, Ni2+, Ca2+, Sr2+, and Ba2+. In the 
absence of Pb2+, the GR-5 catalytic has a background which is close to the blank and addition of 
100 nM Pb2+ resulted in a five-fold fluorescence enhancement. The 8-17 DNAzyme sensor has 
also subjected to the same test and in the absence of the target Pb2+, the 8-17 sensor has a four-
fold fluorescence enhancement. With the addition of 100 nM Pb2+, the 8-17 sensor gives a five-
fold signal enhancement and this enhancement is similar to that of the metal soup only. From this 
result, it clearly demonstrates the GR-5 catalytic beacon has a much higher selectivity than the 8-
17 DNAzyme sensor.  
 
5.3.2.5 Sensitivity of the 8-17 and GR-5 catalytic beacon 
Other than the selectivity, the sensitivity of the GR-5 sensor is also critical for its 
application in environmental detection of Pb2+ as a 72 nM detection limit is required to meet the 
EPA maximum contaminant level. To assess and compare the sensitivity of the two catalytic 
beacons, the time course fluorescence change was recorded in different concentrations of Pb2+.  
From the fluorescence trances (Figure 5.7 a, b), the presence of 25 nM Pb2+ can be differentiated 
from the background visually. For the 8-17 DNAzyme sensor, 50 nM can be differentiated 
visually. The GR-5 catalytic beacon has a faster kinetics as it reaches maximum fluorescence in 
less than one minute (2 µM Pb2+). However, for the 8-17 DNAzyme sensor, even after 150 s, it 
 
Figure 5.6 Selectivity of GR-5 catalytic beacon in the presence of various metal 
ions. 
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still has not reached the maximum. Fast kinetics can be beneficial for sensing application since 
less time is required to obtain results. The initial rates for both sensors have been measured and it 
is clearer that the GR-5 catalytic beacon is a faster sensor and it also has a wider linear range. 
From the linear region on the initial rate measurements, the limits of detection for both sensors 
have been calculated based on 3σ/slope. The GR-5 catalytic beacon has a LoD of 3.8 nM while 
that of the 8-17 sensor is 7.8 nM, which also agree with previous study. Both LoDs are much 
lower than the 72 nM maximum contamination level defined by the EPA.  
 
5.4 Conclusions 
In summary, a much more selective and slight more sensitive Pb2+ sensor has been 
developed based on the GR-5 DNAzyme. Other than catalytic beacon sensors, the “new” 
DNAzyme can also be applied in other sensing systems, such as colorimetric and electrochemical 
sensors for Pb2+ detection offering a higher selectivity and sensitivity.  
The high selectivity of the GR-5 DNAzyme can in part attribute to the selection has 
originally carried out with Pb2+ as the cofactor, while 8-17 DNAzymes are isolated with other 
 
Figure 5.7 Pb2+ response of the 8-17 DNAzyme sensor (a) and the GR-5 DNAzyme 
sensor (b). Initial rate profile of the 8-17 DNAzyme sensor (c) and the GR-5 
DNAzyme sensor (d). 
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(metal) cofactors. The selection buffer for the GR-5 DNAzyme contained a large amount of Mg2+ 
(50 mM), as a result, DNAzymes that are also active with Mg2+ and other metal ions with similar 
properties could be removed.  
 It is worthy to note, although the GR-5 and the 8-17 DNAzyme are very similar, the 
substrate does differ at several aspects. First, the GR-5 substrate contains three unpaired base 3ꞌ of 
the cleavage site, where the 8-17 DNAzyme only has a wobble pair. Second, the RNA base where 
the cleavage happens forms a basepair in the GR-5 DNAzyme while in the 8-17 DNAzyme, it is 
unpaired.  Currently, it is less certain whether these features play a role in the high selectivity 
observed for the GR-5 DNAzyme, but future investigations can help to answer these questions.   
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